Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",A1BG,Alpha-1B-glycoprotein,2126,59,1.45 [0.32-6.69],0.6321077145353505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AAMDC,Mth938 domain-containing protein,2059,54,0.82 [0.49-1.39],0.4670780878870575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AARSD1,Alanyl-tRNA editing protein Aarsd1,2439,83,0.70 [0.49-1.01],0.054178862915401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABCA2,ATP-binding cassette sub-family A member 2,2060,56,3.43 [2.24-5.26],1.3968322605141224e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABHD14B,Protein ABHD14B,2431,83,0.97 [0.67-1.39],0.8548117251038161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABL1,Tyrosine-protein kinase ABL1,2439,83,1.35 [1.03-1.77],0.0308023102588933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABO,Histo-blood group ABO system transferase,2130,61,0.89 [0.76-1.05],0.1791455405259359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ABRAXAS2,BRISC complex subunit Abraxas 2,2060,56,1.13 [0.75-1.68],0.5630876173425212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",2383,81,1.30 [1.06-1.61],0.0130618115890952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",2091,58,1.21 [0.89-1.65],0.2301467447293285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",2122,60,0.70 [0.51-0.94],0.0193624965232334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACAN,Aggrecan core protein,2430,81,3.19 [1.60-6.34],0.0009560812906392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE,Angiotensin-converting enzyme,2130,61,2.28 [0.98-5.32],0.0562577921716948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACE2,Angiotensin-converting enzyme 2,2415,83,0.90 [0.67-1.22],0.5062635637572562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACHE,Acetylcholinesterase,2085,56,1.38 [0.72-2.66],0.3303081590531231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOT13,Acyl-coenzyme A thioesterase 13,2124,60,0.87 [0.70-1.09],0.2225672543749294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,2457,82,0.93 [0.63-1.37],0.7057838863668746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP1,Low molecular weight phosphotyrosine protein phosphatase,2062,59,0.45 [0.24-0.86],0.0153892634194155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP5,Tartrate-resistant acid phosphatase type 5,2473,84,2.74 [1.67-4.50],7.033010427161588e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACP6,Lysophosphatidic acid phosphatase type 6,2472,84,2.11 [1.45-3.08],9.759643182538618e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRBP,Acrosin-binding protein,2117,60,0.80 [0.41-1.56],0.5179714432908753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACRV1,Acrosomal protein SP-10,2062,59,1.45 [1.19-1.77],0.0002088464083366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACSL1,Long-chain-fatty-acid--CoA ligase 1,2060,56,1.07 [0.50-2.26],0.865941827877091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTA2,"Actin, aortic smooth muscle",2415,83,2.65 [2.20-3.19],1.4290302712850148e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN2,Alpha-actinin-2,2060,56,1.51 [1.10-2.07],0.0107175594134343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACTN4,Alpha-actinin-4,2404,82,1.65 [1.18-2.31],0.003440484616504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACVRL1,Serine/threonine-protein kinase receptor R3,2433,83,13.91 [9.57-20.23],3.3964797536289324e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY1,Aminoacylase-1,2457,82,0.78 [0.59-1.03],0.0857332561914945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,2060,56,2.00 [1.40-2.84],0.0001283817843526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ACYP1,Acylphosphatase-1,2081,55,0.71 [0.48-1.06],0.0978374755662806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA,Adenosine deaminase,2490,84,0.97 [0.56-1.66],0.9010736613657576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADA2,Adenosine deaminase 2,2443,83,3.18 [2.32-4.36],8.01518583935901e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,2062,59,4.38 [3.05-6.29],1.1883948727933354e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,2415,83,2.45 [1.36-4.44],0.0029733554814338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,2437,83,10.39 [6.55-16.49],2.803668106707724e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,2490,84,15.49 [8.25-29.10],1.5795824628724518e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,2473,84,3.93 [2.57-6.03],3.2537693897960177e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,2124,60,8.62 [5.95-12.48],4.290695417893518e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,2062,59,3.83 [2.06-7.11],2.138595700235204e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,2490,84,0.67 [0.33-1.39],0.282680197492075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,2439,83,3.56 [2.64-4.80],8.100219841803001e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,2415,83,1.78 [1.22-2.60],0.0027032159897086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,2062,59,2.27 [1.29-3.98],0.004284435063974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,2456,83,1.08 [0.71-1.64],0.710320051261121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL2,ADAMTS-like protein 2,2130,58,2.67 [1.56-4.57],0.0003361584419277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL4,ADAMTS-like protein 4,2059,54,0.90 [0.31-2.62],0.851716262028676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADAMTSL5,ADAMTS-like protein 5,2122,60,2.16 [1.38-3.39],0.0007775231226129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,2383,81,0.90 [0.46-1.74],0.7535507047243694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADD1,Alpha-adducin,2085,56,0.58 [0.40-0.84],0.0036382686758877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRB3,Adhesion G protein-coupled receptor B3,2433,83,11.06 [6.78-18.03],5.439811414781244e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRD1,Adhesion G-protein coupled receptor D1,2085,56,1.96 [1.14-3.37],0.0146554579490257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE1,Adhesion G protein-coupled receptor E1,2124,60,2.51 [1.74-3.60],6.822137713548071e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE2,Adhesion G protein-coupled receptor E2,2472,83,8.76 [5.07-15.13],7.547651188217294e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRE5,Adhesion G protein-coupled receptor E5,2480,84,5.68 [3.72-8.68],9.989866258175611e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRF5,Adhesion G protein-coupled receptor F5,2122,60,2.41 [0.93-6.28],0.0705230623344108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG1,Adhesion G-protein coupled receptor G1,2439,83,1.35 [1.16-1.58],0.0001270205646406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRG2,Adhesion G-protein coupled receptor G2,2457,82,0.34 [0.18-0.64],0.0007588845855461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADGRV1,Adhesion G-protein coupled receptor V1,2061,56,1.05 [0.73-1.52],0.7887326958097293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH1B,All-trans-retinol dehydrogenase,2085,56,0.90 [0.67-1.21],0.4866295753184694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,2415,83,0.81 [0.64-1.01],0.0580364107004987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADIPOQ,Adiponectin,2126,59,1.21 [0.86-1.69],0.2667757773174211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADM,Pro-adrenomedullin,2475,84,38.48 [20.06-73.81],4.691564163978379e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ADRA2A,Alpha-2A adrenergic receptor,2060,56,0.71 [0.43-1.19],0.1989200555382176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFAP1,Actin filament-associated protein 1,2085,56,1.04 [0.76-1.43],0.7989287213931318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFM,Afamin,2126,59,0.15 [0.06-0.36],2.248798308049016e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AFP,Alpha-fetoprotein,2430,83,0.47 [0.34-0.64],2.499811449574679e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGBL2,Cytosolic carboxypeptidase 2,2061,56,0.99 [0.76-1.28],0.9243627826970716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGER,Advanced glycosylation end product-specific receptor,2459,83,4.35 [2.97-6.38],5.4478661917350304e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR2,Anterior gradient protein 2 homolog,2375,79,1.62 [1.36-1.93],6.892068033803403e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGR3,Anterior gradient protein 3,2378,81,1.39 [1.01-1.91],0.0440408532277377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRN,Agrin,2472,83,5.53 [4.10-7.44],2.042838434355585e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGRP,Agouti-related protein,2490,84,3.09 [2.10-4.56],1.2431711015852886e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGT,Angiotensinogen,2130,61,1.42 [0.53-3.84],0.4870530883050207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AGXT,Serine--pyruvate aminotransferase,2457,82,1.27 [1.02-1.59],0.0364080978065903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHCY,Adenosylhomocysteinase,2457,82,0.93 [0.69-1.25],0.6158271442744341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK,Neuroblast differentiation-associated protein AHNAK,2059,54,3.38 [1.96-5.81],1.0798346162628548e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHNAK2,Protein AHNAK2,2059,54,3.28 [2.15-4.99],3.303643735287241e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,2117,60,0.62 [0.37-1.03],0.0634445287461181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSG,Alpha-2-HS-glycoprotein,2130,61,0.92 [0.39-2.16],0.8431400798210199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AHSP,Alpha-hemoglobin-stabilizing protein,2460,84,0.75 [0.60-0.95],0.0145718747400895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIDA,"Axin interactor, dorsalization-associated protein",2076,58,1.03 [0.77-1.38],0.8390337894223375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1,Allograft inflammatory factor 1,2383,81,1.07 [0.74-1.56],0.7120832590974975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIF1L,Allograft inflammatory factor 1-like,2059,54,1.49 [1.03-2.13],0.032081656825749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",2436,83,1.09 [0.91-1.31],0.3257405285279958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK1,Adenylate kinase isoenzyme 1,2457,82,0.61 [0.45-0.85],0.0027879550134766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AK2,"Adenylate kinase 2, mitochondrial",2116,60,0.91 [0.71-1.15],0.4080686745935399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKAP12,A-kinase anchor protein 12,2085,56,3.51 [0.93-13.31],0.0645815629744683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B1,Aldo-keto reductase family 1 member B1,2383,81,0.93 [0.71-1.21],0.5842677513531651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1B10,Aldo-keto reductase family 1 member B10,2076,58,1.17 [0.89-1.55],0.2654503465624386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR1C4,Aldo-keto reductase family 1 member C4,2415,83,1.85 [1.40-2.45],1.778813567538963e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKR7L,Aflatoxin B1 aldehyde reductase member 4,2062,59,1.16 [0.85-1.60],0.3502927485676463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT1S1,Proline-rich AKT1 substrate 1,2393,81,0.76 [0.56-1.02],0.0716452942657213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT2,RAC-beta serine/threonine-protein kinase,2118,60,0.87 [0.72-1.05],0.1447457939208935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AKT3,RAC-gamma serine/threonine-protein kinase,2368,81,0.87 [0.62-1.24],0.4510411546848183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALCAM,CD166 antigen,2490,84,15.10 [7.02-32.49],3.761615455060609e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH1A1,Retinal dehydrogenase 1,2467,84,0.67 [0.48-0.92],0.0147186504730536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH2,"Aldehyde dehydrogenase, mitochondrial",2117,60,1.17 [0.81-1.68],0.4033743842833079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",2458,84,0.89 [0.70-1.13],0.3313836787420023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",2118,60,1.56 [0.98-2.48],0.061581664931506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALMS1,Alstrom syndrome protein 1,2091,58,1.37 [0.85-2.19],0.1953369737637894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPI,Intestinal-type alkaline phosphatase,2062,59,1.16 [0.96-1.40],0.1238155165461781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ALPP,"Alkaline phosphatase, placental type",2439,83,1.04 [0.87-1.24],0.6697425425550156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBN,Ameloblastin,2404,82,1.16 [0.63-2.12],0.6379209620556934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMBP,Protein AMBP,2473,84,45.91 [24.65-85.52],1.7593943780681436e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,2130,58,0.75 [0.28-1.97],0.5565419997373353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMFR,E3 ubiquitin-protein ligase AMFR,2393,81,1.24 [0.92-1.68],0.1603827804686887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO1,Amphoterin-induced protein 1,2076,58,0.72 [0.39-1.33],0.291747324780202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMIGO2,Amphoterin-induced protein 2,2439,83,1.96 [0.90-4.25],0.0895119784961616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMN,Protein amnionless,2404,82,1.95 [1.31-2.89],0.0010242912835949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOT,Angiomotin,2085,56,0.72 [0.37-1.39],0.3311596197038981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMOTL2,Angiomotin-like protein 2,2108,58,1.39 [0.91-2.13],0.1270412698027397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMPD3,AMP deaminase 3,2116,60,0.80 [0.57-1.12],0.2005950722614007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,2002,55,1.03 [0.64-1.66],0.9064754393956994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2A,Pancreatic alpha-amylase,2379,80,1.47 [1.03-2.11],0.0349071408819097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AMY2B,Alpha-amylase 2B,2307,78,1.45 [1.02-2.07],0.0399936360093279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANG,Angiogenin,2455,83,3.86 [2.49-5.98],1.7315539437305247e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT1,Angiopoietin-1,2451,83,0.91 [0.72-1.13],0.3916378955598435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPT2,Angiopoietin-2,2475,84,4.02 [2.71-5.96],4.559476074732578e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL1,Angiopoietin-related protein 1,2415,80,3.94 [2.12-7.33],1.506008026101968e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL2,Angiopoietin-related protein 2,2461,83,1.66 [1.05-2.62],0.0307578913164802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL3,Angiopoietin-related protein 3,2460,83,1.97 [1.19-3.25],0.008009643994096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL4,Angiopoietin-related protein 4,2471,83,5.15 [3.46-7.65],5.29466831796589e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANGPTL7,Angiopoietin-related protein 7,2475,84,2.98 [1.97-4.52],2.542811249489719e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANK2,Ankyrin-2,2060,56,0.99 [0.67-1.46],0.9430143579394804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,2062,59,0.89 [0.65-1.21],0.4574520643653944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRA2,Ankyrin repeat family A protein 2,2044,59,0.96 [0.61-1.51],0.8658378374704153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANKRD54,Ankyrin repeat domain-containing protein 54,2383,81,1.04 [0.76-1.41],0.8193796129131514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,2059,54,0.59 [0.24-1.43],0.2387094801842497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANPEP,Aminopeptidase N,2459,83,1.66 [0.88-3.14],0.1180287632132812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA1,Annexin A1,2073,56,0.81 [0.44-1.49],0.4889271219132911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA10,Annexin A10,2393,81,1.37 [1.13-1.66],0.0016092816699977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA11,Annexin A11,2457,84,0.80 [0.60-1.05],0.106584999969356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA2,Annexin A2,2027,54,1.16 [0.82-1.64],0.4112201385320936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA3,Annexin A3,2473,84,0.83 [0.63-1.10],0.1897593985780682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA4,Annexin A4,2445,82,0.73 [0.55-0.98],0.0337551929587231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ANXA5,Annexin A5,2385,80,3.10 [2.24-4.28],7.37047488427515e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC1,Amiloride-sensitive amine oxidase [copper-containing],2404,82,0.93 [0.64-1.36],0.7150872199447058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AOC3,Membrane primary amine oxidase,2464,83,10.09 [5.73-17.77],1.1204391272511997e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP1G2,AP-1 complex subunit gamma-like 2,2117,60,1.09 [0.80-1.48],0.5824072219236818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP2B1,AP-2 complex subunit beta,2076,58,0.82 [0.47-1.44],0.4932544865195698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3B1,AP-3 complex subunit beta-1,2124,60,1.15 [0.83-1.59],0.3953243116331517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AP3S2,AP-3 complex subunit sigma-2,2116,60,1.41 [0.87-2.29],0.1609853430993687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,2439,83,1.44 [1.01-2.06],0.0420032520349844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APCS,Serum amyloid P-component,2101,59,0.54 [0.26-1.15],0.1091696192095244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,2469,84,0.85 [0.61-1.19],0.3470434673566596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APLP1,Amyloid-like protein 1,2457,82,0.89 [0.61-1.29],0.5418396242300029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA1,Apolipoprotein A-I,2126,59,0.21 [0.08-0.53],0.0009254698145825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA2,Apolipoprotein A-II,2130,61,3.08 [2.01-4.72],2.548802281108101e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOA4,Apolipoprotein A-IV,2126,59,5.49 [3.54-8.52],2.9749805165736315e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOB,Apolipoprotein B-100,2130,61,0.56 [0.20-1.58],0.2741539160805482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOBR,Apolipoprotein B receptor,2059,54,1.17 [0.62-2.21],0.6348018607671666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOC1,Apolipoprotein C-I,2121,59,0.35 [0.19-0.62],0.0003771656460747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOD,Apolipoprotein D,2041,57,0.52 [0.24-1.14],0.1021536924394029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOE,Apolipoprotein E,2126,59,0.79 [0.49-1.28],0.3398637424169088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOF,Apolipoprotein F,2130,61,1.66 [0.80-3.46],0.1755186432511329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOH,Beta-2-glycoprotein 1,2467,84,1.80 [1.19-2.73],0.005051858126149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOL1,Apolipoprotein L1,2130,61,0.59 [0.36-0.97],0.037263508532999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APOM,Apolipoprotein M,2464,83,0.38 [0.20-0.71],0.002540346133782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APP,Amyloid-beta precursor protein,2466,84,0.91 [0.68-1.22],0.5421082457797473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APPL2,DCC-interacting protein 13-beta,2085,56,0.85 [0.67-1.06],0.1487420563973851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",APRT,Adenine phosphoribosyltransferase,2435,83,0.91 [0.60-1.38],0.6710337214205448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARAF,Serine/threonine-protein kinase A-Raf,2091,58,1.19 [0.85-1.68],0.308982515446977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AREG,Amphiregulin,2439,83,4.24 [3.17-5.67],2.13881865528398e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARF6,ADP-ribosylation factor 6,2124,60,0.85 [0.68-1.07],0.1645511753323764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARFIP1,Arfaptin-1,2118,60,0.96 [0.66-1.39],0.8371732861126097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG1,Arginase-1,2423,83,0.53 [0.37-0.77],0.000796667834568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARG2,"Arginase-2, mitochondrial",2117,60,0.90 [0.48-1.71],0.7559837812589447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP1,Rho GTPase-activating protein 1,2383,81,0.69 [0.45-1.07],0.0993676690930411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP25,Rho GTPase-activating protein 25,2383,81,0.98 [0.70-1.37],0.9031068900327394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP30,Rho GTPase-activating protein 30,2091,58,1.31 [0.74-2.31],0.3484319027188332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP45,Rho GTPase-activating protein 45,2085,56,0.87 [0.63-1.20],0.3992151149845893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGAP5,Rho GTPase-activating protein 5,2044,59,1.17 [0.88-1.56],0.2766415304837249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF1,Rho guanine nucleotide exchange factor 1,2116,60,0.96 [0.72-1.28],0.7722905068232556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF10,Rho guanine nucleotide exchange factor 10,2118,60,0.98 [0.75-1.27],0.8561804746106378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF12,Rho guanine nucleotide exchange factor 12,2461,84,0.96 [0.80-1.16],0.6990817717291263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARHGEF5,Rho guanine nucleotide exchange factor 5,2061,56,1.42 [1.08-1.87],0.0118699553738863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID3A,AT-rich interactive domain-containing protein 3A,2061,56,1.48 [0.77-2.83],0.2348210663025823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARID4B,AT-rich interactive domain-containing protein 4B,2393,81,0.80 [0.47-1.35],0.3975187903662155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL13B,ADP-ribosylation factor-like protein 13B,2060,56,1.19 [0.84-1.67],0.3320302211389456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,2060,56,0.80 [0.40-1.58],0.5148264452098804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARMCX2,Armadillo repeat-containing X-linked protein 2,2061,56,1.11 [0.72-1.72],0.6238539661208957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNT,Aryl hydrocarbon receptor nuclear translocator,2404,82,1.26 [0.83-1.91],0.2814140586784492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,2060,56,1.07 [0.66-1.75],0.7796098008764606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSA,Arylsulfatase A,2467,84,0.81 [0.53-1.25],0.3471676431570927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARSB,Arylsulfatase B,2439,83,0.89 [0.63-1.27],0.5353635006048669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART3,Ecto-ADP-ribosyltransferase 3,2464,83,7.44 [5.26-10.53],9.090094893082304e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ART5,Ecto-ADP-ribosyltransferase 5,2061,56,1.37 [1.04-1.81],0.0231699761367624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ARTN,Artemin,2404,82,1.03 [0.64-1.66],0.9084554125345472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH1,Acid ceramidase,2117,58,1.20 [0.72-1.99],0.4793963831023323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASAH2,Neutral ceramidase,2437,83,0.85 [0.61-1.18],0.3271745842492059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR1,Asialoglycoprotein receptor 1,2437,83,7.62 [5.23-11.12],4.851542648596578e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASGR2,Asialoglycoprotein receptor 2,2130,61,18.77 [9.84-35.81],5.630462982690782e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPN,Asporin,2122,60,1.72 [0.79-3.76],0.1751253709291185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASPSCR1,Tether containing UBX domain for GLUT4,2118,60,0.86 [0.58-1.27],0.4374871479405348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASRGL1,Isoaspartyl peptidase/L-asparaginase,2059,54,0.82 [0.63-1.07],0.1444599897339518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ASS1,Argininosuccinate synthase,2060,56,1.04 [0.77-1.41],0.7871396607008703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF2,Cyclic AMP-dependent transcription factor ATF-2,2393,81,1.11 [0.84-1.46],0.4670069108659843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATF4,Cyclic AMP-dependent transcription factor ATF-4,2044,59,0.60 [0.27-1.32],0.2036321306769682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG16L1,Autophagy-related protein 16-1,2124,60,1.01 [0.75-1.35],0.9615575101427062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATG4A,Cysteine protease ATG4A,2383,81,0.67 [0.47-0.95],0.0240401481863289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATOX1,Copper transport protein ATOX1,2456,83,1.20 [0.90-1.60],0.2095427747723126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,2060,56,1.33 [0.85-2.08],0.2136854076192846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,2060,56,0.82 [0.34-1.98],0.654522765841653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,2060,56,1.21 [0.66-2.25],0.5382598566924135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP1B4,Protein ATP1B4,2044,59,1.05 [0.58-1.87],0.881498682173406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP2B4,Plasma membrane calcium-transporting ATPase 4,2060,56,0.94 [0.60-1.47],0.7825348961800682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5F1D,"ATP synthase subunit delta, mitochondrial",2060,56,1.05 [0.62-1.78],0.8605870644816475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5IF1,"ATPase inhibitor, mitochondrial",2472,83,0.97 [0.81-1.16],0.7081482382752406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP5PO,"ATP synthase subunit O, mitochondrial",2393,81,1.00 [0.63-1.59],0.9951971127332372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6AP2,Renin receptor,2383,81,1.94 [1.35-2.77],0.0002988802638525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1D,V-type proton ATPase subunit D,2439,83,1.16 [0.58-2.29],0.6778579556827148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1F,V-type proton ATPase subunit F,2389,81,0.72 [0.52-0.98],0.0397730194083529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G1,V-type proton ATPase subunit G 1,2059,54,0.74 [0.50-1.08],0.1203345601802274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATP6V1G2,V-type proton ATPase subunit G 2,2060,56,0.93 [0.69-1.26],0.6270866616925723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRAID,All-trans retinoic acid-induced differentiation factor,2124,60,1.06 [0.09-12.50],0.9635427693667394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATRN,"Attractin, Isoform 2",2126,59,0.72 [0.17-3.04],0.6509595726257338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN10,Ataxin-10,2393,81,0.99 [0.76-1.29],0.9219195255547988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2,Ataxin-2,2061,56,0.90 [0.69-1.15],0.3924869902644525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN2L,Ataxin-2-like protein,2118,60,0.88 [0.52-1.49],0.6286159643012101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ATXN3,Ataxin-3,2116,60,0.77 [0.52-1.16],0.2169677834195639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXIN1,Axin-1,2461,84,0.95 [0.78-1.16],0.6249072829154252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AXL,Tyrosine-protein kinase receptor UFO,2464,83,7.65 [4.35-13.43],1.445137961777782e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZI2,5-azacytidine-induced protein 2,2118,60,1.18 [0.77-1.81],0.4498644389858031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",AZU1,Azurocidin,2395,81,0.98 [0.76-1.26],0.8734990298317766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B2M,Beta-2-microglobulin,2126,59,9.54 [5.94-15.32],1.09404214327789e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,2060,56,0.63 [0.17-2.39],0.497422313790107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",2059,54,3.78 [1.88-7.62],0.0001968820207582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GALT1,"Beta-1,4-galactosyltransferase 1",2472,83,16.43 [10.84-24.91],1.157085981549024e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",B4GAT1,"Beta-1,4-glucuronyltransferase 1",2467,84,5.03 [2.26-11.20],7.508796016067165e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BABAM1,BRISC and BRCA1-A complex member 1,2062,59,0.64 [0.23-1.83],0.4080222795090255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BACH1,Transcription regulator protein BACH1,2461,84,0.86 [0.65-1.13],0.2875390247201752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG3,BAG family molecular chaperone regulator 3,2433,83,2.46 [1.55-3.91],0.0001323999200851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG4,BAG family molecular chaperone regulator 4,2062,59,1.46 [0.97-2.21],0.0694010084394057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAG6,Large proline-rich protein BAG6,2415,83,1.08 [0.64-1.83],0.7638205429080164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,2383,81,1.29 [1.00-1.66],0.0540066386587578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAMBI,BMP and activin membrane-bound inhibitor homolog,2383,81,3.77 [2.82-5.04],4.129002409327902e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BANK1,B-cell scaffold protein with ankyrin repeats,2461,84,0.89 [0.75-1.07],0.2086744640930839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAP18,Chromatin complexes subunit BAP18,2116,60,1.14 [0.83-1.58],0.4221370203623793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BATF,Basic leucine zipper transcriptional factor ATF-like,2076,58,1.01 [0.74-1.37],0.9557751012821708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BAX,Apoptosis regulator BAX,2387,80,1.01 [0.81-1.26],0.9221525306268608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAM,Basal cell adhesion molecule,2467,84,4.04 [1.92-8.49],0.0002275349426878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAN,Brevican core protein,2437,83,0.80 [0.47-1.36],0.4078178098447721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",2122,60,0.84 [0.37-1.91],0.6805748027238709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",2061,56,0.40 [0.19-0.85],0.0172875237977513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCHE,Cholinesterase,2089,60,0.69 [0.33-1.41],0.3030029989420186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2,Apoptosis regulator Bcl-2,2124,60,1.85 [1.43-2.38],2.6078320887213724e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L1,Bcl-2-like protein 1,2116,60,0.80 [0.62-1.03],0.0770673713136644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",2461,84,3.71 [2.15-6.42],2.7321497667595742e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL2L15,Bcl-2-like protein 15,2062,59,1.40 [1.03-1.89],0.0305416205131794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7A,B-cell CLL/lymphoma 7 protein family member A,2044,59,1.03 [0.70-1.50],0.8919472120495447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCL7B,B-cell CLL/lymphoma 7 protein family member B,2117,60,0.93 [0.51-1.69],0.8075944945890083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BCR,Breakpoint cluster region protein,2461,84,0.91 [0.73-1.12],0.3574791413339031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BDNF,Brain-derived neurotrophic factor,2130,58,1.06 [0.78-1.44],0.7075431031816799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BECN1,Beclin-1,2059,54,0.85 [0.53-1.36],0.5064734713143969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BEX3,Protein BEX3,2044,59,1.17 [0.73-1.88],0.5243918646280473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGLAP,Osteocalcin,2130,58,1.09 [0.84-1.40],0.5199542571604472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BGN,Biglycan,2381,81,1.02 [0.87-1.19],0.8378433230932032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHLHE40,Class E basic helix-loop-helix protein 40,2061,56,0.83 [0.55-1.26],0.3848857184157314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,2060,56,0.88 [0.31-2.54],0.8200384103731944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BID,BH3-interacting domain death agonist,2461,84,0.84 [0.62-1.13],0.2486709332448306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIN2,Bridging integrator 2,2467,84,0.89 [0.71-1.11],0.2868033073379737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BIRC2,Baculoviral IAP repeat-containing protein 2,2383,81,1.00 [0.72-1.37],0.9792503186094408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLMH,Bleomycin hydrolase,2490,84,0.75 [0.42-1.34],0.3314729776010711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLNK,B-cell linker protein,2062,59,1.30 [0.80-2.12],0.2954120084371196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,2061,56,0.91 [0.65-1.29],0.6114297453640153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,2116,60,0.78 [0.41-1.50],0.4623020096265285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BLVRB,Flavin reductase,2467,84,0.67 [0.49-0.92],0.0116339789031216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP10,Bone morphogenetic protein 10,2085,56,3.10 [1.80-5.35],4.611956122596989e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP4,Bone morphogenetic protein 4,2433,83,1.59 [1.14-2.24],0.0070217873344563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMP6,Bone morphogenetic protein 6,2414,83,1.26 [0.77-2.07],0.3517200939706345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BMPER,BMP-binding endothelial regulator protein,2085,56,7.74 [4.69-12.80],1.412584447282643e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,2122,60,0.46 [0.21-1.02],0.0563066645693037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,2062,59,2.00 [1.29-3.08],0.0018103746556157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOC,Brother of CDO,2415,83,10.29 [5.22-20.28],1.608469866497663e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA1,BolA-like protein 1,2061,56,1.37 [1.00-1.87],0.0522511046510327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BOLA2_BOLA2B,BolA-like protein 2,2059,54,0.55 [0.34-0.88],0.0128471402317066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFA2,BPI fold-containing family A member 2,1994,51,0.92 [0.72-1.17],0.4855051831439718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB1,BPI fold-containing family B member 1,2457,82,0.90 [0.67-1.21],0.4823301725812426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BPIFB2,BPI fold-containing family B member 2,2119,60,1.02 [0.73-1.43],0.9041837423037296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRAP,BRCA1-associated protein,2102,59,0.94 [0.75-1.18],0.6077626458639204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD1,Bromodomain-containing protein 1,2091,58,0.76 [0.30-1.91],0.5641722099914722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD2,Bromodomain-containing protein 2,2061,56,0.53 [0.21-1.31],0.1702664894736844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRD3,Bromodomain-containing protein 3,2060,56,0.87 [0.46-1.63],0.6602752883240872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRDT,Bromodomain testis-specific protein,2060,56,0.57 [0.28-1.17],0.1235286000643836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRK1,Protein BRICK1,2393,81,1.64 [1.08-2.49],0.019420968524575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRME1,Break repair meiotic recombinase recruitment factor 1,2061,56,0.61 [0.28-1.32],0.2134637803246627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BRSK2,Serine/threonine-protein kinase BRSK2,2118,60,1.47 [0.77-2.83],0.2454282340858562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSG,Basigin,2484,84,27.17 [15.93-46.34],7.680906872993596e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BSND,Barttin,2044,59,1.31 [0.71-2.41],0.3852620491857833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,2476,84,1.18 [0.75-1.84],0.468765245376249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BST2,Bone marrow stromal antigen 2,2476,84,1.75 [1.32-2.32],0.0001183585472052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTC,Probetacellulin,2383,81,1.06 [0.81-1.38],0.6596986340022772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTD,Biotinidase,2126,59,0.76 [0.24-2.39],0.6325323867464585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTLA,B- and T-lymphocyte attenuator,2044,59,1.12 [0.90-1.38],0.3025640147248903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN1A1,Butyrophilin subfamily 1 member A1,2114,60,1.03 [0.56-1.92],0.9159221690172132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN2A1,Butyrophilin subfamily 2 member A1,2472,83,14.79 [8.20-26.69],3.7465472983479767e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTN3A2,Butyrophilin subfamily 3 member A2,2461,84,5.62 [3.99-7.91],6.032470034768913e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",BTNL10,Butyrophilin-like protein 10,2044,59,1.39 [0.82-2.35],0.2260460656373769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C19orf12,Protein C19orf12,2393,81,0.85 [0.66-1.11],0.2396581942154691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1GALT1C1,C1GALT1-specific chaperone 1,2060,56,1.07 [0.53-2.17],0.8443283108954124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QA,Complement C1q subcomponent subunit A,2476,84,11.55 [5.51-24.23],9.582238284348463e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",2118,60,0.99 [0.68-1.44],0.9653383709127822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QL2,Complement C1q-like protein 2,2062,59,1.09 [0.61-1.94],0.7697295635767296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,2464,83,1.92 [1.46-2.52],3.092001690700488e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,2085,56,1.91 [0.96-3.77],0.0635031421387765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,2118,60,1.96 [1.04-3.70],0.0368623773121504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,2082,55,2.18 [1.20-3.96],0.0100964677257021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1R,Complement C1r subcomponent,2126,59,0.56 [0.12-2.74],0.475937558530692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1RL,Complement C1r subcomponent-like protein,2119,59,0.89 [0.26-3.01],0.8472537486756996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C1S,Complement C1s subcomponent,2126,59,1.05 [0.31-3.55],0.9421534625005829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2,Complement C2,2464,83,6.73 [2.53-17.90],0.0001326856002382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2CD2L,Phospholipid transfer protein C2CD2L,2389,81,2.10 [1.50-2.93],1.404508532724042e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C2orf69,UPF0565 protein C2orf69,2076,58,1.05 [0.66-1.68],0.8300629761899612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C3,Complement C3,2021,59,0.56 [0.28-1.13],0.1050652991695489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C4BPB,C4b-binding protein beta chain,2456,83,1.56 [0.99-2.48],0.0578306299093023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C5,Complement C5,2126,59,0.91 [0.17-5.01],0.9180481261195564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7,Complement component C7,2077,59,3.33 [1.72-6.46],0.0003740482989461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C7orf50,Uncharacterized protein C7orf50,2116,60,0.92 [0.28-3.04],0.8950277120350536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C8B,Complement component C8 beta chain,2126,59,0.94 [0.42-2.12],0.8789423461588712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9,Complement component C9,2130,61,1.07 [0.74-1.57],0.7125032084571031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",C9orf40,Uncharacterized protein C9orf40,2124,60,0.71 [0.52-0.97],0.031408264695028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA1,Carbonic anhydrase 1,2419,82,0.63 [0.45-0.88],0.0068254468243733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA11,Carbonic anhydrase-related protein 11,2383,81,1.33 [0.83-2.12],0.2317312876540617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA12,Carbonic anhydrase 12,2439,83,10.05 [6.98-14.48],2.9293117283539777e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA13,Carbonic anhydrase 13,2435,80,0.86 [0.72-1.04],0.1186300211619437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA14,Carbonic anhydrase 14,2475,84,5.35 [3.61-7.93],6.46398860488088e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA2,Carbonic anhydrase 2,2457,84,0.61 [0.46-0.81],0.0008058163886017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA3,Carbonic anhydrase 3,2488,84,1.66 [1.25-2.21],0.0004460121687494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA4,Carbonic anhydrase 4,2490,84,8.29 [4.28-16.08],3.72009760762915e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA5A,"Carbonic anhydrase 5A, mitochondrial",2415,83,1.43 [1.21-1.70],3.001332672862983e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA6,Carbonic anhydrase 6,2461,83,0.66 [0.49-0.89],0.0058570370451119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA7,Carbonic anhydrase 7,2091,58,0.99 [0.46-2.09],0.9701888533384444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA8,Carbonic anhydrase-related protein,2062,59,1.14 [0.45-2.91],0.7812682204876575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CA9,Carbonic anhydrase 9,2475,84,2.52 [1.93-3.29],1.0762755642424014e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CABP2,Calcium-binding protein 2,2076,58,0.91 [0.59-1.39],0.6562990541536243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,2061,56,0.70 [0.28-1.74],0.4473327681085001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,2060,56,1.12 [0.75-1.68],0.5852996189216314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,2061,56,1.22 [0.83-1.78],0.3171882068328963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,2118,60,1.03 [0.77-1.37],0.8636538419928236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CACYBP,Calcyclin-binding protein,2084,55,0.90 [0.69-1.15],0.3943153197525793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CADPS,Calcium-dependent secretion activator 1,2076,58,0.84 [0.41-1.71],0.6278846754700163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB1,Calbindin,2439,83,3.51 [2.59-4.76],6.823855210850175e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALB2,Calretinin,2393,81,4.68 [3.09-7.07],2.577735054661092e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCA,Calcitonin,2433,83,2.08 [1.69-2.56],3.362105374655452e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCB,Calcitonin gene-related peptide 2,2116,60,3.08 [2.37-3.99],3.683125815713665e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,2467,84,0.95 [0.79-1.15],0.6304382164292226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,2059,54,0.91 [0.64-1.31],0.6247555980948525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CALY,Neuron-specific vesicular protein calcyon,2060,56,0.68 [0.29-1.60],0.3771567390254144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,2383,81,1.16 [0.75-1.79],0.5144264092573098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,2076,58,1.20 [0.76-1.89],0.4295170444838201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,2118,60,1.03 [0.81-1.30],0.8358668653120657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CANT1,Soluble calcium-activated nucleotidase 1,2448,82,12.50 [5.29-29.51],8.277613977863488e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPG,Macrophage-capping protein,2435,83,2.06 [1.61-2.63],6.8636299283497525e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPN3,Calpain-3,2117,60,0.82 [0.41-1.65],0.5738119754350837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAPS,Calcyphosin,2116,60,1.20 [1.00-1.44],0.0461316080140926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CARHSP1,Calcium-regulated heat-stable protein 1,2393,81,0.63 [0.42-0.96],0.0301021127510177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASC3,Protein CASC3,2076,58,0.85 [0.46-1.57],0.6020114800133196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP1,Caspase-1,2393,81,0.96 [0.73-1.26],0.7792114755302952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP10,Caspase-10,2393,81,0.90 [0.69-1.18],0.4381814944588228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP2,Caspase-2,2461,84,0.83 [0.62-1.11],0.2100180175861241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP3,Caspase-3,2490,84,0.88 [0.70-1.09],0.2358473931639075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP4,Caspase-4,2091,58,0.96 [0.82-1.12],0.6168797790672944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP7,Caspase-7,2116,60,0.88 [0.65-1.20],0.4332594293049565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP8,Caspase-8,2470,84,0.93 [0.68-1.27],0.6567474430234717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASP9,Caspase-9,2062,59,0.88 [0.57-1.36],0.5616737816111204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CASQ2,Calsequestrin-2,2060,56,1.26 [0.74-2.13],0.3960435931061181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CAT,Catalase,2098,60,0.47 [0.30-0.75],0.0014542148354788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLIF,Cobalamin binding intrinsic factor,2457,82,1.75 [1.40-2.18],7.487244310182146e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN1,Cerebellin-1,2061,56,0.99 [0.72-1.36],0.9534591062571468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBLN4,Cerebellin-4,2475,84,0.61 [0.35-1.06],0.0769696198397725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBS,Cystathionine beta-synthase,2059,54,0.89 [0.56-1.41],0.6074058362132948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CBX2,Chromobox protein homolog 2,2060,56,0.94 [0.46-1.94],0.8707451539118058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,2437,83,0.99 [0.76-1.30],0.9527379136308256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCAR2,Cell cycle and apoptosis regulator protein 2,2116,60,1.13 [0.77-1.66],0.5394824945744947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC134,Coiled-coil domain-containing protein 134,2117,60,1.29 [0.77-2.16],0.3276724430025005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC28A,Coiled-coil domain-containing protein 28A,2076,58,0.78 [0.34-1.78],0.551990932561752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC50,Coiled-coil domain-containing protein 50,2118,60,1.26 [0.96-1.64],0.0899207310089397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCDC80,Coiled-coil domain-containing protein 80,2457,82,6.69 [4.65-9.61],1.1110804389372451e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,2059,54,2.10 [1.58-2.79],2.587342235203552e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL11,Eotaxin,2490,84,3.63 [2.28-5.79],6.091902965580605e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL13,C-C motif chemokine 13,2485,84,1.05 [0.79-1.39],0.7558803478790901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL14,C-C motif chemokine 14,2455,83,3.48 [2.60-4.66],5.088866124102695e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL15,C-C motif chemokine 15,2490,84,4.17 [3.05-5.71],4.256929094978071e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL16,C-C motif chemokine 16,2490,84,2.62 [1.84-3.74],1.0100837365925845e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL17,C-C motif chemokine 17,2462,83,1.12 [0.91-1.37],0.274202577405496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL18,C-C motif chemokine 18,2430,82,1.22 [0.97-1.54],0.0862133823213179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL19,C-C motif chemokine 19,2476,84,1.09 [0.95-1.24],0.225806465386314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL2,C-C motif chemokine 2,2433,83,1.65 [1.15-2.36],0.0061997302574095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL20,C-C motif chemokine 20,2490,84,1.54 [1.33-1.79],1.4134385056361369e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL21,C-C motif chemokine 21,2472,83,2.18 [1.70-2.80],1.269065785392206e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL22,C-C motif chemokine 22,2443,83,1.53 [1.10-2.13],0.0110670021570238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL23,C-C motif chemokine 23,2472,83,2.98 [1.96-4.53],3.376961302340668e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL24,C-C motif chemokine 24,2471,83,1.32 [1.05-1.66],0.0164508190880954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL25,C-C motif chemokine 25,2490,84,3.11 [2.17-4.46],6.541456822680491e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL26,C-C motif chemokine 26,2461,84,1.01 [0.82-1.23],0.9566347870195322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL27,C-C motif chemokine 27,2457,82,1.65 [1.19-2.28],0.0024661727163776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL28,C-C motif chemokine 28,2457,84,1.09 [0.79-1.50],0.6157141652546789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL3,C-C motif chemokine 3,2461,84,1.45 [1.24-1.70],4.521440972799555e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL4,C-C motif chemokine 4,2467,83,1.23 [0.97-1.56],0.0903852311193624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL5,C-C motif chemokine 5,2464,83,0.92 [0.76-1.11],0.4024896491329034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL7,C-C motif chemokine 7,2461,84,1.61 [1.21-2.15],0.0011381937369862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCL8,C-C motif chemokine 8,2473,84,1.77 [1.28-2.45],0.0005770385729413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN1,CCN family member 1,2437,83,1.26 [0.94-1.68],0.1232245761306157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN2,CCN family member 2,2461,83,1.26 [0.90-1.78],0.1806446835766407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN3,CCN family member 3,2484,84,6.94 [5.09-9.47],2.2331685313850113e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN4,CCN family member 4,2475,84,5.93 [4.16-8.45],6.890446457279679e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCN5,CCN family member 5,2467,84,7.60 [5.15-11.21],1.4920204853899241e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCND2,G1/S-specific cyclin-D2,2091,58,1.31 [0.66-2.59],0.4437802076663525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCNE1,G1/S-specific cyclin-E1,2062,59,1.02 [0.75-1.38],0.8977589497758085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCS,Copper chaperone for superoxide dismutase,2437,83,0.36 [0.23-0.56],4.719120706725574e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CCT5,T-complex protein 1 subunit epsilon,2383,81,0.61 [0.37-1.00],0.0502815934755236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD101,Immunoglobulin superfamily member 2,2124,60,1.17 [0.67-2.06],0.5774772149529874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD109,CD109 antigen,2467,84,3.27 [1.93-5.53],1.014663998529278e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD14,Monocyte differentiation antigen CD14,2417,82,5.63 [3.81-8.32],3.7914278377598455e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD160,CD160 antigen,2490,84,4.88 [3.74-6.37],2.5500151394944363e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD163,Scavenger receptor cysteine-rich type 1 protein M130,2464,83,1.95 [1.31-2.92],0.0011163137157053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164,Sialomucin core protein 24,2467,84,2.82 [1.99-4.00],6.228677652062378e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD164L2,CD164 sialomucin-like 2 protein,2076,58,1.27 [0.67-2.43],0.4604369054257106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD177,CD177 antigen,2460,84,1.15 [0.98-1.36],0.0905151628420906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD1C,T-cell surface glycoprotein CD1c,2456,83,0.67 [0.35-1.30],0.2393407629456839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2,T-cell surface antigen CD2,2060,56,1.57 [1.07-2.33],0.0227324405954492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200,OX-2 membrane glycoprotein,2461,84,4.24 [2.90-6.20],9.93055407713854e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD200R1,Cell surface glycoprotein CD200 receptor 1,2453,84,1.49 [0.88-2.52],0.1387877560657535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD207,C-type lectin domain family 4 member K,2393,81,5.45 [3.57-8.33],4.378271718484356e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD209,CD209 antigen,2471,83,2.50 [1.49-4.20],0.0005381540428362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD22,B-cell receptor CD22,2490,84,1.21 [0.78-1.86],0.3933735251752311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD226,CD226 antigen,2062,59,1.38 [0.77-2.46],0.2754774553929898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD244,Natural killer cell receptor 2B4,2490,84,3.72 [2.08-6.66],9.965080892027184e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD248,Endosialin,2130,58,3.50 [2.02-6.04],7.384349786731448e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD27,CD27 antigen,2456,83,7.58 [5.75-9.99],1.0564651151849895e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD274,Programmed cell death 1 ligand 1,2437,83,3.39 [2.54-4.53],1.5597729263530872e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD276,CD276 antigen,2462,83,9.77 [6.32-15.11],1.1659587434789981e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD28,T-cell-specific surface glycoprotein CD28,2383,81,3.20 [2.15-4.74],7.93512877353016e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD2AP,CD2-associated protein,2457,82,0.81 [0.60-1.11],0.2007635485213408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300A,CMRF35-like molecule 8,2085,56,17.90 [9.62-33.30],8.163900215722731e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300C,CMRF35-like molecule 6,2476,84,13.08 [8.60-19.90],3.092053538403261e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300E,CMRF35-like molecule 2,2469,84,6.54 [4.75-9.02],2.112779405947248e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LF,CMRF35-like molecule 1,2475,84,3.29 [2.42-4.49],5.148186247442095e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD300LG,CMRF35-like molecule 9,2467,84,7.37 [5.13-10.61],4.2559323288105576e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD302,CD302 antigen,2439,83,8.93 [6.51-12.27],1.0100077237289732e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD33,Myeloid cell surface antigen CD33,2456,83,1.08 [0.84-1.39],0.553125457380244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD34,Hematopoietic progenitor cell antigen CD34,2471,84,3.96 [1.87-8.40],0.0003212810575138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD36,Platelet glycoprotein 4,2062,59,1.67 [1.01-2.76],0.0461550912754081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,2439,83,8.34 [5.60-12.42],1.560555360209007e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3D,T-cell surface glycoprotein CD3 delta chain,2061,56,1.03 [0.44-2.39],0.9492928965719414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3E,T-cell surface glycoprotein CD3 epsilon chain,2091,58,0.52 [0.22-1.23],0.1352297616766308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD3G,T-cell surface glycoprotein CD3 gamma chain,2062,59,1.05 [0.82-1.35],0.6886392943125006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD4,T-cell surface glycoprotein CD4,2460,84,5.39 [3.86-7.55],7.179467706523162e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40,Tumor necrosis factor receptor superfamily member 5,2466,83,1.94 [1.45-2.60],7.981380603911647e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD40LG,CD40 ligand,2490,84,0.88 [0.70-1.12],0.3097690196715856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD46,Membrane cofactor protein,2446,83,10.53 [6.33-17.51],1.1655658743311356e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD48,CD48 antigen,2471,83,12.83 [7.57-21.75],2.6601196092611425e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5,T-cell surface glycoprotein CD5,2473,84,3.84 [2.95-4.98],7.126918105503492e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD55,Complement decay-accelerating factor,2374,77,5.90 [4.13-8.45],2.7318546474160375e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD58,Lymphocyte function-associated antigen 3,2455,83,7.09 [2.33-21.62],0.0005680557328501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD59,CD59 glycoprotein,2364,80,12.60 [8.49-18.71],2.866278892163409e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD5L,CD5 antigen-like,2114,59,1.98 [1.21-3.24],0.0067290966668646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD6,T-cell differentiation antigen CD6,2484,84,1.16 [0.79-1.68],0.4497108623568213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD63,CD63 antigen,2433,83,0.72 [0.49-1.08],0.1116091458541144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD69,Early activation antigen CD69,2446,82,0.85 [0.68-1.06],0.147424900212128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD7,T-cell antigen CD7,2056,59,4.35 [3.18-5.95],3.2787707650098314e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD70,CD70 antigen,2461,84,2.20 [1.51-3.20],3.543987362305687e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD72,B-cell differentiation antigen CD72,2085,56,4.15 [2.89-5.96],1.2010632241772252e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD74,HLA class II histocompatibility antigen gamma chain,2476,84,12.22 [8.27-18.08],4.518652545555267e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD79B,B-cell antigen receptor complex-associated protein beta chain,2490,84,6.10 [4.76-7.83],7.491140515434352e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD80,T-lymphocyte activation antigen CD80,2122,60,3.92 [2.27-6.78],9.913539939374313e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD82,CD82 antigen,2091,58,1.20 [0.78-1.86],0.4003616520557567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD83,CD83 antigen,2461,84,6.50 [4.43-9.54],1.1579539176930317e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD84,SLAM family member 5,2461,84,1.00 [0.55-1.82],0.9940784803331024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD86,T-lymphocyte activation antigen CD86,2124,60,1.27 [0.57-2.81],0.5534467914192647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD8A,T-cell surface glycoprotein CD8 alpha chain,2476,84,1.86 [1.36-2.55],0.0001072776440608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD93,Complement component C1q receptor,2385,79,9.23 [6.20-13.75],8.147169780544219e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99,CD99 antigen,2467,84,27.85 [14.64-52.98],3.664543196303516e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CD99L2,CD99 antigen-like protein 2,2467,84,16.60 [9.03-30.53],1.6166384365588294e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDA,Cytidine deaminase,2119,60,1.47 [0.97-2.22],0.0696787618073068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDAN1,Codanin-1,2116,60,0.54 [0.17-1.73],0.2984319539565169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC123,Cell division cycle protein 123 homolog,2044,59,0.88 [0.58-1.36],0.5736482282883986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC25A,M-phase inducer phosphatase 1,2044,59,0.58 [0.27-1.22],0.1503893510729094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC26,Anaphase-promoting complex subunit CDC26,2120,59,0.93 [0.63-1.36],0.6968895581713299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC27,Cell division cycle protein 27 homolog,2383,81,0.97 [0.70-1.35],0.8558421029114569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC37,Hsp90 co-chaperone Cdc37,2456,83,0.92 [0.72-1.16],0.4708963026109715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDC42BPB,Serine/threonine-protein kinase MRCK beta,2124,60,1.00 [0.78-1.27],0.9752448048689728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDCP1,CUB domain-containing protein 1,2437,83,1.34 [0.98-1.83],0.0626076723908474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH1,Cadherin-1,2376,78,3.02 [2.39-3.82],2.6320514511819687e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH15,Cadherin-15,2472,84,1.40 [1.15-1.70],0.0007305723331461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH17,Cadherin-17,2457,82,1.74 [1.37-2.20],4.128518402229105e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH2,Cadherin-2,2457,82,1.92 [1.27-2.88],0.0018097424259281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH22,Cadherin-22,2091,58,1.17 [0.47-2.90],0.7319811406456971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH23,Cadherin-23,2116,60,0.85 [0.31-2.32],0.7579384616494155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH3,Cadherin-3,2476,84,7.24 [5.20-10.08],8.608965354752532e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH4,Cadherin-4,2061,56,0.71 [0.37-1.36],0.3020147172680119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH5,Cadherin-5,2490,84,3.34 [1.85-6.01],6.0072502932562496e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDH6,Cadherin-6,2457,82,3.09 [1.98-4.81],6.436457913321289e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR1,Cadherin-related family member 1,2393,81,1.28 [0.88-1.86],0.1983194283171716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR2,Cadherin-related family member 2,2439,83,0.92 [0.68-1.24],0.5765932999721356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDHR5,Cadherin-related family member 5,2457,82,0.89 [0.54-1.47],0.6501861794910285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK1,Cyclin-dependent kinase 1,2044,59,0.61 [0.31-1.18],0.1417768298711981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,2118,60,1.27 [0.86-1.87],0.2252365887830485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKL5,Cyclin-dependent kinase-like 5,2061,56,0.81 [0.44-1.49],0.5066887563223441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN1A,Cyclin-dependent kinase inhibitor 1,2439,83,1.08 [0.90-1.30],0.3816784733874432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,2439,83,0.95 [0.77-1.16],0.5982142743382958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDNF,Cerebral dopamine neurotrophic factor,2439,83,2.05 [1.73-2.43],1.4016553659949906e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,2467,83,2.06 [1.01-4.22],0.0475626391336449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CDSN,Corneodesmosin,2480,84,4.98 [3.53-7.05],9.65651406213806e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,2452,83,2.30 [1.04-5.13],0.0408577414250044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,2124,60,0.77 [0.57-1.04],0.0866793141338187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,2091,58,0.83 [0.55-1.25],0.3706591892621595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,2124,60,3.36 [2.31-4.89],2.2396291346906542e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,2091,58,1.23 [0.73-2.08],0.4407315743787531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,2461,84,1.42 [1.16-1.73],0.0007673468357756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,2383,81,1.25 [0.87-1.79],0.2203810443651141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,2357,79,1.62 [1.21-2.16],0.0012891773143944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,2130,58,1.68 [0.96-2.95],0.0687022388768243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,2415,83,2.33 [1.69-3.21],2.0808126096013602e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPA,CCAAT/enhancer-binding protein alpha,2062,59,1.23 [0.67-2.27],0.4984251322927323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEBPB,CCAAT/enhancer-binding protein beta,2415,83,1.06 [0.65-1.74],0.8083234088690545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA2A,Chymotrypsin-like elastase family member 2A,2130,58,0.95 [0.67-1.33],0.7491423008333189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELA3A,Chymotrypsin-like elastase family member 3A,2486,84,0.95 [0.72-1.25],0.730501357556053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,2085,56,7.16 [3.93-13.04],1.1988956487866634e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEMIP2,Cell surface hyaluronidase,2062,59,1.82 [1.04-3.17],0.0349380528416688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEND1,Cell cycle exit and neuronal differentiation protein 1,2061,56,1.47 [1.15-1.86],0.0017187720573297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPF,Centromere protein F,2091,58,0.43 [0.25-0.74],0.0020237647266093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CENPJ,Centromere protein J,2091,58,0.97 [0.68-1.38],0.8575229435319636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP112,Centrosomal protein of 112 kDa,2060,56,1.01 [0.58-1.76],0.9646084904882946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP152,Centrosomal protein of 152 kDa,2044,59,1.46 [0.96-2.22],0.0784541978080403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP164,Centrosomal protein of 164 kDa,2404,82,1.12 [0.86-1.45],0.3936442944468248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP170,Centrosomal protein of 170 kDa,2059,54,0.83 [0.57-1.21],0.3291007902610177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP20,Centrosomal protein 20,2383,81,0.95 [0.73-1.24],0.7059619641926689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP290,Centrosomal protein of 290 kDa,2091,58,0.91 [0.55-1.52],0.7280713444942424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP350,Centrosome-associated protein 350,2044,59,0.88 [0.43-1.80],0.727651515377513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP43,Centrosomal protein 43,2398,81,0.81 [0.60-1.08],0.1530975221432697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CEP85,Centrosomal protein of 85 kDa,2383,81,1.05 [0.77-1.42],0.762979755585035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CERT,Ceramide transfer protein,2393,81,1.02 [0.73-1.41],0.924199846995746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES1,Liver carboxylesterase 1,2467,84,0.82 [0.68-1.00],0.0485813798238041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES2,Cocaine esterase,2439,83,1.19 [0.85-1.65],0.3119414929026367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CES3,Carboxylesterase 3,2439,83,0.88 [0.66-1.19],0.4128903838705443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN2,Centrin-2,2393,81,0.99 [0.74-1.32],0.9302310425652058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CETN3,Centrin-3,2124,60,0.93 [0.67-1.29],0.6632441169076218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFB,Complement factor B,2090,59,1.37 [0.64-2.95],0.4168574061846684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFC1,Cryptic protein,2383,81,1.98 [1.52-2.57],3.058642805795915e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFD,Complement factor D,2126,59,13.44 [7.12-25.35],1.0437266115780197e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFH,Complement factor H,2009,57,0.87 [0.28-2.68],0.8016728451166928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR2,Complement factor H-related protein 2,2111,58,2.00 [1.17-3.41],0.0116966330355569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR4,Complement factor H-related protein 4,2123,59,1.06 [0.75-1.50],0.7489857451534381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFHR5,Complement factor H-related protein 5,2095,60,1.00 [0.58-1.74],0.989763561079718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFI,Complement factor I,2126,59,0.86 [0.24-3.04],0.8145863765741554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CFP,Properdin,2126,59,0.24 [0.09-0.63],0.0036881279435997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGA,Glycoprotein hormones alpha chain,2467,84,2.21 [1.81-2.71],2.0631176954846926e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,2130,61,2.02 [1.02-3.98],0.0429401077470828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGN,Cingulin,2076,58,1.24 [0.73-2.08],0.4248182916187474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CGREF1,Cell growth regulator with EF hand domain protein 1,2457,82,5.99 [4.27-8.42],4.979722904698538e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,2383,81,0.74 [0.51-1.07],0.1111026476198523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHAD,Chondroadherin,2085,56,0.67 [0.41-1.10],0.1136645144580529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",2116,60,7.26 [5.15-10.23],9.036352338050044e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHCHD6,MICOS complex subunit MIC25,2117,60,2.48 [1.72-3.60],1.4594352991827389e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHEK2,Serine/threonine-protein kinase Chk2,2415,83,0.70 [0.38-1.30],0.2596933295017078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGA,Chromogranin-A,2130,58,1.76 [1.50-2.07],3.0945590296058256e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHGB,Secretogranin-1,2466,84,6.99 [4.94-9.88],3.937801799748194e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHI3L1,Chitinase-3-like protein 1,2404,81,1.73 [1.43-2.09],2.0497508117496785e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHIT1,Chitotriosidase-1,2474,82,1.02 [0.90-1.16],0.7637662797456279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHL1,Neural cell adhesion molecule L1-like protein,2459,82,1.63 [0.91-2.92],0.0985687417712518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHM,Rab proteins geranylgeranyltransferase component A 1,2076,58,0.86 [0.56-1.34],0.5091365810537378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP1A,Charged multivesicular body protein 1a,2437,83,0.89 [0.69-1.15],0.3688780572721947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHMP6,Charged multivesicular body protein 6,2122,60,0.74 [0.48-1.14],0.1718009666333631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHP1,Calcineurin B homologous protein 1,2061,56,0.96 [0.66-1.41],0.8435758314963774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL1,Chordin-like protein 1,2471,83,15.40 [9.92-23.90],3.648320726268535e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRDL2,Chordin-like protein 2,2457,82,1.67 [1.13-2.48],0.0103925642125726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CHRM1,Muscarinic acetylcholine receptor M1,2076,58,0.49 [0.21-1.12],0.0909271921806898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIAPIN1,Anamorsin,2456,83,1.01 [0.73-1.39],0.966923001388846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CILP,Cartilage intermediate layer protein 1,2130,58,5.28 [3.39-8.24],2.1310897895878322e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CINP,Cyclin-dependent kinase 2-interacting protein,2091,58,0.66 [0.33-1.31],0.2322056707752588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIRBP,Cold-inducible RNA-binding protein,2124,60,0.86 [0.67-1.12],0.2767947581349285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CIT,Citron Rho-interacting kinase,2076,58,0.92 [0.53-1.58],0.7491438774670518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKAP4,Cytoskeleton-associated protein 4,2479,84,5.67 [4.48-7.18],5.105515667594722e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKB,Creatine kinase B-type,2130,58,3.41 [2.46-4.72],1.2766320827219466e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",2454,83,1.17 [0.86-1.59],0.3211444412785077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLASP1,CLIP-associating protein 1,2044,59,0.79 [0.54-1.16],0.2277869479655853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLC,Galectin-10,2453,82,1.75 [1.37-2.22],5.2919323271035135e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC10A,C-type lectin domain family 10 member A,2437,83,4.23 [2.55-7.02],2.473311548603798e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC11A,C-type lectin domain family 11 member A,2463,84,1.30 [0.88-1.93],0.1929782440714266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC12A,C-type lectin domain family 12 member A,2062,59,3.91 [1.51-10.12],0.0050533915840274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC14A,C-type lectin domain family 14 member A,2467,84,12.32 [8.53-17.80],7.292945028646614e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1A,C-type lectin domain family 1 member A,2415,83,7.25 [5.02-10.46],3.8815695123438196e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC1B,C-type lectin domain family 1 member B,2476,84,0.98 [0.80-1.20],0.8449522599470614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC2L,C-type lectin domain family 2 member L,2076,58,0.99 [0.59-1.68],0.9834852123859908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC3B,Tetranectin,2079,59,0.30 [0.11-0.81],0.0171246832434871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4A,C-type lectin domain family 4 member A,2461,84,1.00 [0.59-1.68],0.9881133531517012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4C,C-type lectin domain family 4 member C,2461,84,1.18 [0.81-1.72],0.3979462577073021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4D,C-type lectin domain family 4 member D,2461,84,2.36 [1.86-2.98],8.708918910200746e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4G,C-type lectin domain family 4 member G,2461,84,2.65 [1.49-4.73],0.0009460283258802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC4M,C-type lectin domain family 4 member M,2128,58,1.08 [0.63-1.84],0.790968166039293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC5A,C-type lectin domain family 5 member A,2452,82,6.11 [4.02-9.28],2.245525829795111e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC6A,C-type lectin domain family 6 member A,2383,81,2.60 [1.95-3.48],9.686622062011014e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLEC7A,C-type lectin domain family 7 member A,2490,84,4.74 [3.46-6.48],2.115520179646304e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLGN,Calmegin,2076,58,3.24 [2.14-4.90],2.9446493517877105e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIC5,Chloride intracellular channel protein 5,2076,58,2.47 [1.61-3.79],3.5326322977157694e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLINT1,Clathrin interactor 1,2044,59,1.24 [0.81-1.91],0.3235593766778907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLIP2,CAP-Gly domain-containing linker protein 2,2461,84,0.98 [0.82-1.16],0.7848131248003073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLMP,CXADR-like membrane protein,2475,84,32.33 [19.76-52.92],1.6646968729422353e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLNS1A,Methylosome subunit pICln,2076,58,0.42 [0.18-0.98],0.0454061705086915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",2433,83,1.00 [0.81-1.22],0.966682337486114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLPS,Colipase,2460,84,1.16 [0.92-1.47],0.219251424976137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSPN,Claspin,2389,81,1.42 [0.98-2.07],0.0642162934135731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN1,Calsyntenin-1,2393,81,1.17 [0.83-1.65],0.3663915704660633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN2,Calsyntenin-2,2490,84,2.08 [1.47-2.94],3.496203359729398e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLSTN3,Calsyntenin-3,2116,60,2.14 [1.04-4.41],0.0380200389334212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLTA,Clathrin light chain A,2415,83,0.97 [0.62-1.50],0.8766880535369386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLU,Clusterin,2126,59,0.35 [0.08-1.43],0.1434348982224113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CLUL1,Clusterin-like protein 1,2453,82,0.92 [0.61-1.39],0.6839823684808797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMC1,COX assembly mitochondrial protein homolog,2122,60,0.87 [0.66-1.15],0.3318513554817823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CMIP,C-Maf-inducing protein,2117,60,0.95 [0.71-1.27],0.7198245605343299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNDP1,Beta-Ala-His dipeptidase,2464,83,0.76 [0.52-1.12],0.1610229503967492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNGB3,Cyclic nucleotide-gated cation channel beta-3,2061,56,1.07 [0.71-1.59],0.7586448237289052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",2056,54,0.81 [0.57-1.14],0.2223564094546311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY2,Protein canopy homolog 2,2415,83,1.03 [0.75-1.41],0.863720902923399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNPY4,Protein canopy homolog 4,2439,83,1.04 [0.80-1.35],0.7585343601090991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNST,Consortin,2457,82,0.87 [0.73-1.04],0.122259573237378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTF,Ciliary neurotrophic factor,2061,56,0.63 [0.30-1.31],0.2145519598488365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN1,Contactin-1,2490,84,4.66 [2.35-9.27],1.1188757789331624e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN2,Contactin-2,2475,84,2.42 [1.61-3.65],2.262637830102838e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN3,Contactin-3,2467,84,1.21 [0.63-2.33],0.5664126530474108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN4,Contactin-4,2467,84,1.85 [0.84-4.08],0.1260572295034052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTN5,Contactin-5,2466,83,0.52 [0.31-0.87],0.0130798387343488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP2,Contactin-associated protein-like 2,2461,84,1.83 [1.26-2.66],0.001481596529894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CNTNAP4,Contactin-associated protein-like 4,2076,58,1.04 [0.83-1.31],0.7172951560107177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COCH,Cochlin,2122,60,2.29 [1.50-3.50],0.0001264450686452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL15A1,Collagen alpha-1(XV) chain,2130,58,7.88 [4.51-13.75],3.9078065155410793e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL18A1,Collagen alpha-1(XVIII) chain,2470,84,40.86 [22.20-75.19],9.097826148631064e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL1A1,Collagen alpha-1(I) chain,2490,84,2.78 [1.48-5.24],0.0015189447571358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL24A1,Collagen alpha-1(XXIV) chain,2124,60,2.46 [1.57-3.85],8.451063021999384e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL28A1,Collagen alpha-1(XXVIII) chain,2076,58,1.15 [0.86-1.53],0.3506650186595826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL2A1,Collagen alpha-1(II) chain,2059,54,0.95 [0.68-1.32],0.7599039404250356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL3A1,Collagen alpha-1(III) chain,2130,58,2.87 [1.16-7.10],0.0225375576798551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A1,Collagen alpha-1(IV) chain,2457,82,2.62 [1.96-3.50],8.009492443121055e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL4A4,Collagen alpha-4(IV) chain,2086,58,0.86 [0.53-1.39],0.5364065287232204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL5A1,Collagen alpha-1(V) chain,2085,56,1.79 [1.29-2.51],0.000594459001076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL6A3,Collagen alpha-3(VI) chain,2490,84,8.91 [6.49-12.24],1.4805774493130663e-41
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A1,Collagen alpha-1(IX) chain,2461,84,1.38 [0.95-2.00],0.0900511708320968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COL9A2,Collagen alpha-2(IX) chain,2091,58,1.28 [0.74-2.22],0.3786649550104851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COLEC12,Collectin-12,2462,83,20.14 [13.20-30.74],4.784330713900447e-44
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD1,COMM domain-containing protein 1,2059,54,0.94 [0.60-1.47],0.7793496991418755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMMD9,COMM domain-containing protein 9,2117,60,0.87 [0.45-1.67],0.6729098727941868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMP,Cartilage oligomeric matrix protein,2434,83,1.24 [0.72-2.14],0.4301287735632214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COMT,Catechol O-methyltransferase,2393,81,0.84 [0.65-1.08],0.1727540374257037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPB2,Coatomer subunit beta',2060,56,0.97 [0.54-1.75],0.9183400108217188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COPE,Coatomer subunit epsilon,2393,81,0.90 [0.56-1.45],0.6605642354553425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",2059,54,1.40 [0.75-2.60],0.2920401834491803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO1A,Coronin-1A,2414,80,0.99 [0.79-1.25],0.9400873826519224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CORO6,Coronin-6,2061,56,1.87 [1.36-2.56],9.948277037005524e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",2439,83,1.41 [1.08-1.84],0.0122770355631012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",COX6B1,Cytochrome c oxidase subunit 6B1,2122,60,0.81 [0.37-1.76],0.591533396878317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA1,Carboxypeptidase A1,2490,84,1.16 [0.91-1.49],0.2343354557185047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA2,Carboxypeptidase A2,2470,84,1.70 [1.35-2.15],8.313739904136156e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPA4,Carboxypeptidase A4,2040,54,3.85 [2.15-6.88],5.366603870687656e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB1,Carboxypeptidase B,2490,84,1.35 [1.06-1.72],0.0149988696443584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPB2,Carboxypeptidase B2,2121,59,0.76 [0.25-2.27],0.6172743008241148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPE,Carboxypeptidase E,2455,82,2.08 [1.17-3.70],0.0130799731636359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPLX2,Complexin-2,2044,59,2.10 [1.07-4.14],0.0320068273777761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPM,Carboxypeptidase M,2463,84,1.70 [1.02-2.85],0.0425014411319675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",2062,59,0.85 [0.34-2.13],0.7244757741986898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPPED1,Serine/threonine-protein phosphatase CPPED1,2476,84,0.86 [0.63-1.16],0.3105379435196616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPQ,Carboxypeptidase Q,2128,58,2.04 [1.05-3.97],0.0363602511933643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPTP,Ceramide-1-phosphate transfer protein,2060,56,2.08 [1.19-3.63],0.0099691775625537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPVL,Probable serine carboxypeptidase CPVL,2471,84,2.82 [1.74-4.58],2.514965559500236e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM1,Probable carboxypeptidase X1,2456,83,1.19 [0.91-1.56],0.2130129798864501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CPXM2,Inactive carboxypeptidase-like protein X2,2122,60,14.52 [7.43-28.35],4.679612222542034e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR1,Complement receptor type 1,2122,61,2.09 [1.11-3.94],0.0232476440982407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CR2,Complement receptor type 2,2464,83,2.07 [1.45-2.94],5.661325623715142e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,2383,81,1.08 [0.86-1.34],0.5149995049961489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRADD,Death domain-containing protein CRADD,2433,83,0.84 [0.64-1.10],0.2018417602400869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREB3,Cyclic AMP-responsive element-binding protein 3,2044,59,0.70 [0.40-1.22],0.2072372576309311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREBZF,CREB/ATF bZIP transcription factor,2044,59,1.34 [0.47-3.82],0.5775839685524617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CREG1,Protein CREG1,2422,80,0.88 [0.55-1.40],0.588981747937141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD1,Protein disulfide isomerase CRELD1,2085,56,5.47 [2.92-10.26],1.122908840066287e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRELD2,Protein disulfide isomerase CRELD2,2471,83,2.61 [1.99-3.44],6.685520739930941e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRH,Corticoliberin,2381,81,0.82 [0.64-1.04],0.1024532539223049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHBP,Corticotropin-releasing factor-binding protein,2462,83,10.02 [5.09-19.71],2.4682059708245704e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRHR1,Corticotropin-releasing factor receptor 1,2415,83,0.88 [0.62-1.24],0.4559027259115786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIM1,Cysteine-rich motor neuron 1 protein,2472,83,39.03 [19.20-79.34],4.351014809991508e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRIP2,Cysteine-rich protein 2,2437,83,3.81 [2.75-5.27],9.827261173629857e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP2,Cysteine-rich secretory protein 2,2475,84,0.86 [0.61-1.20],0.3645192476006251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRISP3,Cysteine-rich secretory protein 3,2111,60,0.47 [0.20-1.10],0.0833422342902811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRKL,Crk-like protein,2464,83,0.94 [0.78-1.13],0.5146083088715714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRLF1,Cytokine receptor-like factor 1,2472,83,4.38 [2.05-9.38],0.0001441814218449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRNN,Cornulin,2372,82,1.60 [1.22-2.08],0.0005302201617611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAC1,Cartilage acidic protein 1,2490,84,0.89 [0.49-1.61],0.6932139509441575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAM,Cytotoxic and regulatory T-cell molecule,2437,83,2.73 [1.90-3.92],5.800263164661305e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRTAP,Cartilage-associated protein,2076,58,0.83 [0.46-1.50],0.537447321697931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRX,Cone-rod homeobox protein,2415,83,1.11 [0.95-1.31],0.1847819988460789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB1,Beta-crystallin B1,2122,60,0.95 [0.64-1.39],0.7732503056827433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYBB2,Beta-crystallin B2,2116,60,1.03 [0.79-1.35],0.8065272467430586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYGD,Gamma-crystallin D,2116,60,0.97 [0.76-1.26],0.8418471205147323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYM,Ketimine reductase mu-crystallin,2061,56,1.19 [0.84-1.70],0.3266588362832752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CRYZL1,Quinone oxidoreductase-like protein 1,2059,54,0.68 [0.51-0.92],0.0131898779696659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSDE1,Cold shock domain-containing protein E1,2060,56,1.07 [0.87-1.32],0.5345880780545225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1,Macrophage colony-stimulating factor 1,2472,83,26.06 [15.16-44.81],4.202295014459521e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF1R,Macrophage colony-stimulating factor 1 receptor,2130,61,2.33 [1.38-3.91],0.0014340575007869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2,Granulocyte-macrophage colony-stimulating factor,2060,56,1.66 [0.98-2.81],0.0607424544379466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,2437,83,1.51 [1.15-1.98],0.0033813666924215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF2RB,Cytokine receptor common subunit beta,2062,59,0.96 [0.53-1.73],0.8934376589579376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3,Granulocyte colony-stimulating factor,2404,82,1.23 [0.82-1.86],0.3136326104532848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSF3R,Granulocyte colony-stimulating factor receptor,2062,59,1.56 [0.81-3.03],0.187180432899611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSH1,Chorionic somatomammotropin hormone 1,2130,61,0.64 [0.27-1.49],0.2966695090850542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK1D,Casein kinase I isoform delta,2062,59,0.97 [0.63-1.48],0.873906985222439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSNK2A1,Casein kinase II subunit alpha,2118,60,0.56 [0.31-1.01],0.0550150472808349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG4,Chondroitin sulfate proteoglycan 4,2130,58,7.84 [4.15-14.83],2.361579520862768e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSPG5,Chondroitin sulfate proteoglycan 5,2061,56,1.56 [0.99-2.44],0.0535268497990712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSRP3,Cysteine and glycine-rich protein 3,2060,56,1.43 [1.16-1.75],0.0006093764869432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST1,Cystatin-SN,1855,47,1.64 [1.32-2.04],6.7911212769631135e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST3,Cystatin-C,2455,82,10.81 [7.25-16.11],1.411196435607013e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST5,Cystatin-D,2414,82,1.72 [1.23-2.39],0.0014207636636997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST6,Cystatin-M,2390,82,4.57 [3.30-6.33],7.166215252488274e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CST7,Cystatin-F,2467,83,1.23 [1.05-1.44],0.0102243820501458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CSTB,Cystatin-B,2434,81,2.84 [1.88-4.29],6.760209216119418e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTAG1A_CTAG1B,Cancer/testis antigen 1,2088,58,0.93 [0.54-1.58],0.777857939376093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTBS,Di-N-acetylchitobiase,2097,60,1.45 [0.62-3.41],0.3885767427210089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTF1,Cardiotrophin-1,2415,83,0.88 [0.69-1.12],0.2992239428805386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTHRC1,Collagen triple helix repeat-containing protein 1,2130,58,7.00 [4.30-11.39],4.615358529771717e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTLA4,Cytotoxic T-lymphocyte protein 4,2130,58,1.02 [0.46-2.23],0.9700758357539429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTNNA1,Catenin alpha-1,2061,56,0.81 [0.32-2.06],0.6583747619555442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRB1,Chymotrypsinogen B,2467,84,1.22 [0.94-1.59],0.1339468222827647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRC,Chymotrypsin-C,2466,83,0.72 [0.56-0.91],0.0058941390316989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTRL,Chymotrypsin-like protease CTRL-1,2116,60,0.73 [0.56-0.97],0.0297013366639346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSB,Cathepsin B,2460,84,2.86 [2.10-3.88],1.7231482600495088e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSC,Dipeptidyl peptidase 1,2453,83,0.88 [0.57-1.36],0.5747177549894205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSD,Cathepsin D,2310,76,1.73 [1.17-2.56],0.0059793914246327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSE,Cathepsin E,2085,56,1.81 [1.17-2.81],0.0079211603320379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSF,Cathepsin F,2456,83,1.13 [0.70-1.83],0.6249087126693151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSH,Pro-cathepsin H,2411,83,1.64 [1.27-2.13],0.0001748089920777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSL,Cathepsin L1,2457,82,5.61 [3.24-9.71],7.303584422658438e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSO,Cathepsin O,2490,84,4.58 [2.93-7.18],3.086656148168341e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSS,Cathepsin S,1965,73,5.76 [2.60-12.72],1.536520196920392e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSV,Cathepsin L2,2466,84,0.43 [0.27-0.70],0.0006735310747274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CTSZ,Cathepsin Z,2458,83,7.15 [4.44-11.52],5.933679703443913e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CUZD1,CUB and zona pellucida-like domain-containing protein 1,2076,58,0.96 [0.54-1.69],0.8817333495568381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CWC15,Spliceosome-associated protein CWC15 homolog,2111,59,1.30 [0.97-1.75],0.0838934996959851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CX3CL1,Fractalkine,2437,83,6.25 [4.44-8.79],7.608089954101911e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXADR,Coxsackievirus and adenovirus receptor,2461,84,3.64 [2.65-4.99],1.3117904008339468e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL1,Growth-regulated alpha protein,2463,83,1.10 [0.90-1.35],0.355666675891391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL10,C-X-C motif chemokine 10,2472,83,1.35 [1.03-1.76],0.0294704108447323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL11,C-X-C motif chemokine 11,2476,84,1.13 [0.90-1.42],0.3067241864567072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL12,Stromal cell-derived factor 1,2404,82,0.87 [0.53-1.43],0.5865031712788984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL13,C-X-C motif chemokine 13,2476,84,1.37 [1.09-1.73],0.0074616583137642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL14,C-X-C motif chemokine 14,2404,82,1.44 [1.15-1.79],0.0013485949414574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL16,C-X-C motif chemokine 16,2489,84,18.11 [9.63-34.03],2.3284936053579724e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL17,C-X-C motif chemokine 17,2490,84,1.44 [0.94-2.22],0.0971105992886428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL3,C-X-C motif chemokine 3,2466,83,0.85 [0.70-1.04],0.1222649828235493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL5,C-X-C motif chemokine 5,2450,81,0.96 [0.81-1.14],0.6314678988354074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL6,C-X-C motif chemokine 6,2490,84,1.21 [0.94-1.56],0.1439506284453033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL8,Interleukin-8,2435,84,1.31 [1.06-1.62],0.0127402341858167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CXCL9,C-X-C motif chemokine 9,2472,83,2.28 [1.85-2.81],7.922670306100654e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5A,Cytochrome b5,2044,59,1.32 [1.00-1.74],0.054149556382054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYB5R2,NADH-cytochrome b5 reductase 2,2098,59,1.70 [1.16-2.48],0.0060124890062276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",2060,56,0.85 [0.60-1.21],0.3693973075861907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTH3,Cytohesin-3,2044,59,1.36 [1.04-1.78],0.0269128205573733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",CYTL1,Cytokine-like protein 1,2130,58,8.73 [4.76-16.01],2.578530988190365e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAAM1,Disheveled-associated activator of morphogenesis 1,2085,56,0.86 [0.62-1.18],0.3346512473097239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAB2,Disabled homolog 2,2475,84,0.97 [0.81-1.15],0.7043966695352091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAG1,Dystroglycan,2472,83,1.46 [0.95-2.23],0.0812856414306513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAND5,DAN domain family member 5,2062,59,0.66 [0.49-0.89],0.0074519079288383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPK2,Death-associated protein kinase 2,2062,59,0.94 [0.60-1.47],0.7795010248726565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,2461,84,0.91 [0.78-1.05],0.1840023081680617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DARS1,"Aspartate--tRNA ligase, cytoplasmic",2433,83,0.73 [0.56-0.95],0.0190113209585254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBH,Dopamine beta-hydroxylase,2127,61,1.01 [0.82-1.25],0.928043984211853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBI,Acyl-CoA-binding protein,2453,83,1.37 [1.05-1.77],0.0193343089905596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBN1,Drebrin,2062,59,1.31 [0.82-2.09],0.2632682652303239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DBNL,Drebrin-like protein,2472,83,0.90 [0.73-1.12],0.3558091717601438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",2456,83,6.90 [4.16-11.44],7.820966707933577e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCC,Netrin receptor DCC,2076,58,0.16 [0.05-0.48],0.0012359967306339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCDC2C,Doublecortin domain-containing protein 2C,2044,59,0.74 [0.48-1.16],0.1964347759750493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCLRE1C,Protein artemis,2044,59,0.95 [0.40-2.28],0.9091452633721336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCN,Decorin,2415,83,10.19 [5.45-19.05],3.411717719967698e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTD,Deoxycytidylate deaminase,2085,56,0.88 [0.67-1.15],0.3489796179241806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN1,Dynactin subunit 1,2475,84,0.87 [0.64-1.19],0.3920031500978908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN2,Dynactin subunit 2,2439,83,0.89 [0.72-1.10],0.286255084441219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTN6,Dynactin subunit 6,2393,81,0.83 [0.61-1.14],0.2483209762597668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCTPP1,dCTP pyrophosphatase 1,2457,82,2.61 [1.50-4.54],0.0007105410413739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D1,DCN1-like protein 1,2061,56,1.00 [0.70-1.42],0.9925818967213292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCUN1D2,DCN1-like protein 2,2044,59,0.88 [0.62-1.26],0.4817534518028099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DCXR,L-xylulose reductase,2456,83,0.66 [0.47-0.91],0.0120650413836107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDA1,DET1- and DDB1-associated protein 1,2060,56,0.93 [0.43-1.99],0.8468110499115282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",2439,83,2.20 [1.52-3.19],2.9506703954971868e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDC,Aromatic-L-amino-acid decarboxylase,2457,82,1.03 [0.70-1.50],0.8875556069827502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDHD2,Phospholipase DDHD2,2118,60,0.86 [0.58-1.26],0.4354089775757557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDI2,Protein DDI1 homolog 2,2085,56,0.63 [0.44-0.88],0.0073996399625653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDR1,Epithelial discoidin domain-containing receptor 1,2476,84,7.67 [4.22-13.93],2.248846073570948e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDT,D-dopachrome decarboxylase,2130,58,0.94 [0.52-1.70],0.83883679475829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX1,ATP-dependent RNA helicase DDX1,2124,60,1.52 [1.00-2.31],0.0510808556155309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX25,ATP-dependent RNA helicase DDX25,2076,58,1.11 [0.53-2.30],0.7859096706455224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX39A,ATP-dependent RNA helicase DDX39A,2062,59,1.06 [0.36-3.13],0.918313961451492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX4,Probable ATP-dependent RNA helicase DDX4,2062,59,0.85 [0.49-1.46],0.5507781477981335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX53,Probable ATP-dependent RNA helicase DDX53,2076,58,0.48 [0.23-1.01],0.0527906796118574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DDX58,Antiviral innate immune response receptor RIG-I,2383,81,1.01 [0.73-1.40],0.9365356923310282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",2461,84,0.95 [0.77-1.18],0.6604360770306618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFA1_DEFA1B,Neutrophil defensin 1,2412,80,2.61 [2.08-3.28],1.7020924034063862e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB103A_DEFB103B,Beta-defensin 103,2047,59,1.16 [0.72-1.87],0.537580225279165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB104A_DEFB104B,Beta-defensin 104,2061,56,1.12 [0.67-1.87],0.6565187031445872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB116,Beta-defensin 116,2061,56,1.04 [0.73-1.47],0.8388821325056504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB118,Beta-defensin 118,2061,56,0.83 [0.49-1.42],0.5019589210073573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DEFB4A_DEFB4B,Beta-defensin 4A,2420,82,1.06 [0.93-1.21],0.3902159024232982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENND2B,DENN domain-containing protein 2B,2060,56,0.79 [0.42-1.51],0.4802660471065919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DENR,Density-regulated protein,2062,59,0.80 [0.50-1.29],0.3600574349342971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DFFA,DNA fragmentation factor subunit alpha,2490,84,0.82 [0.60-1.12],0.2051117876046277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGCR6,Protein DGCR6,2061,56,1.05 [0.54-2.05],0.8757190649790242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKA,Diacylglycerol kinase alpha,2062,59,1.07 [0.68-1.68],0.7626183151640973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DGKZ,Diacylglycerol kinase zeta,2404,82,0.55 [0.31-0.98],0.0424684082404053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHODH,Dihydroorotate dehydrogenase,2060,56,1.00 [0.55-1.82],0.996642165200764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHPS,Deoxyhypusine synthase,2117,60,1.76 [1.15-2.70],0.0090995120921185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,2116,60,0.88 [0.50-1.55],0.6535078409589937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIABLO,"Diablo homolog, mitochondrial",2452,82,0.83 [0.70-0.99],0.037237470254586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK1C,Divergent protein kinase domain 1C,2076,58,0.96 [0.50-1.85],0.9020431645888356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DIPK2B,Divergent protein kinase domain 2B,2085,56,2.49 [1.29-4.84],0.0068362959848286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK1,Dickkopf-related protein 1,2476,84,1.08 [0.78-1.49],0.6545757269303158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK3,Dickkopf-related protein 3,2490,84,10.93 [6.18-19.33],2.01942440589247e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKK4,Dickkopf-related protein 4,2433,83,3.26 [2.47-4.31],1.090610083842774e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DKKL1,Dickkopf-like protein 1,2439,83,1.03 [0.81-1.31],0.8031109935855645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLG4,Disks large homolog 4,2116,60,0.96 [0.68-1.37],0.8261017533874369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLGAP5,Disks large-associated protein 5,2118,60,1.40 [0.95-2.08],0.0924341232312281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLK1,Protein delta homolog 1,2490,84,2.59 [1.91-3.51],9.264911181888435e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL1,Delta-like protein 1,2456,83,21.84 [14.27-33.43],8.702998605466617e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DLL4,Delta-like protein 4,2059,54,0.55 [0.29-1.03],0.0619053692704548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMD,Dystrophin,2059,54,2.49 [1.78-3.48],8.458646745866257e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DMP1,Dentin matrix acidic phosphoprotein 1,2059,54,0.44 [0.32-0.61],5.968995345199489e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA1,DnaJ homolog subfamily A member 1,2044,59,1.09 [0.58-2.05],0.7977812919035203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA2,DnaJ homolog subfamily A member 2,2485,84,0.93 [0.74-1.19],0.5736217937919724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJA4,DnaJ homolog subfamily A member 4,2116,60,0.75 [0.53-1.06],0.0979537014859908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB1,DnaJ homolog subfamily B member 1,2439,83,0.88 [0.70-1.11],0.284858326115986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB14,DnaJ homolog subfamily B member 14,2124,60,1.00 [0.67-1.47],0.9805125921362536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB2,DnaJ homolog subfamily B member 2,2085,56,0.64 [0.39-1.05],0.0800147584100645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB6,DnaJ homolog subfamily B member 6,2064,55,0.95 [0.70-1.30],0.7557508837342002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJB8,DnaJ homolog subfamily B member 8,2415,83,1.13 [0.79-1.62],0.4927277069106196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC21,DnaJ homolog subfamily C member 21,2116,60,0.79 [0.41-1.54],0.4929131497421146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC6,Putative tyrosine-protein phosphatase auxilin,2059,54,0.78 [0.56-1.07],0.1256659728362429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNAJC9,DnaJ homolog subfamily C member 9,2124,60,0.83 [0.60-1.16],0.2803466315834653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNER,Delta and Notch-like epidermal growth factor-related receptor,2460,83,0.38 [0.19-0.78],0.0083005723605818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNLZ,DNL-type zinc finger protein,2061,56,0.76 [0.51-1.15],0.1960213899853971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM1,Dynamin-1,2124,60,0.84 [0.68-1.04],0.1148367671965997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNM3,Dynamin-3,2118,60,2.13 [1.52-3.00],1.2573967611635644e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNMBP,Dynamin-binding protein,2437,83,1.40 [1.05-1.85],0.0214874819561544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPEP,Aspartyl aminopeptidase,2116,60,1.15 [0.76-1.75],0.5072977908197075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,2465,83,0.64 [0.44-0.94],0.0235801045037514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOC2B,Double C2-like domain-containing protein beta,2076,58,0.79 [0.37-1.68],0.5385369311685881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOCK9,Dedicator of cytokinesis protein 9,2061,56,0.81 [0.60-1.09],0.1696178273595466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK1,Docking protein 1,2116,60,0.89 [0.75-1.06],0.1981040884427035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DOK2,Docking protein 2,2457,82,0.92 [0.79-1.08],0.3280765010115049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP1,Dipeptidase 1,2433,83,0.66 [0.44-0.97],0.0343078891458275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPEP2,Dipeptidase 2,2439,83,1.72 [0.92-3.21],0.0888819755769277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP10,Inactive dipeptidyl peptidase 10,2461,84,0.96 [0.60-1.54],0.8810364293095791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP4,Dipeptidyl peptidase 4,2419,81,0.47 [0.26-0.83],0.0097501478589435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP6,Dipeptidyl aminopeptidase-like protein 6,2439,83,2.19 [1.37-3.52],0.0011102137856676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPP7,Dipeptidyl peptidase 2,2441,82,0.93 [0.68-1.28],0.665244513714363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPT,Dermatopontin,2490,84,41.34 [18.57-92.03],7.91018888950547e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DPY30,Protein dpy-30 homolog,2469,84,1.97 [1.57-2.46],4.132534600388563e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRAXIN,Draxin,2437,83,5.03 [3.50-7.23],3.0534005970654375e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DRG2,Developmentally-regulated GTP-binding protein 2,2439,83,0.96 [0.68-1.38],0.8433664141128292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSC2,Desmocollin-2,2443,83,9.39 [6.62-13.33],4.5247419009918414e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSCAM,Down syndrome cell adhesion molecule,2118,60,2.41 [1.34-4.33],0.0032678844485554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG2,Desmoglein-2,2467,84,5.88 [3.64-9.52],5.194964143720397e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG3,Desmoglein-3,2467,84,5.76 [3.66-9.05],3.4067472508204883e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DSG4,Desmoglein-4,2431,83,1.71 [1.23-2.37],0.0012545356227809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTD1,D-aminoacyl-tRNA deacylase 1,2085,56,0.84 [0.62-1.13],0.2454956710232301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTNB,Dystrobrevin beta,2113,59,3.42 [2.49-4.70],3.615707816517816e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX2,Probable E3 ubiquitin-protein ligase DTX2,2076,58,1.16 [0.76-1.76],0.4959082594046275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTX3,Probable E3 ubiquitin-protein ligase DTX3,2439,83,8.46 [5.21-13.75],6.566844729780977e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DTYMK,Thymidylate kinase,2122,60,0.84 [0.58-1.21],0.3448055827540844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUOX2,Dual oxidase 2,2415,83,0.95 [0.70-1.27],0.7157672997861266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP13,Dual specificity protein phosphatase 13 isoform A,2117,60,1.35 [0.87-2.10],0.1843237105573577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP29,Dual specificity phosphatase 29,2076,58,1.25 [0.88-1.76],0.2156468464495524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUSP3,Dual specificity protein phosphatase 3,2393,81,0.91 [0.70-1.18],0.4731475326601332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",2124,60,0.91 [0.72-1.16],0.4662753180874556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DXO,Decapping and exoribonuclease protein,2116,60,0.79 [0.44-1.42],0.4324481048555737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,2117,60,1.28 [0.76-2.15],0.3468618013044949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT1,Dynein light chain Tctex-type 1,2076,58,1.05 [0.76-1.44],0.7833624914124412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",DYNLT3,Dynein light chain Tctex-type 3,2117,60,0.79 [0.45-1.41],0.4276394575164896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,2437,83,0.90 [0.73-1.11],0.3120715595043551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EBI3_IL27,Interleukin-27,2472,84,7.54 [4.35-13.06],5.84137815627152e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECE1,Endothelin-converting enzyme 1,2393,81,1.06 [0.61-1.85],0.8372853649184577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",2122,60,1.24 [0.94-1.63],0.1316486720853463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECHS1,"Enoyl-CoA hydratase, mitochondrial",2059,54,1.02 [0.78-1.34],0.8580953091905572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECI2,Enoyl-CoA delta isomerase 2,2060,56,0.92 [0.61-1.41],0.7082309171377517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECM1,Extracellular matrix protein 1,2070,58,1.38 [0.71-2.69],0.347627938727055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ECSCR,Endothelial cell-specific chemotaxis regulator,2061,56,1.04 [0.61-1.74],0.8962681802725281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDA2R,Tumor necrosis factor receptor superfamily member 27,2475,84,7.88 [6.03-10.30],1.2738149727884238e-51
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDAR,Tumor necrosis factor receptor superfamily member EDAR,2461,84,1.09 [0.87-1.36],0.4666168651746777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDDM3B,Epididymal secretory protein E3-beta,2117,60,1.63 [1.14-2.32],0.0075017595411668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,2060,56,1.24 [0.63-2.45],0.5274130172249096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDF1,Endothelial differentiation-related factor 1,2118,60,1.04 [0.71-1.53],0.8228197139476723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,2415,83,2.36 [1.59-3.50],2.0046538864916163e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDN1,Endothelin-1,2059,54,10.54 [5.65-19.65],1.3079565644966365e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EDNRB,Endothelin receptor type B,2062,59,1.25 [0.68-2.29],0.4699787797192046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EEF1D,Elongation factor 1-delta,2122,60,1.04 [0.79-1.37],0.7714099805004492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB14,EF-hand calcium-binding domain-containing protein 14,2124,60,9.64 [6.26-14.83],6.690978923435641e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFCAB2,Dynein regulatory complex protein 8,2091,58,1.08 [0.51-2.27],0.8366790650946866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,2463,83,11.21 [7.30-17.21],2.303252962827676e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFHD1,EF-hand domain-containing protein D1,2118,60,5.55 [3.90-7.91],2.1131749429613168e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA1,Ephrin-A1,2464,84,13.73 [9.66-19.51],2.952186606334709e-48
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNA4,Ephrin-A4,2433,83,11.07 [8.08-15.16],1.3162055053519145e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EFNB2,Ephrin-B2,2076,58,1.71 [1.39-2.09],2.5838096080443805e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGF,Pro-epidermal growth factor,2460,83,0.91 [0.76-1.09],0.3232363537981046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFL7,Epidermal growth factor-like protein 7,2383,81,2.49 [1.71-3.63],1.987051572868141e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFLAM,Pikachurin,2124,60,3.94 [2.65-5.86],1.3454939721422027e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGFR,Epidermal growth factor receptor,2490,84,0.54 [0.17-1.67],0.2835929391405426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EGLN1,Egl nine homolog 1,2461,84,1.17 [0.87-1.57],0.2888271770127306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHBP1,EH domain-binding protein 1,2122,60,0.92 [0.66-1.30],0.6524471658296491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EHD3,EH domain-containing protein 3,2059,54,0.83 [0.67-1.03],0.0872958780079115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",2116,60,0.75 [0.45-1.27],0.2907369445127463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",2115,59,0.93 [0.74-1.18],0.5691685436191218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,2060,56,0.87 [0.58-1.32],0.5131228040451019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,2059,54,0.41 [0.19-0.89],0.0251617344147948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4B,Eukaryotic translation initiation factor 4B,2437,83,0.63 [0.45-0.88],0.0076944547791471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4E,Eukaryotic translation initiation factor 4E,2062,59,0.80 [0.60-1.07],0.1298970680203328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,2457,82,0.79 [0.57-1.07],0.1309163733222529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,2490,84,0.98 [0.80-1.20],0.8101813403847514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,2118,60,1.15 [0.80-1.65],0.4546971266524984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5,Eukaryotic translation initiation factor 5,2060,56,0.65 [0.32-1.30],0.2229055305377198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EIF5A,Eukaryotic translation initiation factor 5A-1,2404,82,0.48 [0.24-0.98],0.0450322878465052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAC1,Zinc phosphodiesterase ELAC protein 1,2118,60,0.82 [0.61-1.11],0.2095872807025247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELAVL4,ELAV-like protein 4,2061,56,1.34 [1.08-1.66],0.0082995136716887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELN,Elastin,2122,60,9.21 [5.00-16.96],9.944533380710458e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOA,Elongin-A,2439,83,0.95 [0.67-1.34],0.7719016071095695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ELOB,Elongin-B,2060,56,1.85 [1.12-3.05],0.0158554439094422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENAH,Protein enabled homolog,2404,82,1.88 [1.43-2.47],6.986853184414155e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENDOU,Poly(U)-specific endoribonuclease,1961,55,3.80 [2.73-5.29],2.7282844995991524e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENG,Endoglin,2490,84,3.89 [1.39-10.86],0.0094625818315953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO1,Alpha-enolase,2463,83,0.91 [0.71-1.18],0.4827800378974672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO2,Gamma-enolase,2476,84,0.92 [0.68-1.24],0.5692908400157848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENO3,Beta-enolase,2059,54,0.73 [0.48-1.11],0.1387921192777372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOPH1,Enolase-phosphatase E1,2117,60,0.82 [0.48-1.40],0.4680036758199863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,2060,56,1.15 [0.49-2.70],0.7413086697542159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPEP,Glutamyl aminopeptidase,2060,56,0.90 [0.50-1.63],0.7267883309448622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,2490,84,2.04 [1.05-3.98],0.0364725179076445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,2472,83,0.82 [0.57-1.19],0.2938832056333678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,2059,54,2.23 [1.08-4.62],0.0311586666999462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,2385,82,1.17 [0.93-1.46],0.1761832288083916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENSA,Alpha-endosulfine,2117,60,1.18 [0.76-1.84],0.4564989422755515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,2383,81,0.96 [0.62-1.50],0.8722704780252089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,2415,83,1.09 [0.45-2.66],0.8541544498935102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,2415,83,3.02 [1.28-7.10],0.0114920132550304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ENTR1,Endosome-associated-trafficking regulator 1,2059,54,0.90 [0.60-1.34],0.5941778750054318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EP300,Histone acetyltransferase p300,2062,59,1.24 [0.62-2.48],0.5398774565584519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPB41L5,Band 4.1-like protein 5,2076,58,1.23 [0.89-1.68],0.2074813755486026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPCAM,Epithelial cell adhesion molecule,2461,83,1.05 [0.85-1.31],0.6471528689039407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPGN,Epigen,2117,60,0.81 [0.38-1.70],0.5734792713013797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA1,Ephrin type-A receptor 1,2465,83,11.71 [6.85-20.01],2.3388877427540013e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA10,Ephrin type-A receptor 10,2393,81,1.03 [0.78-1.38],0.8264959246318722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA2,Ephrin type-A receptor 2,2361,82,11.64 [8.29-16.35],1.2017186022243982e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHA4,Ephrin type-A receptor 4,2085,56,13.57 [6.49-28.36],4.098741934608749e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB4,Ephrin type-B receptor 4,2490,84,25.09 [16.15-38.97],1.3473931456314544e-46
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHB6,Ephrin type-B receptor 6,2433,83,10.41 [7.12-15.22],1.273693813525189e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPHX2,Bifunctional epoxide hydrolase 2,2415,83,0.89 [0.64-1.25],0.5098528982669808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPN1,Epsin-1,2091,58,0.88 [0.46-1.72],0.7168781949546911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPO,Erythropoietin,2461,84,1.35 [1.09-1.66],0.0052960887310423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPPK1,Epiplakin,2059,54,1.26 [0.89-1.78],0.1872217939980256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,2472,84,5.18 [3.51-7.66],1.517111737195418e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB2,Receptor tyrosine-protein kinase erbB-2,2456,83,0.65 [0.36-1.20],0.1676195913062496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB3,Receptor tyrosine-protein kinase erbB-3,2455,83,1.56 [0.61-4.01],0.3555555046236155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBB4,Receptor tyrosine-protein kinase erbB-4,2456,83,2.41 [1.18-4.94],0.0161850401502182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERBIN,Erbin,2439,83,0.95 [0.78-1.15],0.5868622759649049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERC2,ERC protein 2,2076,58,1.33 [1.00-1.75],0.0466322291053572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERCC1,DNA excision repair protein ERCC-1,2044,59,0.77 [0.32-1.85],0.554660559215602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EREG,Proepiregulin,2433,83,0.82 [0.63-1.06],0.1274630342575773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERI1,3'-5' exoribonuclease 1,2091,58,1.00 [0.48-2.10],0.9987530667491316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERMAP,Erythroid membrane-associated protein,2062,59,2.75 [1.67-4.52],7.06827459460902e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,2117,60,0.46 [0.23-0.94],0.032172000671676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP29,Endoplasmic reticulum resident protein 29,2085,56,0.84 [0.67-1.04],0.1155835337083154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERP44,Endoplasmic reticulum resident protein 44,2437,83,1.01 [0.47-2.13],0.988658097551036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,2060,56,0.72 [0.36-1.44],0.353744733996871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESAM,Endothelial cell-selective adhesion molecule,2490,84,8.47 [5.60-12.81],4.0332687352629895e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESM1,Endothelial cell-specific molecule 1,2462,83,1.58 [0.93-2.68],0.0881620411401284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESPL1,Separin,2044,59,1.07 [0.74-1.57],0.7079631350744499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESR1,Estrogen receptor,2062,59,1.15 [0.73-1.80],0.5558850732538714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ESYT2,Extended synaptotagmin-2,2116,60,1.03 [0.76-1.40],0.8321588570634627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI2B,Protein EVI2B,2044,59,0.94 [0.45-1.94],0.8574788282057565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVI5,Ecotropic viral integration site 5 protein homolog,2062,59,0.91 [0.69-1.21],0.509847550416422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EVPL,Envoplakin,2091,58,1.58 [0.78-3.20],0.2031751303685752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXOSC10,Exosome component 10,2060,56,0.71 [0.39-1.29],0.2617292576579951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EXTL1,Exostosin-like 1,2060,56,1.31 [0.88-1.94],0.1868847303111853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",EZR,Ezrin,2476,84,1.78 [0.84-3.75],0.1294307582233852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F10,Coagulation factor X,2130,61,0.68 [0.32-1.48],0.3354687852205468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11,Coagulation factor XI,2100,58,1.51 [0.64-3.55],0.3463419311239186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F11R,Junctional adhesion molecule A,2467,84,1.47 [1.05-2.05],0.0264470818911458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F12,Coagulation factor XII,2126,59,0.52 [0.30-0.91],0.0228074331970141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F13B,Coagulation factor XIII B chain,2114,59,1.74 [0.67-4.49],0.2556795170182624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2,Prothrombin,2126,59,0.34 [0.06-1.74],0.1931637875914849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F2R,Proteinase-activated receptor 1,2471,83,2.02 [1.44-2.84],5.001675790474362e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F3,Tissue factor,2459,84,11.32 [6.50-19.71],9.898407439585829e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F7,Coagulation factor VII,2460,83,1.93 [1.07-3.49],0.0296586904077521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",F9,Coagulation factor IX,2464,83,1.58 [0.53-4.73],0.4103628178587309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP1,"Fatty acid-binding protein, liver",2462,83,2.16 [1.83-2.55],7.14170293606571e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP2,"Fatty acid-binding protein, intestinal",2457,82,1.82 [1.51-2.19],2.0377860047307554e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP3,"Fatty acid-binding protein, heart",2122,60,3.57 [2.77-4.59],9.375901205684368e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP4,"Fatty acid-binding protein, adipocyte",2490,84,3.40 [2.65-4.36],4.6714080769409005e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP5,Fatty acid-binding protein 5,2469,84,1.37 [1.03-1.84],0.033430746783655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP6,Gastrotropin,2412,82,1.80 [1.42-2.30],1.8822463584990805e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FABP9,Fatty acid-binding protein 9,2461,84,2.03 [1.47-2.80],1.519291188897402e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FADD,FAS-associated death domain protein,2457,82,0.75 [0.57-0.98],0.0365392068737354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM13A,Protein FAM13A,2124,60,1.01 [0.69-1.46],0.9782169131982456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171A2,Protein FAM171A2,2118,60,1.11 [0.96-1.27],0.1649732920802881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM171B,Protein FAM171B,2117,60,3.21 [1.86-5.56],3.032545800311999e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM172A,Cotranscriptional regulator FAM172A,2059,54,0.71 [0.45-1.12],0.1431470599949591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM20A,Pseudokinase FAM20A,2122,60,2.11 [0.90-4.93],0.0850135651947597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3B,Protein FAM3B,2439,83,9.04 [5.22-15.66],4.174560607034199e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3C,Protein FAM3C,2457,82,17.26 [11.35-26.25],1.884665135862256e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAM3D,Protein FAM3D,2124,60,2.33 [1.75-3.11],6.4964993287074755e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAP,Prolyl endopeptidase FAP,2490,84,1.49 [0.79-2.80],0.2177255392253334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FARSA,Phenylalanine--tRNA ligase alpha subunit,2076,58,1.01 [0.70-1.46],0.942060753673454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FAS,Tumor necrosis factor receptor superfamily member 6,2485,84,2.61 [2.02-3.37],2.3069133430008297e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FASLG,Tumor necrosis factor ligand superfamily member 6,2490,84,1.63 [0.98-2.71],0.0576992518357501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBLN2,Fibulin-2,2130,58,9.52 [5.45-16.61],2.1949981276139718e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBN2,Fibrillin-2,2076,58,1.60 [1.06-2.41],0.0250860234717482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FBP1,"Fructose-1,6-bisphosphatase 1",2457,82,0.94 [0.73-1.21],0.6349290271518506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,2122,60,1.74 [1.25-2.42],0.0009208932759824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCAR,Immunoglobulin alpha Fc receptor,2461,84,1.29 [0.90-1.85],0.1629626040216293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,2118,60,2.56 [1.44-4.55],0.0013618419950207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCER2,Low affinity immunoglobulin epsilon Fc receptor,2467,84,2.21 [1.84-2.64],1.3127002095795877e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,2452,83,1.33 [0.92-1.94],0.1307596786020415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,2383,81,1.12 [0.81-1.54],0.4995744106669749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,2457,82,1.73 [1.14-2.60],0.0094918501944948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN1,Ficolin-1,2127,61,1.47 [0.90-2.41],0.1235108652550233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCN2,Ficolin-2,2447,83,0.79 [0.49-1.28],0.3355862644409837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL1,Fc receptor-like protein 1,2457,82,2.02 [1.40-2.92],0.0001854686801778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL2,Fc receptor-like protein 2,2481,83,2.06 [1.58-2.67],7.925094338844031e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL3,Fc receptor-like protein 3,2404,82,1.24 [0.89-1.71],0.2029798735187477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL5,Fc receptor-like protein 5,2467,84,0.98 [0.71-1.34],0.8766999615718326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRL6,Fc receptor-like protein 6,2461,84,1.83 [1.38-2.43],2.836144250522176e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FCRLB,Fc receptor-like B,2383,81,1.57 [1.16-2.14],0.0038463761912625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX1,"Adrenodoxin, mitochondrial",2060,56,1.91 [1.51-2.43],9.040733304851504e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FDX2,"Ferredoxin-2, mitochondrial",2060,56,0.92 [0.55-1.53],0.7426122217237578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FEN1,Flap endonuclease 1,2383,81,0.97 [0.73-1.28],0.8105404202953176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FES,Tyrosine-protein kinase Fes/Fps,2383,81,0.89 [0.59-1.34],0.5734366139535579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FETUB,Fetuin-B,2464,83,1.04 [0.60-1.82],0.8839760132337009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGA,Fibrinogen alpha chain,2082,59,2.64 [1.29-5.38],0.0076006315269153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",2118,60,0.95 [0.70-1.30],0.7573935298815535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF12,Fibroblast growth factor 12,2062,59,1.19 [0.78-1.82],0.4155257224390839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF16,Fibroblast growth factor 16,2062,59,0.88 [0.50-1.53],0.6438047875393589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF19,Fibroblast growth factor 19,2472,83,1.39 [1.10-1.75],0.0059897058420506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF2,Fibroblast growth factor 2,2461,84,1.12 [0.85-1.47],0.4346370701298183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF20,Fibroblast growth factor 20,2062,59,1.24 [0.74-2.07],0.4149751762982169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF21,Fibroblast growth factor 21,2472,84,1.43 [1.24-1.65],6.583749757207747e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF23,Fibroblast growth factor 23,2467,84,2.07 [1.73-2.47],1.0873321023263724e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF3,Fibroblast growth factor 3,2062,59,2.15 [1.05-4.38],0.0353934407391499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF5,Fibroblast growth factor 5,2404,82,3.89 [2.78-5.44],2.2658057140830786e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF6,Fibroblast growth factor 6,2062,59,1.36 [0.94-1.98],0.106473193091036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF7,Fibroblast growth factor 7,2044,59,0.84 [0.57-1.23],0.3678278949977941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGF9,Fibroblast growth factor 9,2041,59,1.39 [0.73-2.64],0.3157802611850435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP1,Fibroblast growth factor-binding protein 1,2456,83,0.50 [0.33-0.77],0.001714310431535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP2,Fibroblast growth factor-binding protein 2,2130,58,0.45 [0.27-0.73],0.0015026649964978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFBP3,Fibroblast growth factor-binding protein 3,2116,60,1.07 [0.56-2.04],0.8293962084676054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR2,Fibroblast growth factor receptor 2,2456,83,6.81 [4.32-10.73],1.5292308544508586e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGFR4,Fibroblast growth factor receptor 4,2085,56,1.73 [1.06-2.82],0.0269343299116458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGL1,Fibrinogen-like protein 1,2130,61,2.23 [1.59-3.11],2.6772388491286755e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FGR,Tyrosine-protein kinase Fgr,2393,81,0.94 [0.68-1.28],0.6886381485975792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FH,"Fumarate hydratase, mitochondrial",2061,56,0.94 [0.68-1.30],0.7100375360657543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIP2A,FHF complex subunit HOOK interacting protein 2A,2060,56,0.53 [0.28-0.99],0.0467325722133582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FHIT,Bis(5'-adenosyl)-triphosphatase,2393,81,0.64 [0.48-0.84],0.0014928456183274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FIS1,Mitochondrial fission 1 protein,2460,83,1.10 [0.85-1.41],0.4822635970137802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,2118,60,0.89 [0.69-1.15],0.3721050858871171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,2467,82,0.93 [0.78-1.11],0.4162317132908256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,2437,83,1.13 [0.69-1.84],0.6287124341441339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,2437,83,0.99 [0.79-1.22],0.8970305274416721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,2389,81,1.00 [0.66-1.53],0.9927944196654116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FKBPL,FK506-binding protein-like,2124,60,0.75 [0.48-1.17],0.2055791094109946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLI1,Friend leukemia integration 1 transcription factor,2383,81,0.95 [0.79-1.15],0.618967550165261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,2437,83,20.25 [10.98-37.37],6.3305950545690935e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT1,Vascular endothelial growth factor receptor 1,2437,83,2.73 [1.92-3.89],2.7106895372466548e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3,Receptor-type tyrosine-protein kinase FLT3,2383,81,1.33 [0.70-2.53],0.3870394931671769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT3LG,Fms-related tyrosine kinase 3 ligand,2490,84,2.03 [1.18-3.48],0.0102935204483651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FLT4,Vascular endothelial growth factor receptor 3,2456,83,1.52 [0.85-2.69],0.1552264546129256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMNL1,Formin-like protein 1,2393,81,1.00 [0.76-1.31],0.9826598011531892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FMR1,Synaptic functional regulator FMR1,2383,81,1.18 [0.69-2.02],0.5494762186543701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FN1,Fibronectin,2126,59,0.45 [0.18-1.12],0.0855299849995668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNDC1,Fibronectin type III domain-containing protein 1,2116,60,3.32 [2.06-5.35],8.119954865598604e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,2117,60,1.55 [0.71-3.35],0.2698837727058309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLH1,Glutamate carboxypeptidase 2,2062,59,1.15 [0.93-1.44],0.196967097198805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR1,Folate receptor alpha,2447,83,12.35 [7.98-19.10],1.3580111105175153e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR2,Folate receptor beta,2476,84,9.29 [5.34-16.14],2.75848676180351e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOLR3,Folate receptor gamma,2450,83,1.04 [0.95-1.14],0.3588524234451752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOS,Proto-oncogene c-Fos,2041,59,2.39 [1.18-4.83],0.0151387347677053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOSB,Protein fosB,2393,81,1.08 [0.65-1.79],0.7764683981706695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXJ3,Forkhead box protein J3,2062,59,0.82 [0.47-1.45],0.5018743438471597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO1,Forkhead box protein O1,2461,84,0.92 [0.73-1.16],0.4811030835889238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FOXO3,Forkhead box protein O3,2383,81,0.93 [0.74-1.16],0.5062182184886104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD4B,FERM domain-containing protein 4B,2060,56,1.05 [0.73-1.53],0.7816494056872488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRMD7,FERM domain-containing protein 7,2076,58,0.60 [0.29-1.25],0.1720107077708946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FRZB,Secreted frizzled-related protein 3,2430,83,0.97 [0.46-2.04],0.9322474531352252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSHB,Follitropin subunit beta,2059,54,1.61 [0.95-2.73],0.0769221965746867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FST,Follistatin,2471,83,1.61 [1.07-2.42],0.022984578838971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL1,Follistatin-related protein 1,2059,54,22.15 [9.22-53.23],4.381095712616292e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FSTL3,Follistatin-related protein 3,2460,83,11.54 [8.29-16.07],1.7392361844183334e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FTCD,Formimidoyltransferase-cyclodeaminase,2112,59,1.02 [0.80-1.31],0.8533989098496408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUCA1,Tissue alpha-L-fucosidase,2477,84,0.94 [0.75-1.18],0.6081086187862903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUOM,Fucose mutarotase,2085,56,0.97 [0.68-1.40],0.8826162633383909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FURIN,Furin,2456,83,0.87 [0.50-1.53],0.6372754666256628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUS,RNA-binding protein FUS,2375,81,1.71 [1.10-2.64],0.016138548296234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",2087,58,0.92 [0.59-1.42],0.7001385074937397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,2476,84,2.55 [1.73-3.76],2.586506841881043e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FUT8,"Alpha-(1,6)-fucosyltransferase",2437,83,1.07 [0.76-1.50],0.7006767755316805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXN,"Frataxin, mitochondrial",2475,84,0.94 [0.72-1.24],0.6754730228325212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FXYD5,FXYD domain-containing ion transport regulator 5,2404,82,1.01 [0.74-1.37],0.9496665104800566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FYB1,FYN-binding protein 1,2460,84,0.91 [0.74-1.12],0.3785159363780841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD10,Frizzled-10,2076,58,0.93 [0.57-1.52],0.7637374177334376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",FZD8,Frizzled-8,2061,56,1.81 [1.26-2.61],0.0014920847410461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAP,Gamma-aminobutyric acid receptor-associated protein,2117,60,1.93 [1.37-2.70],0.000138414141116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,2091,58,0.77 [0.49-1.22],0.2641258038687427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,2061,56,1.04 [0.67-1.60],0.871588687640453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD1,Glutamate decarboxylase 1,2044,59,0.82 [0.31-2.14],0.6810208951554284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAD2,Glutamate decarboxylase 2,2062,59,1.19 [0.78-1.81],0.4241511080795178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,2091,58,0.85 [0.46-1.58],0.6037877515770067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,2059,54,0.62 [0.36-1.07],0.0853056369722926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAGE2A,G antigen 2A,2044,59,0.86 [0.55-1.33],0.4973065931551956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAL,Galanin peptides,2472,83,1.09 [0.82-1.45],0.5338742418970316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,2439,83,1.31 [0.68-2.52],0.4225766420105258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,2475,84,1.47 [0.76-2.82],0.252415680535298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,2404,82,1.70 [1.12-2.58],0.0132103691346482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,2122,60,0.81 [0.34-1.93],0.637884873826376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GALNT7,N-acetylgalactosaminyltransferase 7,2439,83,2.05 [0.81-5.16],0.128694000630279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAMT,Guanidinoacetate N-methyltransferase,2060,56,1.02 [0.50-2.08],0.9673091092335252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,2037,54,0.47 [0.20-1.11],0.0840971765590172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GART,Trifunctional purine biosynthetic protein adenosine-3,2118,60,0.48 [0.15-1.52],0.210160586510038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS2,Growth arrest-specific protein 2,2091,58,0.71 [0.40-1.25],0.2317470226439617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAS6,Growth arrest-specific protein 6,2477,84,14.35 [7.15-28.81],6.891697417306674e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GASK1A,Golgi-associated kinase 1A,2060,56,0.61 [0.34-1.08],0.0879732424343303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GAST,Gastrin,2116,60,1.32 [1.15-1.51],5.5202893334139767e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,2044,59,0.79 [0.30-2.08],0.6275119081374663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",2059,54,0.94 [0.66-1.33],0.7202301374249265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBA,Lysosomal acid glucosylceramidase,2076,58,1.20 [0.82-1.75],0.3569219512936961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP1,Guanylate-binding protein 1,2113,60,1.49 [1.03-2.15],0.0335170205626537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP2,Guanylate-binding protein 2,2404,82,1.30 [0.96-1.75],0.0885827674881643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP4,Guanylate-binding protein 4,2393,81,1.19 [0.80-1.78],0.3914586399083644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GBP6,Guanylate-binding protein 6,2060,56,0.77 [0.38-1.57],0.4741009437207605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GC,Vitamin D-binding protein,2126,59,1.04 [0.40-2.72],0.9366466562235272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCC1,GRIP and coiled-coil domain-containing protein 1,2116,60,0.93 [0.74-1.18],0.5495670821835851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCG,Pro-glucagon,2383,81,1.52 [1.31-1.76],5.488963601937888e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,2025,53,1.98 [1.46-2.70],1.41155252257463e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCLM,Glutamate--cysteine ligase regulatory subunit,2060,56,0.81 [0.43-1.53],0.5236591868173364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",2439,83,4.07 [2.45-6.76],6.108256242703865e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF15,Growth/differentiation factor 15,2490,84,3.57 [2.95-4.33],1.3369467723842383e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDF2,Growth/differentiation factor 2,2457,82,1.03 [0.60-1.77],0.9048275808246272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GDNF,Glial cell line-derived neurotrophic factor,2393,81,2.26 [1.44-3.55],0.0003967019475616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GET3,ATPase GET3,2122,60,0.91 [0.56-1.49],0.7070696099945903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFAP,Glial fibrillary acidic protein,2380,80,1.54 [1.02-2.31],0.0400720745619972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFER,FAD-linked sulfhydryl oxidase ALR,2383,81,1.45 [1.08-1.96],0.01444461682258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,2383,81,1.00 [0.84-1.19],0.9915939345122788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA1,GDNF family receptor alpha-1,2472,84,23.72 [15.71-35.81],2.6500489999950366e-51
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA2,GDNF family receptor alpha-2,2439,83,11.17 [4.73-26.38],3.642428875500115e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRA3,GDNF family receptor alpha-3,2434,83,9.89 [6.03-16.22],1.0422280576963992e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GFRAL,GDNF family receptor alpha-like,2049,58,0.74 [0.47-1.14],0.1731168119792931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGA1,ADP-ribosylation factor-binding protein GGA1,2393,81,1.06 [0.79-1.42],0.6999910450802789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGACT,Gamma-glutamylaminecyclotransferase,2122,60,0.87 [0.59-1.26],0.4523817381087622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGCT,Gamma-glutamylcyclotransferase,2120,60,0.70 [0.40-1.23],0.2166884521062164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGH,Gamma-glutamyl hydrolase,2419,80,1.20 [0.66-2.17],0.5440429717471404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT1,Glutathione hydrolase 1 proenzyme,2464,84,0.92 [0.64-1.31],0.6392077829999289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GGT5,Glutathione hydrolase 5 proenzyme,2437,83,11.52 [6.81-19.48],7.696282972554487e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH1,Somatotropin,2457,82,1.13 [1.02-1.26],0.0215390166372446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GH2,Growth hormone variant,2383,81,0.94 [0.82-1.08],0.3979877889062261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHR,Growth hormone receptor,2085,56,0.43 [0.18-1.02],0.0549226331590278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRHR,Growth hormone-releasing hormone receptor,2393,81,1.23 [0.88-1.72],0.2288353551854128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GHRL,Appetite-regulating hormone,2457,82,1.51 [1.20-1.89],0.0004926817228899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GID8,Glucose-induced degradation protein 8 homolog,2118,60,1.44 [0.85-2.43],0.1786769342474396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIGYF2,GRB10-interacting GYF protein 2,2118,60,1.51 [1.12-2.04],0.0071730810228625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP7,GTPase IMAP family member 7,2085,56,0.74 [0.32-1.74],0.4909665286992061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIMAP8,GTPase IMAP family member 8,2044,59,0.84 [0.48-1.46],0.5396350456114646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIP,Gastric inhibitory polypeptide,2059,54,1.48 [0.94-2.32],0.0881564397336157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC2,PDZ domain-containing protein GIPC2,2116,60,9.07 [5.55-14.81],1.249482193982204e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPC3,PDZ domain-containing protein GIPC3,2124,60,0.85 [0.67-1.09],0.2041457734172256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIPR,Gastric inhibitory polypeptide receptor,2062,59,1.35 [0.80-2.27],0.2596402368685202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GIT1,ARF GTPase-activating protein GIT1,2062,59,0.88 [0.68-1.15],0.3584887148862276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GJA8,Gap junction alpha-8 protein,2044,59,1.30 [0.93-1.79],0.1201216193423938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GKN1,Gastrokine-1,2353,78,2.30 [1.08-4.87],0.030265761651454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLA,Alpha-galactosidase A,2084,55,1.19 [0.61-2.33],0.6063644493747069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLB1,Beta-galactosidase,2437,83,0.70 [0.43-1.13],0.1441509916228986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLI2,Zinc finger protein GLI2,2062,59,1.00 [0.42-2.38],0.9911585262178396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLO1,Lactoylglutathione lyase,2415,83,0.93 [0.66-1.32],0.6806067759395363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLOD4,Glyoxalase domain-containing protein 4,2459,83,0.82 [0.46-1.46],0.4982823247652607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLP1R,Glucagon-like peptide 1 receptor,2061,56,1.13 [0.56-2.30],0.733350307542811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX,Glutaredoxin-1,2442,81,0.67 [0.47-0.96],0.0285949603077611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",2085,56,0.87 [0.64-1.18],0.3609149592611124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,2393,81,1.12 [0.75-1.66],0.583311018354643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GLYR1,Putative oxidoreductase GLYR1,2117,60,1.32 [0.90-1.94],0.1585524746057876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GM2A,Ganglioside GM2 activator,2085,58,6.92 [4.86-9.86],9.893704774942863e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMFG,Glia maturation factor gamma,2122,60,0.80 [0.56-1.14],0.2116965525185686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR,GMP reductase 1,2490,84,0.61 [0.43-0.88],0.0072823799573789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GMPR2,GMP reductase 2,2085,56,0.64 [0.42-0.95],0.0290395973432126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNAS,Neuroendocrine secretory protein 55,2118,60,1.32 [1.06-1.65],0.0142062452923318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,2383,81,0.98 [0.73-1.33],0.9193528781506728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,2076,58,1.18 [0.81-1.72],0.3833072448316984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNLY,Granulysin,2467,84,1.26 [0.88-1.80],0.2092210479472871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA1,Glucosamine-6-phosphate isomerase 1,2059,54,0.66 [0.26-1.68],0.3820675767525445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GNPDA2,Glucosamine-6-phosphate isomerase 2,2085,56,0.33 [0.18-0.62],0.000529466940613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLGA3,Golgin subfamily A member 3,2118,60,1.04 [0.75-1.44],0.8052688487152213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOLM2,Protein GOLM2,2476,84,2.29 [1.57-3.34],1.6344654388807486e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,2461,84,0.89 [0.73-1.07],0.2082609079415212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GORASP2,Golgi reassembly-stacking protein 2,2124,60,0.81 [0.46-1.39],0.4393916344872287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GOT1,"Aspartate aminotransferase, cytoplasmic",2130,58,1.09 [0.65-1.83],0.7403936209156612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BA,Platelet glycoprotein Ib alpha chain,2447,83,1.44 [0.83-2.52],0.1937522132443973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP1BB,Platelet glycoprotein Ib beta chain,2060,56,1.19 [0.81-1.73],0.376006605607674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,2385,82,0.98 [0.80-1.22],0.8881637724882896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP5,Platelet glycoprotein V,2085,56,0.67 [0.34-1.32],0.2478325505613451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GP6,Platelet glycoprotein VI,2460,84,0.94 [0.75-1.17],0.5626225949886918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPA33,Cell surface A33 antigen,2439,83,0.91 [0.79-1.06],0.2383194180380938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC1,Glypican-1,2475,84,13.49 [7.54-24.11],1.6828427728408053e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPC5,Glypican-5,2437,83,0.87 [0.62-1.23],0.4335232721109364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPD1,Glycerol-3-phosphate dehydrogenase,2117,60,1.32 [0.91-1.92],0.1417194648616042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPHA2,Glycoprotein hormone alpha-2,2124,60,2.00 [1.45-2.75],2.2240757518146223e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPI,Glucose-6-phosphate isomerase,2130,61,0.86 [0.51-1.47],0.5918948980584378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,2124,60,2.59 [1.68-4.00],1.7469984177096114e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPKOW,G-patch domain and KOW motifs-containing protein,2393,81,1.62 [1.12-2.34],0.0097975365532353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPNMB,Transmembrane glycoprotein NMB,2400,80,6.55 [3.49-12.31],5.220232862046384e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR101,Probable G-protein coupled receptor 101,2061,56,0.63 [0.33-1.20],0.1615347687131999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR158,Probable G-protein coupled receptor 158,2118,60,2.88 [1.88-4.42],1.331401251954969e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR15L,Protein GPR15L,2124,60,1.57 [1.11-2.23],0.0112409256611708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPR37,Prosaposin receptor GPR37,2415,83,4.60 [3.54-5.98],5.1113343459180735e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GPRC5C,G-protein coupled receptor family C group 5 member C,2117,60,1.82 [1.31-2.54],0.0003994216408545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRAP2,GRB2-related adapter protein 2,2457,82,0.90 [0.77-1.04],0.1533434720472111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,2122,60,0.82 [0.55-1.23],0.3380062203289409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIK2,"Glutamate receptor ionotropic, kainate 2",2118,60,0.74 [0.37-1.48],0.3908473754223139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",2061,56,1.18 [0.74-1.88],0.4963647302402545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRK5,G protein-coupled receptor kinase 5,2415,83,0.80 [0.53-1.22],0.2990519070105839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRN,Progranulin,2453,84,11.45 [6.61-19.81],3.048872748224205e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRP,Gastrin-releasing peptide,2059,54,2.50 [1.57-3.97],0.000114839984001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRPEL1,"GrpE protein homolog 1, mitochondrial",2439,83,1.95 [1.52-2.50],1.3423417617878477e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GRSF1,G-rich sequence factor 1,2032,59,1.02 [0.75-1.39],0.889230925791746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSAP,Gamma-secretase-activating protein,2383,81,1.02 [0.81-1.28],0.8529598833391345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSN,Gelsolin,2123,61,1.82 [0.51-6.56],0.3592865146389643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSR,"Glutathione reductase, mitochondrial",2119,61,0.80 [0.32-1.98],0.6266173709094921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA1,Glutathione S-transferase A1,2453,82,0.78 [0.63-0.98],0.029216831436498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTA3,Glutathione S-transferase A3,2383,81,0.82 [0.65-1.04],0.1079419159629292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTM4,Glutathione S-transferase Mu 4,2060,56,1.02 [0.73-1.43],0.8872055896482375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTP1,Glutathione S-transferase P,2374,80,1.02 [0.76-1.38],0.8774908280069371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GSTT2B,Glutathione S-transferase theta-2B,2116,60,1.06 [0.95-1.17],0.2946524358077574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,2091,58,0.86 [0.56-1.33],0.4963066706395538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GTPBP2,GTP-binding protein 2,2076,58,0.77 [0.56-1.07],0.1234112674913616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCA2A,Guanylin,2455,84,7.09 [5.23-9.60],1.2353381681830524e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUCY2C,Heat-stable enterotoxin receptor,2091,58,1.15 [0.87-1.51],0.3215436213537438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUK1,Guanylate kinase,2060,56,1.58 [0.87-2.85],0.1322687029370048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GUSB,Beta-glucuronidase,2473,84,0.81 [0.61-1.06],0.1279971899075931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GYS1,"Glycogen [starch] synthase, muscle",2415,83,0.94 [0.76-1.17],0.5748458227521727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMA,Granzyme A,2490,84,2.75 [1.60-4.71],0.0002337100213049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMB,Granzyme B,2461,84,0.92 [0.67-1.28],0.6332121728259192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",GZMH,Granzyme H,2415,83,1.15 [0.91-1.46],0.2335243408774429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",H2AP,Huntingtin-interacting protein M,2044,59,0.94 [0.54-1.64],0.826835273498058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",2060,56,1.24 [0.97-1.58],0.0875716980896437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",2470,84,0.66 [0.50-0.87],0.0028953108277227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAO1,Hydroxyacid oxidase 1,2475,84,1.06 [0.92-1.23],0.4221885023897562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HARS1,"Histidine--tRNA ligase, cytoplasmic",2467,84,0.81 [0.63-1.05],0.1126050864238799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR1,Hepatitis A virus cellular receptor 1,2473,84,3.32 [2.85-3.87],9.81863014927756e-53
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HAVCR2,Hepatitis A virus cellular receptor 2,2467,84,9.42 [6.71-13.23],2.896187214364276e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBEGF,Proheparin-binding EGF-like growth factor,2470,84,0.90 [0.70-1.16],0.4165632861401785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBQ1,Hemoglobin subunit theta-1,2475,84,0.52 [0.37-0.73],0.0001347199004677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HBZ,Hemoglobin subunit zeta,2122,60,0.69 [0.53-0.89],0.0044079983655143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCG22,Protein PBMUCL2,2060,56,0.92 [0.58-1.46],0.7271217442377034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HCLS1,Hematopoietic lineage cell-specific protein,2490,84,0.75 [0.53-1.08],0.1217962279848797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC8,Histone deacetylase 8,2062,59,0.56 [0.28-1.12],0.1023647782777795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDAC9,Histone deacetylase 9,2061,56,1.22 [0.92-1.63],0.1714868381207815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDDC2,5'-deoxynucleotidase HDDC2,2124,60,0.55 [0.30-1.01],0.0537142563564666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGF,Hepatoma-derived growth factor,2469,84,0.92 [0.74-1.13],0.4162184418186839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HDGFL2,Hepatoma-derived growth factor-related protein 2,2116,60,1.41 [0.99-2.00],0.0577874469450546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEBP1,Heme-binding protein 1,2415,83,0.84 [0.56-1.25],0.3887358191425144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEG1,Protein HEG homolog 1,2085,56,2.16 [0.91-5.08],0.0794173411630063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPACAM2,HEPACAM family member 2,2116,60,0.90 [0.52-1.55],0.7001748045991574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEPH,Hephaestin,2122,60,16.76 [6.51-43.18],5.245472711904775e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HEXIM1,Protein HEXIM1,2461,84,0.90 [0.70-1.16],0.4173925733387619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGF,Hepatocyte growth factor,2490,84,1.57 [0.97-2.55],0.0692902879023067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGFAC,Hepatocyte growth factor activator,2112,60,1.89 [0.72-4.97],0.1993378001524065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,2383,81,0.80 [0.61-1.06],0.1208400967247285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HHEX,Hematopoietically-expressed homeobox protein HHEX,2116,60,1.30 [0.93-1.81],0.1192963058033916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIF1A,Hypoxia-inducible factor 1-alpha,2062,59,1.31 [0.99-1.72],0.0548099580725144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1,Huntingtin-interacting protein 1,2060,56,0.89 [0.39-2.05],0.7910671467363697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HIP1R,Huntingtin-interacting protein 1-related protein,2114,60,1.71 [1.45-2.01],7.817811126514116e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HJV,Hemojuvelin,2118,60,2.10 [1.42-3.09],0.0001796613401166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HK2,Hexokinase-2,2415,83,1.05 [0.51-2.14],0.8990330942153438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",2118,60,4.34 [2.02-9.35],0.0001762871402983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",2452,83,1.32 [0.80-2.19],0.2739066459631206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",2461,84,5.20 [3.89-6.94],6.283149746609944e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMBS,Porphobilinogen deaminase,2475,84,0.40 [0.25-0.62],3.817365081681965e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMCN2,Hemicentin-2,2082,55,2.01 [1.29-3.13],0.0021826117106915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",2059,54,0.65 [0.36-1.18],0.1532445737671278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",2060,56,0.44 [0.21-0.91],0.026834789198703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMMR,Hyaluronan mediated motility receptor,2040,58,1.19 [0.76-1.87],0.4454511647661756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX1,Heme oxygenase 1,2437,81,0.84 [0.56-1.26],0.4015270787977127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HMOX2,Heme oxygenase 2,2393,81,1.63 [1.21-2.19],0.0012388820577475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNF1A,Hepatocyte nuclear factor 1-alpha,2076,58,1.03 [0.75-1.42],0.8366427450145099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNMT,Histamine N-methyltransferase,2426,82,2.86 [2.12-3.86],5.712676088466858e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,2409,83,0.93 [0.72-1.21],0.6097634309432349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,2118,60,1.48 [0.99-2.21],0.0565236870921789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPCAL1,Hippocalcin-like protein 1,2490,84,0.90 [0.70-1.16],0.4113774604724034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPGDS,Hematopoietic prostaglandin D synthase,2383,81,0.35 [0.20-0.60],0.0001447537295267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HPSE,Heparanase,2109,58,1.04 [0.80-1.36],0.7802004756092825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRAS,GTPase Hras,2086,58,1.05 [0.83-1.34],0.6630977169888843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,2059,54,6.08 [3.80-9.73],4.794607153749855e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HRG,Histidine-rich glycoprotein,2114,59,0.85 [0.39-1.86],0.6846606287769161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS1BP3,HCLS1-binding protein 3,2059,54,0.96 [0.71-1.30],0.8032634093381044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,2439,83,2.52 [1.57-4.03],0.0001156456753966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,2475,84,2.04 [1.48-2.81],1.4074240076585876e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,2062,59,3.87 [2.66-5.64],1.689539129211869e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSBP1,Heat shock factor-binding protein 1,2059,54,1.02 [0.76-1.35],0.916873565261002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,2461,84,0.92 [0.59-1.44],0.7155089679274602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,2116,60,1.28 [0.89-1.85],0.186295755256323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSD17B3,Testosterone 17-beta-dehydrogenase 3,2060,56,0.49 [0.25-0.95],0.0333386064206367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,2059,54,1.70 [1.01-2.88],0.0469216760851545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSP90B1,Endoplasmin,2381,80,1.16 [0.90-1.51],0.2563624253318882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA1A,Heat shock 70 kDa protein 1A,2465,83,1.00 [0.76-1.33],0.9914539121847608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPA2,Heat shock-related 70 kDa protein 2,2117,60,3.44 [2.47-4.80],3.3891437233291e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB1,Heat shock protein beta-1,2419,80,0.79 [0.61-1.02],0.0759549803280692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPB6,Heat shock protein beta-6,2475,84,5.05 [3.66-6.98],8.726242945737917e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,2443,83,8.74 [6.14-12.44],2.529388453302573e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1A,5-hydroxytryptamine receptor 1A,2061,56,1.03 [0.76-1.38],0.8631682387807657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTR1B,5-hydroxytryptamine receptor 1B,2061,56,0.68 [0.34-1.36],0.2763790522880891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HTRA2,"Serine protease HTRA2, mitochondrial",2456,83,1.07 [0.78-1.47],0.6844551130464835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYAL1,Hyaluronidase-1,2441,81,2.89 [1.49-5.58],0.0016300024348784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",HYOU1,Hypoxia up-regulated protein 1,2490,84,37.44 [19.90-70.44],2.675340050108729e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICA1,Islet cell autoantigen 1,2404,82,0.85 [0.66-1.11],0.2306586052878704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM1,Intercellular adhesion molecule 1,2448,83,2.12 [1.21-3.73],0.0087550722830223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM2,Intercellular adhesion molecule 2,2490,84,5.49 [2.97-10.12],5.034023145732299e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM3,Intercellular adhesion molecule 3,2490,84,2.87 [1.52-5.41],0.0011204636268339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM4,Intercellular adhesion molecule 4,2461,84,0.74 [0.51-1.07],0.1110564798281481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICAM5,Intercellular adhesion molecule 5,2457,82,1.27 [0.83-1.94],0.2761016589178802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ICOSLG,ICOS ligand,2439,83,8.52 [3.18-22.78],1.9853412528738984e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ID4,DNA-binding protein inhibitor ID-4,2091,58,1.28 [0.83-2.00],0.266289093132489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDI2,Isopentenyl-diphosphate delta-isomerase 2,2393,81,1.62 [1.23-2.14],0.0005319262140799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDO1,"Indoleamine 2,3-dioxygenase 1",2059,54,1.28 [0.90-1.83],0.1686401531147042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDS,Iduronate 2-sulfatase,2490,84,0.55 [0.07-4.01],0.5522660197901272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IDUA,Alpha-L-iduronidase,2475,84,1.24 [0.82-1.89],0.3060095010062029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,2068,58,4.37 [2.65-7.22],8.155033239109002e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,2091,58,0.96 [0.57-1.63],0.8901152712820886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,2091,58,1.02 [0.53-1.94],0.9557259850749156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNAR1,Interferon alpha/beta receptor 1,2124,60,2.62 [1.31-5.24],0.0065055331361858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNG,Interferon gamma,2404,82,1.45 [1.23-1.71],1.2728827182205149e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR1,Interferon gamma receptor 1,2472,83,31.67 [17.75-56.51],1.373115579907106e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNGR2,Interferon gamma receptor 2,2437,83,1.10 [0.77-1.56],0.6057311153107088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL1,Interferon lambda-1,2393,81,1.62 [1.23-2.13],0.0006626834070481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNL2,Interferon lambda-2,2061,56,1.45 [1.05-1.99],0.0225885157065917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNLR1,Interferon lambda receptor 1,2461,84,1.55 [1.03-2.32],0.0355568544668871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFNW1,Interferon omega-1,2060,56,0.45 [0.16-1.25],0.1247803605227419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IFT20,Intraflagellar transport protein 20 homolog,2076,58,1.04 [0.57-1.92],0.8972204735545254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGBP1,Immunoglobulin-binding protein 1,2118,60,0.63 [0.41-0.96],0.0331643276047795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,2061,56,0.60 [0.29-1.28],0.1870188167256097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,2130,58,2.21 [0.89-5.47],0.0868882805031772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF1R,Insulin-like growth factor 1 receptor,2439,83,12.42 [7.59-20.31],1.0594158220808864e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,2060,56,0.84 [0.43-1.63],0.6069415795397559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGF2R,Cation-independent mannose-6-phosphate receptor,2467,84,2.35 [1.07-5.15],0.0334230673355341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP1,Insulin-like growth factor-binding protein 1,2488,84,1.70 [1.46-1.97],5.927910150686537e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP2,Insulin-like growth factor-binding protein 2,2485,84,3.38 [2.63-4.34],1.4659018002559549e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP3,Insulin-like growth factor-binding protein 3,2464,83,0.61 [0.40-0.93],0.0221107210960586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP4,Insulin-like growth factor-binding protein 4,2439,82,5.12 [4.13-6.35],8.274711663461119e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP6,Insulin-like growth factor-binding protein 6,2449,82,5.88 [4.39-7.87],1.6626217359120695e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBP7,Insulin-like growth factor-binding protein 7,2490,84,4.06 [3.04-5.42],2.41621353272686e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFBPL1,Insulin-like growth factor-binding protein-like 1,2457,82,4.09 [2.86-5.87],1.790251549444744e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGFL4,Insulin growth factor-like family member 4,2062,59,0.78 [0.49-1.23],0.2849508097273229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGHMBP2,DNA-binding protein SMUBP-2,2060,56,1.18 [0.75-1.86],0.4798470118282292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLC2,Immunoglobulin lambda constant 2,2121,59,3.76 [2.34-6.04],4.224428055866578e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGLON5,IgLON family member 5,2044,59,1.07 [0.82-1.40],0.6094645586528822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF21,Immunoglobulin superfamily member 21,2059,54,0.65 [0.32-1.32],0.2349023266807566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF3,Immunoglobulin superfamily member 3,2439,83,2.00 [1.43-2.79],5.011118978369487e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF8,Immunoglobulin superfamily member 8,2457,82,3.11 [2.31-4.18],6.202919918401935e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IGSF9,Protein turtle homolog A,2122,60,0.91 [0.70-1.17],0.4545376729342266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKBKG,NF-kappa-B essential modulator,2461,84,0.91 [0.73-1.13],0.4006306441530205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IKZF2,Zinc finger protein Helios,2383,81,0.99 [0.79-1.26],0.9548211489710452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10,Interleukin-10,2404,82,1.39 [1.13-1.69],0.0013502942066918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RA,Interleukin-10 receptor subunit alpha,2404,82,1.25 [0.94-1.65],0.1194286431806118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL10RB,Interleukin-10 receptor subunit beta,2472,83,17.16 [10.67-27.60],9.101681078428171e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL11,Interleukin-11,2404,82,1.10 [0.81-1.47],0.5456948219706044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12A_IL12B,Interleukin-12,2439,83,2.03 [1.67-2.46],1.5941518608371346e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12B,Interleukin-12 subunit beta,2490,84,2.75 [2.02-3.76],1.6496539722207574e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB1,Interleukin-12 receptor subunit beta-1,2404,82,5.05 [3.40-7.52],1.3451957392809373e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL12RB2,Interleukin-12 receptor subunit beta-2,2062,59,1.16 [0.64-2.10],0.6171767609473968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13,Interleukin-13,2404,82,0.64 [0.37-1.12],0.1203120811729574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA1,Interleukin-13 receptor subunit alpha-1,2418,81,1.04 [0.48-2.22],0.9246262034609678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL13RA2,Interleukin-13 receptor subunit alpha-2,2061,56,0.69 [0.28-1.70],0.4213750868739562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15,Interleukin-15,2461,84,2.57 [1.52-4.35],0.0004275886887062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL15RA,Interleukin-15 receptor subunit alpha,2404,82,6.23 [4.36-8.90],7.820456264589185e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL16,Pro-interleukin-16,2490,84,2.15 [1.65-2.81],2.0630048260617336e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17A,Interleukin-17A,2399,81,1.71 [1.26-2.32],0.0005708954965127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17C,Interleukin-17C,2404,82,2.15 [1.83-2.53],9.293302140101288e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17D,Interleukin-17D,2404,82,1.82 [1.34-2.48],0.0001177269783349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17F,Interleukin-17F,2404,82,1.24 [0.97-1.58],0.0807832757184385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RA,Interleukin-17 receptor A,2467,84,1.29 [0.84-1.98],0.2509261699835273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL17RB,Interleukin-17 receptor B,2436,84,1.59 [1.12-2.25],0.009490169650473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18,Interleukin-18,2454,83,2.39 [1.62-3.55],1.3297438212094754e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18BP,Interleukin-18-binding protein,2464,83,11.10 [7.43-16.59],7.990186803371418e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18R1,Interleukin-18 receptor 1,2490,84,4.19 [2.57-6.82],8.524460070610442e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL18RAP,Interleukin-18 receptor accessory protein,2424,82,0.98 [0.86-1.11],0.7394062071208356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL19,Interleukin-19,2402,80,1.50 [1.26-1.78],4.146695879756547e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1A,Interleukin-1 alpha,2404,82,1.34 [1.07-1.69],0.0124223486830705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1B,Interleukin-1 beta,2390,82,1.05 [0.77-1.43],0.7536056331925198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R1,Interleukin-1 receptor type 1,2464,84,16.58 [9.67-28.45],1.978265798173158e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1R2,Interleukin-1 receptor type 2,2458,83,1.03 [0.43-2.48],0.939821745659196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RAP,Interleukin-1 receptor accessory protein,2467,84,1.13 [0.76-1.69],0.5476087046557433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL1,Interleukin-1 receptor-like 1,2485,84,2.58 [1.67-3.98],1.7889323334157e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RL2,Interleukin-1 receptor-like 2,2404,82,1.06 [0.63-1.80],0.8212775072538214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL1RN,Interleukin-1 receptor antagonist protein,2454,83,1.52 [1.15-2.00],0.0030748396007541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2,Interleukin-2,2404,82,0.72 [0.39-1.31],0.2773920145815649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20,Interleukin-20,2404,82,0.91 [0.59-1.40],0.672861209713655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RA,Interleukin-20 receptor subunit alpha,2404,82,1.29 [0.90-1.84],0.1610152141117671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL20RB,Interleukin-20 receptor subunit beta,2062,59,0.95 [0.53-1.73],0.8783618999893223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL21R,Interleukin-21 receptor,2062,59,1.01 [0.65-1.57],0.974404706422348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22,Interleukin-22,2117,60,1.52 [1.11-2.07],0.0085441939903738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL22RA1,Interleukin-22 receptor subunit alpha-1,2404,82,1.39 [0.98-1.99],0.0685567186477839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL24,Interleukin-24,2404,82,1.35 [0.98-1.86],0.067406124266619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL25,Interleukin-25,2037,59,2.16 [0.98-4.74],0.0547094549450046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RA,Interleukin-2 receptor subunit alpha,2444,83,4.06 [3.12-5.29],2.5359833325174348e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RB,Interleukin-2 receptor subunit beta,2404,82,1.71 [1.14-2.56],0.0092292369679782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL2RG,Cytokine receptor common subunit gamma,2117,60,2.62 [1.68-4.09],2.0622788182482887e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3,Interleukin-3,2044,59,0.86 [0.58-1.29],0.4730634478679678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31,Interleukin-31,2062,59,1.00 [0.63-1.58],0.9954577460175952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL31RA,Interleukin-31 receptor subunit alpha,2054,59,2.06 [1.15-3.70],0.0152013294932383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL32,Interleukin-32,2461,84,1.54 [1.14-2.07],0.0050534344181808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL33,Interleukin-33,2404,82,1.91 [1.21-3.01],0.0053160473935588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL34,Interleukin-34,2387,80,1.53 [0.89-2.64],0.1222393123805197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36A,Interleukin-36 alpha,2062,59,1.29 [0.91-1.83],0.1585556036808902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL36G,Interleukin-36 gamma,2056,59,1.28 [0.97-1.70],0.0791767390504521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL3RA,Interleukin-3 receptor subunit alpha,2404,82,2.03 [1.17-3.54],0.0121810582539884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4,Interleukin-4,2404,82,0.97 [0.80-1.17],0.7343944643131644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL4R,Interleukin-4 receptor subunit alpha,2461,84,7.02 [4.88-10.08],6.586400134017461e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5,Interleukin-5,2404,82,0.97 [0.83-1.13],0.6853238812212384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL5RA,Interleukin-5 receptor subunit alpha,2461,84,1.90 [1.42-2.55],1.6835687261452664e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6,Interleukin-6,2439,83,1.32 [1.11-1.57],0.0018531122709415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6R,Interleukin-6 receptor subunit alpha,2445,83,3.19 [1.84-5.54],3.663506513378848e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL6ST,Interleukin-6 receptor subunit beta,2457,82,11.86 [4.58-30.72],3.5095155607032685e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7,Interleukin-7,2461,84,0.76 [0.56-1.05],0.0959609748359391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL7R,Interleukin-7 receptor subunit alpha,2467,84,1.20 [0.83-1.74],0.3350343411618858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IL9,Interleukin-9,2091,58,0.83 [0.50-1.39],0.4819991691622508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,2390,81,0.87 [0.61-1.25],0.4498138054296698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMMT,MICOS complex subunit MIC60,2117,60,2.94 [2.02-4.26],1.4600649022306153e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPA1,Inositol monophosphatase 1,2437,83,0.82 [0.59-1.15],0.2624081129346927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPACT,Protein IMPACT,2116,60,0.79 [0.50-1.24],0.2977962009245812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IMPG1,Interphotoreceptor matrix proteoglycan 1,2061,56,0.75 [0.29-1.92],0.5450993827717976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ING1,Inhibitor of growth protein 1,2389,81,1.09 [0.77-1.55],0.6259191141354807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBB,Inhibin beta B chain,2085,56,4.74 [3.28-6.86],1.3190637251078646e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INHBC,Inhibin beta C chain,2467,84,2.12 [1.22-3.68],0.0073167243770962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP1,Inositol polyphosphate 1-phosphatase,2439,83,1.39 [1.00-1.93],0.0471754180745505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",2059,54,0.86 [0.54-1.38],0.5299163436682826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",2118,60,0.56 [0.26-1.17],0.1217265187603674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",2439,83,0.97 [0.79-1.18],0.7422156553396805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL3,Insulin-like 3,2116,60,1.14 [0.87-1.49],0.344678097703859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL4,Early placenta insulin-like peptide,2117,60,2.86 [2.19-3.74],1.6182579934897174e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSL5,Insulin-like peptide INSL5,2124,60,1.58 [1.27-1.97],3.693231646326748e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",INSR,Insulin receptor,2062,59,8.89 [2.78-28.45],0.0002330706334354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IPCEF1,Interactor protein for cytohesin exchange factors 1,2433,83,1.03 [0.82-1.29],0.8127269132698687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IQGAP2,Ras GTPase-activating-like protein IQGAP2,2439,83,1.14 [0.82-1.58],0.4481423622838544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",2415,83,1.05 [0.85-1.29],0.6429421168913263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK1,Interleukin-1 receptor-associated kinase 1,2404,82,0.98 [0.73-1.31],0.8920581033248394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IRAK4,Interleukin-1 receptor-associated kinase 4,2461,84,0.89 [0.74-1.06],0.1932977225818337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,2360,79,1.29 [0.76-2.19],0.3364703690187323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM1,Isthmin-1,2461,84,1.78 [1.32-2.39],0.0001655213301413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ISM2,Isthmin-2,2130,58,1.07 [0.62-1.83],0.80680458542203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IST1,IST1 homolog,2109,60,0.83 [0.64-1.08],0.1748261484163361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA11,Integrin alpha-11,2461,84,0.63 [0.37-1.09],0.0979037481087534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA2,Integrin alpha-2,2085,56,0.53 [0.26-1.09],0.084925711367859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA5,Integrin alpha-5,2467,84,2.30 [1.19-4.47],0.0133408611844446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGA6,Integrin alpha-6,2461,84,0.85 [0.57-1.28],0.4382454656998099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAL,Integrin alpha-L,2062,59,2.17 [1.23-3.84],0.0078888246345506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAM,Integrin alpha-M,2467,84,1.22 [0.70-2.12],0.4878728737245353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAV,Integrin alpha-V,2475,84,0.85 [0.29-2.48],0.7664376791463077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGAX,Integrin alpha-X,2091,58,0.79 [0.44-1.41],0.4199066235233401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1,Integrin beta-1,2456,83,2.03 [0.89-4.65],0.0925932564984074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP1,Integrin beta-1-binding protein 1,2383,81,1.07 [0.66-1.74],0.7858911263450756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB1BP2,Integrin beta-1-binding protein 2,2415,83,0.92 [0.77-1.09],0.3442971549971856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB2,Integrin beta-2,2458,82,2.53 [1.43-4.48],0.0014621292911247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB5,Integrin beta-5,2456,83,1.38 [0.89-2.14],0.155447142883769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB6,Integrin beta-6,2404,82,8.27 [4.60-14.85],1.5316470937586434e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGB7,Integrin beta-7,2475,84,1.73 [1.20-2.49],0.0033460027006458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITGBL1,Integrin beta-like protein 1,2130,58,2.98 [2.10-4.24],1.155251985359773e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,2126,59,1.27 [0.34-4.76],0.7185427814908661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,2464,83,4.71 [2.82-7.86],3.0420389521294438e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,2126,59,1.92 [0.75-4.88],0.1708288291892254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,2117,60,1.07 [0.60-1.89],0.8164437658596619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITM2A,Integral membrane protein 2A,2461,84,1.90 [1.43-2.51],7.566056386544767e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPA,Inosine triphosphate pyrophosphatase,2060,56,0.70 [0.47-1.05],0.0828530361803395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",2059,54,1.25 [0.93-1.69],0.1440959865286556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",2061,56,1.61 [0.98-2.62],0.0589711217842371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",2393,81,1.18 [0.83-1.66],0.3522019343337512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",IZUMO1,Izumo sperm-egg fusion protein 1,2044,59,1.37 [0.88-2.13],0.1699314331970951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM2,Junctional adhesion molecule B,2476,84,16.09 [11.14-23.23],1.2110951897967149e-49
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JAM3,Junctional adhesion molecule C,2085,56,1.80 [1.32-2.45],0.000180744546905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JCHAIN,Immunoglobulin J chain,2404,82,1.73 [1.28-2.33],0.0003517548473883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,2044,59,1.13 [0.75-1.72],0.5605575905603879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JPT2,Jupiter microtubule associated homolog 2,2124,60,0.81 [0.60-1.09],0.1620102923920202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",JUN,Transcription factor AP-1,2404,82,1.55 [1.25-1.93],8.646292275837253e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,2439,83,4.09 [2.70-6.17],2.3150579011595315e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KAZN,Kazrin,2124,60,0.88 [0.69-1.11],0.2873800806630215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNC4,Potassium voltage-gated channel subfamily C member 4,2061,56,1.38 [0.96-1.97],0.0798468028739949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNH2,Potassium voltage-gated channel subfamily H member 2,2076,58,0.84 [0.57-1.25],0.3986399677543002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCNIP4,Kv channel-interacting protein 4,2393,81,0.86 [0.57-1.30],0.483868805669856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KCTD5,BTB/POZ domain-containing protein KCTD5,2078,58,1.49 [1.06-2.11],0.0235989653454542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDM3A,Lysine-specific demethylase 3A,2062,59,1.11 [0.84-1.46],0.4756910330923384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KDR,Vascular endothelial growth factor receptor 2,2456,83,1.46 [0.68-3.17],0.3329217713884591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KEL,Kell blood group glycoprotein,2393,81,0.65 [0.38-1.10],0.1100768244229129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHDC3L,KH domain-containing protein 3,2044,59,0.85 [0.54-1.32],0.4680569378233288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KHK,Ketohexokinase,2059,54,0.98 [0.65-1.48],0.9401513103221528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA0319,Dyslexia-associated protein KIAA0319,2116,60,5.31 [3.38-8.34],3.9959104766457097e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549,UPF0606 protein KIAA1549,2091,58,1.04 [0.71-1.53],0.8377080375697278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA1549L,UPF0606 protein KIAA1549L,2091,58,0.54 [0.20-1.42],0.2097237966167988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIAA2013,Uncharacterized protein KIAA2013,2117,60,0.83 [0.48-1.44],0.5023315205645106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF1C,Kinesin-like protein KIF1C,2060,56,2.64 [1.49-4.68],0.0008914734918939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF20B,Kinesin-like protein KIF20B,2061,56,0.85 [0.59-1.23],0.3869569858556787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIF22,Kinesin-like protein KIF22,2060,56,0.80 [0.65-0.99],0.03978270070934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIFBP,KIF-binding protein,2439,83,0.99 [0.79-1.25],0.9419173672245345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,2117,60,1.36 [1.05-1.76],0.020042131143879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,2383,81,1.49 [1.18-1.87],0.0007157533713403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,2124,60,1.10 [0.95-1.26],0.2030527372651686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,2383,81,1.02 [0.87-1.19],0.8013973088221213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,2044,59,0.96 [0.70-1.33],0.818589179643915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL1,Kin of IRRE-like protein 1,2061,56,0.97 [0.59-1.60],0.9067024560979692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIRREL2,Kin of IRRE-like protein 2,2393,81,3.69 [2.52-5.40],2.068257552449983e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KIT,Mast/stem cell growth factor receptor Kit,2464,83,1.52 [0.81-2.88],0.1944220094378651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KITLG,Kit ligand,2457,82,3.44 [2.13-5.53],3.770199699216556e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLB,Beta-klotho,2393,81,1.40 [1.10-1.78],0.005753880720999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLF4,Krueppel-like factor 4,2061,56,1.31 [0.75-2.29],0.3445455921629095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLHL41,Kelch-like protein 41,2118,60,1.63 [1.25-2.13],0.0002656350706124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK1,Kallikrein-1,2432,81,1.06 [0.91-1.23],0.4636186380396075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK10,Kallikrein-10,2450,83,2.38 [1.62-3.50],9.330556277021371e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK11,Kallikrein-11,2432,83,13.11 [8.74-19.67],1.8899949759584884e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK12,Kallikrein-12,2383,81,1.10 [0.94-1.27],0.2361739303410897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK13,Kallikrein-13,2393,83,1.57 [1.09-2.26],0.0145621860661406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK14,Kallikrein-14,2475,84,2.75 [1.89-4.02],1.5421701247424226e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK15,Kallikrein-15,2111,60,1.96 [1.19-3.22],0.0085265188741373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK3,Prostate-specific antigen,2130,58,0.76 [0.61-0.95],0.015795221419368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK4,Kallikrein-4,2475,84,2.59 [2.17-3.09],1.3899716986305402e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK6,Kallikrein-6,2452,83,7.32 [4.72-11.37],7.067675751880716e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK7,Kallikrein-7,2032,53,1.21 [0.64-2.29],0.5548672549286812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLK8,Kallikrein-8,2361,80,4.81 [3.40-6.79],6.246089465896043e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLKB1,Plasma kallikrein,2083,59,0.51 [0.19-1.37],0.1812383035940113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRB1,Killer cell lectin-like receptor subfamily B member 1,2490,84,9.86 [6.97-13.97],4.660948973448478e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,2061,56,0.87 [0.53-1.42],0.5727414593284142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRD1,Natural killer cells antigen CD94,2490,84,3.68 [2.53-5.37],1.1090465417003587e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRF1,Killer cell lectin-like receptor subfamily F member 1,2062,59,1.72 [1.33-2.23],3.380806908855977e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KLRK1,NKG2-D type II integral membrane protein,2116,60,4.01 [2.94-5.47],2.2433049871065004e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT14,"Keratin, type I cytoskeletal 14",2327,77,1.47 [0.81-2.68],0.2071982326366241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT17,"Keratin, type I cytoskeletal 17",2060,56,1.15 [0.63-2.08],0.6517546828460561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT18,"Keratin, type I cytoskeletal 18",2439,83,1.27 [1.07-1.51],0.0075617582157207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT19,"Keratin, type I cytoskeletal 19",2458,84,2.50 [2.04-3.08],3.7794057863380826e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT5,"Keratin, type II cytoskeletal 5",2393,81,1.43 [1.04-1.97],0.0267583818869492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT6C,"Keratin, type II cytoskeletal 6C",2060,56,1.00 [0.51-1.98],0.996227697151601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KRT8,"Keratin, type II cytoskeletal 8",2061,56,1.24 [1.07-1.44],0.0053264323494418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYAT1,Kynurenine--oxoglutarate transaminase 1,2456,82,0.57 [0.40-0.82],0.0024124967702512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",KYNU,Kynureninase,2490,84,0.80 [0.55-1.16],0.2376976626828855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L1CAM,Neural cell adhesion molecule L1,2456,83,1.70 [0.91-3.17],0.0947498156665236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,2122,60,0.97 [0.73-1.29],0.834475833919695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACRT,Extracellular glycoprotein lacritin,2106,60,1.24 [0.77-2.02],0.3748147775476314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LACTB2,Endoribonuclease LACTB2,2457,82,0.77 [0.56-1.06],0.1131897668449256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAG3,Lymphocyte activation gene 3 protein,2439,83,2.38 [1.90-2.99],6.186232503977481e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,2462,83,4.73 [3.74-5.99],1.7733701168545134e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,2437,83,1.55 [1.27-1.89],1.6980199944530056e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA1,Laminin subunit alpha-1,2060,56,0.84 [0.47-1.50],0.5622511631836378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMA4,Laminin subunit alpha-4,2472,83,4.03 [2.55-6.36],2.1480692638285674e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMB1,Laminin subunit beta-1,2059,54,5.03 [2.23-11.36],9.947059192134094e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP1,Lysosome-associated membrane glycoprotein 1,2083,58,1.49 [0.56-4.00],0.4252632932081921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP2,Lysosome-associated membrane glycoprotein 2,2390,81,0.37 [0.15-0.91],0.0313185987607334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMP3,Lysosome-associated membrane glycoprotein 3,2484,84,2.40 [1.69-3.40],8.924277553906093e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAMTOR5,Ragulator complex protein LAMTOR5,2117,60,1.09 [0.58-2.03],0.7880515700327944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAP3,Cytosol aminopeptidase,2404,82,0.92 [0.61-1.41],0.7071441508619538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LARP1,La-related protein 1,2117,60,1.12 [0.78-1.62],0.5320637298481607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT,Linker for activation of T-cells family member 1,2490,84,0.91 [0.71-1.17],0.4661597071640527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAT2,Linker for activation of T-cells family member 2,2439,83,1.05 [0.90-1.22],0.522158930546467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LATS1,Serine/threonine-protein kinase LATS1,2062,59,1.03 [0.76-1.38],0.866176118762215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LAYN,Layilin,2433,83,8.07 [6.18-10.56],1.1735097850927293e-52
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBP,Lipopolysaccharide-binding protein,2464,83,2.17 [1.57-3.00],2.470182714664468e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LBR,Delta(14)-sterol reductase LBR,2476,84,1.16 [0.92-1.47],0.2042430835072956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCAT,Phosphatidylcholine-sterol acyltransferase,2130,61,0.47 [0.18-1.22],0.122167042636187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN15,Lipocalin-15,2118,60,1.68 [1.37-2.06],6.471144992301611e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCN2,Neutrophil gelatinase-associated lipocalin,2381,79,3.61 [2.75-4.73],2.3596420120665896e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LCP1,Plastin-2,2130,58,0.89 [0.52-1.52],0.6681009641262032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLR,Low-density lipoprotein receptor,2466,83,0.91 [0.63-1.31],0.6137670648149027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LDLRAP1,Low density lipoprotein receptor adapter protein 1,2118,60,0.85 [0.66-1.09],0.2016205096072385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LECT2,Leukocyte cell-derived chemotaxin-2,2122,60,1.64 [1.25-2.15],0.0003275271345438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEFTY2,Left-right determination factor 2,2472,84,1.88 [1.32-2.68],0.0005223688771008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEG1,Protein LEG1 homolog,2009,55,1.25 [0.88-1.78],0.2126728322346789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LELP1,Late cornified envelope-like proline-rich protein 1,2061,56,0.95 [0.63-1.43],0.8057977993044537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEO1,RNA polymerase-associated protein LEO1,2118,60,1.64 [1.05-2.56],0.0295108586203626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEP,Leptin,2457,82,1.09 [0.81-1.48],0.5673650905931014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LEPR,Leptin receptor,2457,82,2.09 [1.20-3.65],0.0094775154933735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LETM1,Mitochondrial proton/calcium exchanger protein,2118,60,1.82 [1.29-2.56],0.0006392401949515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS1,Galectin-1,2457,82,3.82 [2.49-5.85],7.99253681341638e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3,Galectin-3,2463,83,5.36 [3.12-9.21],1.1557332743717207e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS3BP,Galectin-3-binding protein,2126,59,1.38 [0.69-2.78],0.366218277018413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS4,Galectin-4,2462,83,3.42 [2.70-4.33],2.7237329162016905e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS7_LGALS7B,Galectin-7,2449,83,3.28 [2.42-4.44],1.54053085782537e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS8,Galectin-8,2476,84,1.14 [0.83-1.56],0.4346309144068768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGALS9,Galectin-9,2466,83,14.04 [8.54-23.08],2.154988524478967e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LGMN,Legumain,2472,83,1.95 [1.18-3.20],0.0086012565476357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHB,Lutropin subunit beta,2383,81,1.00 [0.80-1.25],0.99688159587993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,2459,83,0.67 [0.52-0.88],0.0034124840040935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIF,Leukemia inhibitory factor,2393,81,0.98 [0.66-1.45],0.91273411989314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIFR,Leukemia inhibitory factor receptor,2461,84,13.58 [7.46-24.70],1.3157038513598317e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,2467,84,1.54 [0.89-2.65],0.1207908395652007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,2130,58,1.00 [0.83-1.20],0.9874746065694804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,2060,56,0.60 [0.30-1.18],0.1383732544369563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,2457,82,6.56 [3.68-11.67],1.6345956941633355e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,2122,60,1.00 [0.72-1.37],0.9863323022217916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,2490,84,2.42 [1.22-4.79],0.0110698197969174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,2480,84,3.27 [1.91-5.58],1.4434506594680548e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,2404,82,5.04 [3.58-7.11],2.62486409047732e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,2490,84,1.31 [0.97-1.77],0.07801912968029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LIPF,Gastric triacylglycerol lipase,2059,54,0.90 [0.61-1.31],0.5773366775522222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB1,Lamin-B1,2121,60,1.30 [0.99-1.72],0.0612419365455955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMNB2,Lamin-B2,2116,60,5.28 [3.52-7.94],1.084533990790027e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD1,Leiomodin-1,2118,60,4.93 [3.55-6.86],2.2357788752581235e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LMOD2,Leiomodin-2,2061,56,0.73 [0.44-1.20],0.2116374520369157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LONP1,"Lon protease homolog, mitochondrial",2059,54,0.97 [0.72-1.32],0.8587083585869366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPA,Apolipoprotein(a),2082,59,1.03 [0.90-1.17],0.704683548648551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPCAT2,Lysophosphatidylcholine acyltransferase 2,2439,83,1.25 [0.94-1.66],0.1244946132434716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPL,Lipoprotein lipase,2457,82,1.55 [1.02-2.35],0.0395218062957487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPO,Lactoperoxidase,2374,80,1.36 [1.01-1.83],0.0423984165904787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LPP,Lipoma-preferred partner,2060,56,0.80 [0.53-1.19],0.270798002601988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,2060,56,1.27 [0.88-1.84],0.2091416366318791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,2076,58,1.47 [0.99-2.18],0.0579748416473532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRG1,Leucine-rich alpha-2-glycoprotein,2126,59,8.66 [3.92-19.14],9.544348192714613e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,2470,84,3.49 [2.37-5.14],2.795253080541057e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,2056,59,2.08 [1.11-3.87],0.0214093139583886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP1,Prolow-density lipoprotein receptor-related protein 1,2439,83,2.06 [1.07-3.97],0.0299547093633961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP11,Low-density lipoprotein receptor-related protein 11,2457,82,10.07 [6.78-14.97],3.290567191397459e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2,Low-density lipoprotein receptor-related protein 2,2076,58,0.94 [0.45-1.99],0.8783308682584212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRP2BP,LRP2-binding protein,2076,58,0.97 [0.70-1.33],0.8340383915158693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,2476,84,1.03 [0.72-1.46],0.8910224403434209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC25,Leucine-rich repeat-containing protein 25,2439,83,1.77 [1.39-2.26],3.4372218423794235e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC37A2,Leucine-rich repeat-containing protein 37A2,2124,60,2.18 [1.24-3.84],0.006664120631825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC38,Leucine-rich repeat-containing protein 38,2076,58,1.55 [0.95-2.55],0.0799098518439235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRC59,Leucine-rich repeat-containing protein 59,2122,60,0.75 [0.43-1.31],0.3073926863599653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,2117,60,0.99 [0.60-1.66],0.9805063830636952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRRN1,Leucine-rich repeat neuronal protein 1,2404,82,0.68 [0.42-1.10],0.1159092414135673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,2076,58,1.27 [0.75-2.18],0.3751498054946728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,2118,60,2.28 [1.00-5.20],0.0495606867160657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM1,U6 snRNA-associated Sm-like protein LSm1,2383,81,0.90 [0.60-1.35],0.6063891507502551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSM8,U6 snRNA-associated Sm-like protein LSm8,2091,58,0.90 [0.65-1.26],0.5501393249877815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LSP1,Lymphocyte-specific protein 1,2461,84,2.06 [1.32-3.20],0.0014403267931779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA,Lymphotoxin-alpha,2461,84,1.50 [0.94-2.40],0.0858736120019814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTA4H,Leukotriene A-4 hydrolase,2475,84,1.06 [0.78-1.45],0.7030414643676588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTB,Lymphotoxin-beta,2117,60,1.76 [1.12-2.78],0.0146799132238924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP2,Latent-transforming growth factor beta-binding protein 2,2490,84,6.87 [4.82-9.79],1.5757055201705926e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBP3,Latent-transforming growth factor beta-binding protein 3,2383,81,1.64 [1.33-2.02],2.7852860278337545e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTBR,Tumor necrosis factor receptor superfamily member 3,2450,83,10.76 [7.64-15.15],3.586509563905629e-42
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LTO1,Protein LTO1 homolog,2404,82,0.99 [0.58-1.67],0.9620779114927354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LUZP2,Leucine zipper protein 2,2117,60,2.22 [1.63-3.01],3.548880655396277e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LXN,Latexin,2424,83,0.57 [0.41-0.78],0.0004164711247225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY6D,Lymphocyte antigen 6D,2447,83,4.08 [3.14-5.30],5.329494072287669e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY75,Lymphocyte antigen 75,2461,84,2.01 [1.22-3.29],0.0057502605952329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY9,T-lymphocyte surface antigen Ly-9,2424,81,2.93 [1.63-5.27],0.0003216641556909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LY96,Lymphocyte antigen 96,2437,83,1.27 [0.76-2.11],0.3631743092575602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYAR,Cell growth-regulating nucleolar protein,2383,81,0.62 [0.39-1.00],0.0512557016538645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYN,Tyrosine-protein kinase Lyn,2439,83,1.02 [0.81-1.28],0.8735164385008751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD1,Ly6/PLAUR domain-containing protein 1,2393,81,0.79 [0.53-1.17],0.2372953315342548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD3,Ly6/PLAUR domain-containing protein 3,2436,82,1.12 [0.65-1.92],0.675000714993965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPD8,Ly6/PLAUR domain-containing protein 8,2383,81,1.37 [1.12-1.68],0.0024065912662419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYPLA2,Acyl-protein thioesterase 2,2061,56,0.99 [0.78-1.26],0.93390272890444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,2076,58,1.05 [0.83-1.32],0.7027435029185437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,2126,59,6.35 [1.96-20.61],0.0020720341717977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LYZL2,Lysozyme-like protein 2,2044,59,2.19 [1.21-3.97],0.0098745126369245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",LZTFL1,Leucine zipper transcription factor-like protein 1,2085,56,0.76 [0.52-1.12],0.1690530708049937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",M6PR,Cation-dependent mannose-6-phosphate receptor,2059,54,0.72 [0.33-1.54],0.3976841168482216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,2425,83,1.63 [1.34-1.99],1.3307604899755443e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAEA,E3 ubiquitin-protein transferase MAEA,2383,81,0.85 [0.49-1.45],0.5470856583656616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAG,Myelin-associated glycoprotein,2076,58,0.86 [0.50-1.46],0.5743871523866999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGEA3,Melanoma-associated antigen 3,2091,58,0.97 [0.73-1.29],0.8335839510597554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAGED1,Melanoma-associated antigen D1,2383,81,1.32 [0.92-1.89],0.1362288007494587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC2,MAM domain-containing protein 2,2122,60,6.80 [4.25-10.88],1.3146190947691484e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAMDC4,Apical endosomal glycoprotein,2117,60,1.19 [0.79-1.80],0.4018089204699898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",2059,54,5.75 [2.03-16.28],0.0009866029846924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAN2B2,Epididymis-specific alpha-mannosidase,2122,60,0.89 [0.60-1.33],0.5675620582317947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",2044,59,1.33 [0.83-2.15],0.2393584655338099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANF,Mesencephalic astrocyte-derived neurotrophic factor,2472,83,0.92 [0.79-1.07],0.2993558549588261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC1,MANSC domain-containing protein 1,2456,83,17.28 [9.94-30.04],5.662999591827509e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MANSC4,MANSC domain-containing protein 4,2060,56,1.25 [0.90-1.75],0.1815402779918619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,2061,56,0.55 [0.24-1.24],0.1482107510095952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,2060,56,1.00 [0.67-1.48],0.9865569138686062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2,Microtubule-associated protein 2,2116,60,1.61 [1.03-2.53],0.0368717923408194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,2124,60,1.32 [0.89-1.98],0.1715873679625862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,2461,84,0.89 [0.73-1.09],0.255453062337911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,2383,81,1.00 [0.81-1.23],0.9723901693627404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,2433,83,0.92 [0.77-1.10],0.3449908603721464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK13,Mitogen-activated protein kinase 13,2044,59,1.24 [0.80-1.94],0.3370303228670872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPK9,Mitogen-activated protein kinase 9,2461,84,1.59 [1.03-2.45],0.0355743986740536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPKAPK2,MAP kinase-activated protein kinase 2,2091,58,0.95 [0.67-1.34],0.7538727461635639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPRE3,Microtubule-associated protein RP/EB family member 3,2044,59,1.01 [0.86-1.20],0.8626188894663677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAPT,Microtubule-associated protein tau,2393,81,1.43 [0.96-2.11],0.0757488314062052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARCO,Macrophage receptor MARCO,2457,82,2.38 [1.14-4.98],0.0209411839105949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MARS1,"Methionine--tRNA ligase, cytoplasmic",2084,55,0.98 [0.72-1.34],0.9101333887599132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MASP1,Mannan-binding lectin serine protease 1,2433,83,1.08 [0.47-2.45],0.8552370218038569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN2,Matrilin-2,2467,83,7.13 [3.85-13.18],3.8395882252683287e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MATN3,Matrilin-3,2433,83,1.30 [0.75-2.28],0.3525148541266523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAVS,Mitochondrial antiviral-signaling protein,2383,81,0.95 [0.76-1.20],0.6907225223907522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MAX,Protein max,2393,81,0.99 [0.82-1.19],0.8883586201427529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MB,Myoglobin,2490,84,2.21 [1.76-2.77],7.728465901701186e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MBL2,Mannose-binding protein C,2098,59,1.05 [0.84-1.30],0.6910327771644145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCAM,Cell surface glycoprotein MUC18,2464,83,2.56 [1.64-3.98],3.428349538641319e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",2118,60,0.50 [0.24-1.01],0.0519485449777085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCEMP1,Mast cell-expressed membrane protein 1,2062,59,0.87 [0.64-1.18],0.3736795782957122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCFD2,Multiple coagulation factor deficiency protein 2,2444,82,1.98 [1.33-2.95],0.0007756677445155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MCTS1,Malignant T-cell-amplified sequence 1,2124,60,1.80 [0.99-3.26],0.0539330243307171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,2437,83,1.50 [1.14-1.98],0.0035012352176914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDH1,"Malate dehydrogenase, cytoplasmic",2116,61,0.43 [0.22-0.84],0.0137334594516111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDK,Midkine,2447,83,2.11 [1.69-2.64],5.505981457552871e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MDM1,Nuclear protein MDM1,2076,58,0.63 [0.27-1.48],0.288165194346813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",2059,54,0.86 [0.64-1.15],0.3025295838592913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED18,Mediator of RNA polymerase II transcription subunit 18,2383,81,0.96 [0.73-1.25],0.7398974673050738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MED21,Mediator of RNA polymerase II transcription subunit 21,2060,56,0.97 [0.56-1.65],0.9001768239526412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF10,Multiple epidermal growth factor-like domains protein 10,2462,83,1.69 [1.07-2.69],0.025918383704283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF11,Multiple epidermal growth factor-like domains protein 11,2060,56,2.20 [1.14-4.24],0.0191260427447622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEGF9,Multiple epidermal growth factor-like domains protein 9,2485,84,3.11 [1.24-7.84],0.016044889904741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MELTF,Melanotransferrin,2122,60,6.28 [2.90-13.62],3.2514531906282184e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MENT,Protein MENT,2085,56,0.33 [0.14-0.81],0.0155384882077481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1A,Meprin A subunit alpha,2124,60,0.79 [0.57-1.10],0.1653206390915863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEP1B,Meprin A subunit beta,2457,82,0.80 [0.68-0.94],0.0052651561234655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MEPE,Matrix extracellular phosphoglycoprotein,2462,83,3.92 [1.75-8.78],0.000879675701589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MERTK,Tyrosine-protein kinase Mer,2490,84,5.27 [2.83-9.80],1.5683455210268128e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MESD,LRP chaperone MESD,2467,84,0.91 [0.78-1.07],0.2579273482215161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MET,Hepatocyte growth factor receptor,2470,82,3.08 [1.23-7.72],0.0166065922443062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1,Methionine aminopeptidase 1,2393,81,0.65 [0.32-1.35],0.2501481453747678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",2461,84,0.94 [0.74-1.20],0.6268408860068675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",METAP2,Methionine aminopeptidase 2,2472,84,0.84 [0.58-1.20],0.3382664537486772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3,Microfibril-associated glycoprotein 3,2415,83,1.25 [0.88-1.77],0.2184539233226948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP3L,Microfibrillar-associated protein 3-like,2076,58,0.70 [0.41-1.19],0.1879201389629963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP4,Microfibril-associated glycoprotein 4,2085,56,5.57 [2.82-11.03],8.046820321160222e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFAP5,Microfibrillar-associated protein 5,2490,84,6.91 [4.59-10.39],1.654241967799467e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MFGE8,Lactadherin,2467,84,1.45 [1.00-2.11],0.0509091369774022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGLL,Monoglyceride lipase,2471,83,0.92 [0.74-1.15],0.4787070254631494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MGMT,Methylated-DNA--protein-cysteine methyltransferase,2461,84,0.95 [0.80-1.11],0.5044086805562658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIA,Melanoma-derived growth regulatory protein,2456,83,3.76 [2.46-5.74],9.794337681077419e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICALL2,MICAL-like protein 2,2076,58,1.06 [0.73-1.53],0.7651179019848413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,2461,84,1.33 [1.09-1.63],0.0059745738931637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MIF,Macrophage migration inhibitory factor,2463,84,0.71 [0.53-0.96],0.0243014704821772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MILR1,Allergin-1,2404,82,1.98 [1.40-2.82],0.0001285185458896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,2117,60,0.83 [0.66-1.05],0.1230635153148549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MINK1,Misshapen-like kinase 1,2116,60,0.85 [0.65-1.12],0.2468581489834264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MITD1,MIT domain-containing protein 1,2437,83,0.93 [0.76-1.14],0.4884113668548873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MKI67,Proliferation marker protein Ki-67,2062,59,1.06 [0.63-1.79],0.8155793716306705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLLT1,Protein ENL,2044,59,1.06 [0.73-1.53],0.7742940466812437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MLN,Promotilin,2461,84,1.46 [1.17-1.84],0.0010232397893842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MME,Neprilysin,2439,83,1.19 [0.95-1.50],0.1320824525335238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP1,Interstitial collagenase,2387,82,1.42 [1.13-1.78],0.0024513324822995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP10,Stromelysin-2,2457,83,3.15 [2.37-4.20],4.261897245459378e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP12,Macrophage metalloelastase,2459,84,2.48 [1.91-3.23],1.3963908994030319e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP13,Collagenase 3,2393,81,1.71 [0.93-3.13],0.0845322771917381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP15,Matrix metalloproteinase-15,2122,60,0.55 [0.24-1.26],0.1593617990537494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP3,Stromelysin-1,2467,84,2.61 [1.95-3.49],8.970017459842863e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP7,Matrilysin,2412,83,7.39 [5.20-10.51],7.582992474482077e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP8,Neutrophil collagenase,2473,84,1.18 [0.93-1.51],0.176876746334322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMP9,Matrix metalloproteinase-9,2464,84,1.07 [0.78-1.47],0.6538311512772809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",2060,56,0.92 [0.54-1.57],0.7572413411878108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MN1,Transcriptional activator MN1,2076,58,1.06 [0.71-1.57],0.7809382992542035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNAT1,CDK-activating kinase assembly factor MAT1,2091,58,1.47 [0.98-2.18],0.0597966339388227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MNDA,Myeloid cell nuclear differentiation antigen,2453,82,0.94 [0.78-1.15],0.5663343891929785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOCS2,Molybdopterin synthase catalytic subunit,2085,56,1.14 [0.77-1.69],0.5021477970413594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MOG,Myelin-oligodendrocyte glycoprotein,2475,84,5.94 [3.95-8.93],1.0816855933413978e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORC3,MORC family CW-type zinc finger protein 3,2116,60,0.65 [0.23-1.83],0.4173921387557914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L1,Mortality factor 4-like protein 1,2091,58,0.89 [0.46-1.74],0.7417127032236561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORF4L2,Mortality factor 4-like protein 2,2044,59,1.08 [0.55-2.10],0.8247113975268673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MORN4,MORN repeat-containing protein 4,2044,59,0.81 [0.57-1.17],0.2645164367186676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPHOSPH8,M-phase phosphoprotein 8,2415,83,0.92 [0.71-1.20],0.5542885947915637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPI,Mannose-6-phosphate isomerase,2439,83,1.18 [0.94-1.49],0.1536842648774087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,2471,83,0.93 [0.73-1.19],0.5599683329081762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPO,Myeloperoxidase,2467,84,1.32 [0.92-1.89],0.1361564123149504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MPRIP,Myosin phosphatase Rho-interacting protein,2113,60,0.72 [0.40-1.31],0.2809550177312532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRC1,Macrophage mannose receptor 1,2130,61,5.74 [2.64-12.46],1.0155712075013735e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRI1,Methylthioribose-1-phosphate isomerase,2076,58,0.85 [0.60-1.22],0.3845118305181285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL24,"39S ribosomal protein L24, mitochondrial",2060,56,1.64 [1.10-2.46],0.0156724937549645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL28,"39S ribosomal protein L28, mitochondrial",2118,60,1.28 [0.83-1.96],0.2642367181559455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL46,"39S ribosomal protein L46, mitochondrial",2393,81,0.68 [0.32-1.45],0.3184928890468176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL52,"39S ribosomal protein L52, mitochondrial",2040,58,1.80 [0.81-3.98],0.1467848039259902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",2118,60,0.79 [0.53-1.18],0.247651277410605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MRPS16,"28S ribosomal protein S16, mitochondrial",2062,59,0.40 [0.14-1.12],0.0803499541333254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLN,Mesothelin,2434,83,1.96 [1.48-2.60],2.6573026873885925e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSLNL,Mesothelin-like protein,2076,58,0.93 [0.45-1.93],0.8395520082685733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSMB,Beta-microseminoprotein,2459,82,2.44 [1.95-3.05],5.814628275809317e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSR1,Macrophage scavenger receptor types I and II,2476,84,2.96 [2.05-4.28],7.277016545219643e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSRA,Mitochondrial peptide methionine sulfoxide reductase,2456,83,0.92 [0.71-1.21],0.5715676893800943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MST1,Hepatocyte growth factor-like protein,2099,60,1.73 [0.97-3.07],0.0625381685087738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MSTN,Growth/differentiation factor 8,2415,83,1.87 [1.32-2.64],0.0004074680434774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTDH,Protein LYRIC,2062,59,1.04 [0.80-1.35],0.7560103131140653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",2116,60,0.58 [0.19-1.75],0.3291343357613406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,2091,58,0.91 [0.73-1.14],0.4114734538340436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTIF3,"Translation initiation factor IF-3, mitochondrial",2124,60,0.86 [0.65-1.15],0.3069317256804185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTPN,Myotrophin,2415,83,0.94 [0.48-1.83],0.8486834106087257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTR,Methionine synthase,2060,56,0.75 [0.46-1.23],0.2621152253011656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS1,Protein MTSS 1,2124,60,0.93 [0.75-1.16],0.5309479284436283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTSS2,Protein MTSS 2,2117,60,0.97 [0.76-1.25],0.8281717118813816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MTUS1,Microtubule-associated tumor suppressor 1,2091,58,1.28 [0.86-1.92],0.2203521553330586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC13,Mucin-13,2393,81,2.14 [1.64-2.79],2.3232500277029752e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC16,Mucin-16,2439,83,1.06 [0.95-1.19],0.284714165704423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUC2,Mucin-2,2130,58,0.77 [0.59-1.02],0.0665135592778304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MUCL3,Mucin-like protein 3,2044,59,1.31 [0.85-2.01],0.2203587084679699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MVK,Mevalonate kinase,2404,82,1.19 [0.97-1.46],0.0975467992895639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MXRA8,Matrix remodeling-associated protein 8,2085,56,4.64 [2.19-9.86],6.412637431124757e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC1,"Myosin-binding protein C, slow-type",2122,60,1.68 [1.30-2.16],5.383310079923845e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYBPC2,"Myosin-binding protein C, fast-type",2059,54,1.42 [1.17-1.73],0.0003476618637755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,2118,60,0.79 [0.52-1.20],0.2694969076147663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYDGF,Myeloid-derived growth factor,2122,60,0.99 [0.76-1.28],0.934935406397057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH4,Myosin-4,2060,56,0.79 [0.40-1.54],0.4833935340272688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH7B,Myosin-7B,2044,59,2.09 [1.29-3.37],0.0025405230768145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYH9,Myosin-9,2130,58,0.85 [0.68-1.06],0.1508964468615048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",2060,56,1.57 [1.20-2.05],0.0009438204863903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL3,Myosin light chain 3,2059,54,1.60 [1.17-2.20],0.0036834976874455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL4,Myosin light chain 4,2059,54,0.82 [0.49-1.38],0.458645280034755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYL6B,Myosin light chain 6B,2076,58,1.08 [0.83-1.40],0.5784305901982912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",2076,58,1.78 [1.37-2.30],1.3796959522103107e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO6,Unconventional myosin-VI,2118,60,1.90 [1.28-2.82],0.001511589945836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYO9B,Unconventional myosin-IXb,2404,82,1.06 [0.79-1.42],0.6785512563271586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOC,Myocilin,2467,84,2.05 [1.35-3.09],0.0006673635622366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM1,Myomesin-1,2061,56,1.32 [0.86-2.03],0.1997569631248169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM2,Myomesin-2,2060,56,1.53 [1.12-2.08],0.0074409889219884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MYOM3,Myomesin-3,2085,56,1.09 [0.84-1.42],0.5125681378687201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZB1,Marginal zone B- and B1-cell-specific protein,2468,83,2.25 [1.62-3.13],1.231321470179497e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",MZT1,Mitotic-spindle organizing protein 1,2383,81,0.97 [0.67-1.43],0.89624472437225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA10,N-alpha-acetyltransferase 10,2060,56,0.95 [0.56-1.60],0.8428049618539346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAA80,N-alpha-acetyltransferase 80,2076,58,0.87 [0.70-1.07],0.1895582047789503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAAA,N-acylethanolamine-hydrolyzing acid amidase,2426,83,1.27 [0.92-1.74],0.1429844338110102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NACC1,Nucleus accumbens-associated protein 1,2117,60,1.26 [0.83-1.89],0.276925120974683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NADK,NAD kinase,2457,82,1.16 [0.85-1.57],0.3595100455393433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGA,Alpha-N-acetylgalactosaminidase,2056,59,1.25 [0.82-1.92],0.2940234454322443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGK,N-acetyl-D-glucosamine kinase,2056,54,0.46 [0.30-0.73],0.0009088651955687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,2085,56,0.81 [0.27-2.42],0.7073409583775817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAMPT,Nicotinamide phosphoribosyltransferase,2383,81,1.00 [0.72-1.39],0.9893483687293972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAP1L4,Nucleosome assembly protein 1-like 4,2120,59,0.44 [0.24-0.79],0.0064013886217966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NAPRT,Nicotinate phosphoribosyltransferase,2116,60,0.46 [0.20-1.07],0.071906066180236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NARS1,"Asparagine--tRNA ligase, cytoplasmic",2118,60,0.74 [0.44-1.25],0.2605803341400994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBL1,Neuroblastoma suppressor of tumorigenicity 1,2456,83,27.06 [16.97-43.15],1.2142584239725264e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NBN,Nibrin,2404,82,0.87 [0.58-1.30],0.4955068188931255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM1,Neural cell adhesion molecule 1,2464,83,1.44 [0.85-2.45],0.1794854654245704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAM2,Neural cell adhesion molecule 2,2467,84,1.54 [0.77-3.08],0.2214666665627335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCAN,Neurocan core protein,2476,84,0.56 [0.35-0.89],0.0136124741232531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCF2,Neutrophil cytosol factor 2,2457,84,0.96 [0.77-1.20],0.7379841685451052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCK2,Cytoplasmic protein NCK2,2472,83,0.92 [0.77-1.11],0.4010889250367809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCLN,Nicalin,2404,82,0.77 [0.46-1.27],0.3010917239736172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR1,Natural cytotoxicity triggering receptor 1,2458,84,7.22 [5.25-9.91],3.112441539356228e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,2124,60,10.52 [6.55-16.91],2.438381231014744e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NCS1,Neuronal calcium sensor 1,2475,84,9.74 [5.58-17.01],1.2253193035739382e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDRG1,Protein NDRG1,2393,81,0.99 [0.72-1.35],0.9272903376558012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,2117,60,1.08 [0.73-1.60],0.7117918317953409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,2059,59,2.57 [1.33-4.94],0.0047350018692964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,2124,60,0.75 [0.56-1.00],0.0533133189127575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",2383,81,1.54 [1.31-1.82],2.646627193717883e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEB,Nebulin,2060,56,1.49 [0.85-2.62],0.1668421414158168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECAP2,Adaptin ear-binding coat-associated protein 2,2060,56,1.05 [0.71-1.56],0.8121823165984581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN1,Nectin-1,2062,59,1.51 [0.81-2.84],0.1952254729879681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN2,Nectin-2,2457,82,12.53 [8.58-18.32],5.7187938956861415e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NECTIN4,Nectin-4,2456,83,6.20 [4.71-8.15],5.856401120072636e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,2062,59,0.62 [0.39-0.97],0.0382621380555324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEDD9,Enhancer of filamentation 1,2062,59,1.38 [0.74-2.55],0.3073475561692723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEFL,Neurofilament light polypeptide,2385,80,3.11 [2.59-3.74],1.4143408986581446e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEK7,Serine/threonine-protein kinase Nek7,2091,58,0.86 [0.58-1.26],0.4357503550588223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL1,Protein kinase C-binding protein NELL1,2456,83,0.33 [0.25-0.45],8.13183821999557e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NELL2,Protein kinase C-binding protein NELL2,2472,83,1.20 [0.64-2.26],0.5740285837195247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NENF,Neudesin,2117,60,1.08 [0.88-1.32],0.468920637346272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEO1,Neogenin,2118,60,3.26 [2.08-5.10],2.3963562488852295e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NEXN,Nexilin,2130,61,0.94 [0.66-1.34],0.7345143566780141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFASC,Neurofascin,2490,84,6.55 [3.87-11.11],2.834311714179379e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFAT5,Nuclear factor of activated T-cells 5,2062,59,1.17 [0.89-1.54],0.2598591203496809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",2461,84,0.93 [0.76-1.13],0.4652957730191626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",2404,82,1.11 [0.82-1.49],0.5101034736414223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFE2,Transcription factor NF-E2 45 kDa subunit,2059,54,0.89 [0.61-1.28],0.5172570710528464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFIC,Nuclear factor 1 C-type,2118,60,1.11 [0.60-2.04],0.7492535701101417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB1,Nuclear factor NF-kappa-B p105 subunit,2060,56,0.91 [0.63-1.31],0.5994804719937736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKB2,Nuclear factor NF-kappa-B p100 subunit,2091,58,1.44 [1.08-1.92],0.012642851999739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFKBIE,NF-kappa-B inhibitor epsilon,2383,81,1.50 [1.03-2.17],0.0328881333253438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",2124,60,0.93 [0.73-1.18],0.5459899513494397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFX1,Transcriptional repressor NF-X1,2060,56,1.06 [0.74-1.50],0.76349216507746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NFYA,Nuclear transcription factor Y subunit alpha,2060,56,1.07 [0.57-1.99],0.8364349105471859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGF,Beta-nerve growth factor,2437,83,6.17 [2.19-17.39],0.0005754084571593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGFR,Tumor necrosis factor receptor superfamily member 16,2122,60,1.71 [1.12-2.62],0.0131700660721449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NGRN,Neugrin,2116,60,5.46 [2.36-12.63],7.34731835564207e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NHLRC3,NHL repeat-containing protein 3,2038,53,4.64 [2.00-10.72],0.0003350268210663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID1,Nidogen-1,2460,83,1.61 [0.96-2.69],0.071123230827922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NID2,Nidogen-2,2467,84,1.15 [0.89-1.48],0.2979050526692293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NINJ1,Ninjurin-1,2383,81,1.14 [0.84-1.56],0.4040887215164769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT1,Deaminated glutathione amidase,2059,54,0.38 [0.23-0.64],0.0002073942354222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NIT2,Omega-amidase NIT2,2113,60,0.85 [0.60-1.22],0.3891662243357217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN1,Neuroligin-1,2076,58,1.03 [0.71-1.50],0.8808085562886231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NLGN2,Neuroligin-2,2061,56,0.63 [0.30-1.32],0.2226078527276904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME1,Nucleoside diphosphate kinase A,2062,59,0.97 [0.30-3.15],0.9642186280937723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NME3,Nucleoside diphosphate kinase 3,2467,83,1.16 [0.50-2.67],0.7312740038545903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMI,N-myc-interactor,2110,60,1.04 [0.74-1.47],0.8206513893013845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,2437,83,1.03 [0.82-1.29],0.7856965089052923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMRK2,Nicotinamide riboside kinase 2,2044,59,0.76 [0.34-1.70],0.508795945052821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,2118,60,0.68 [0.43-1.09],0.1065011850117268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOMO1,Nodal modulator 1,2467,84,1.37 [0.61-3.05],0.4480246202520439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOP56,Nucleolar protein 56,2060,56,1.14 [0.94-1.39],0.192684715951882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS1,"Nitric oxide synthase, brain",2393,81,2.39 [1.92-2.98],8.300892162905591e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS2,"Nitric oxide synthase, inducible",2060,56,0.84 [0.42-1.69],0.6312363534739143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOS3,"Nitric oxide synthase, endothelial",2393,81,1.36 [1.00-1.87],0.0535262647662227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH1,Neurogenic locus notch homolog protein 1,2490,84,28.45 [9.76-82.93],8.647522223355991e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH2,Neurogenic locus notch homolog protein 2,2130,58,10.56 [4.88-22.85],2.206495483948188e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NOTCH3,Neurogenic locus notch homolog protein 3,2490,84,4.49 [2.77-7.25],9.255069490726595e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPC2,NPC intracellular cholesterol transporter 2,2096,58,16.51 [10.07-27.06],1.038918625192978e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPDC1,Neural proliferation differentiation and control protein 1,2457,82,7.01 [5.18-9.48],1.0840043158626776e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS1,Nephrin,2062,59,0.31 [0.15-0.62],0.0009108936907283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPHS2,Podocin,2062,59,1.02 [0.80-1.29],0.9018905397402824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPL,N-acetylneuraminate lyase,2122,60,1.56 [0.97-2.51],0.0641215095333145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPB,Natriuretic peptides B,2415,83,1.42 [1.26-1.60],9.362961401432626e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPPC,C-type natriuretic peptide,2461,84,2.11 [1.68-2.65],1.902437397669909e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPR1,Atrial natriuretic peptide receptor 1,2060,56,0.62 [0.28-1.36],0.2313648479819895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTN,Neuroplastin,2383,81,1.06 [0.83-1.36],0.6349700584316063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX1,Neuronal pentraxin-1,2467,84,1.39 [0.92-2.11],0.1137234094690296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTX2,Neuronal pentraxin-2,2130,58,1.91 [0.94-3.88],0.0737169472177854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPTXR,Neuronal pentraxin receptor,2457,82,1.57 [1.00-2.48],0.0521989164881555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NPY,Pro-neuropeptide Y,2475,84,2.45 [1.78-3.39],5.247062119138904e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRCAM,Neuronal cell adhesion molecule,2457,82,3.09 [1.80-5.31],4.191159334045334e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRGN,Neurogranin,2130,61,0.83 [0.63-1.09],0.1875945398498051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRN1,Neuritin,2118,60,0.76 [0.33-1.75],0.5240619522293231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP1,Neuropilin-1,2466,83,6.91 [3.78-12.62],3.3181379950389433e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRP2,Neuropilin-2,2467,84,2.12 [1.14-3.93],0.0178555429950631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRTN,Neurturin,2404,82,0.77 [0.51-1.16],0.2079856393954693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NRXN3,Neurexin-3,2076,58,1.06 [0.50-2.23],0.8805996663214691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NSFL1C,NSFL1 cofactor p47,2476,84,0.69 [0.51-0.94],0.0181931208302544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",2122,60,0.93 [0.65-1.32],0.6696893792957093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C1A,Cytosolic 5'-nucleotidase 1A,2116,60,3.52 [2.58-4.79],1.3663813342514965e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5C3A,Cytosolic 5'-nucleotidase 3A,2457,84,0.74 [0.59-0.93],0.0085680282213281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NT5E,5'-nucleotidase,2456,83,1.37 [0.97-1.93],0.0729242780738628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF3,Neurotrophin-3,2461,84,2.01 [1.35-2.99],0.0005524182871218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTF4,Neurotrophin-4,2383,81,1.43 [0.93-2.18],0.1007819394121465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK2,BDNF/NT-3 growth factors receptor,2457,82,2.26 [1.10-4.63],0.0259454928740824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTRK3,NT-3 growth factor receptor,2476,84,1.26 [0.54-2.94],0.5879760969154247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NTproBNP,N-terminal prohormone of brain natriuretic peptide,2457,82,1.58 [1.41-1.76],6.030859000600214e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUB1,NEDD8 ultimate buster 1,2461,84,0.91 [0.71-1.16],0.4512767450368818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,2117,60,1.01 [0.79-1.30],0.9247248438628964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUCB2,Nucleobindin-2,2471,84,4.37 [2.87-6.66],6.434217607232808e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDC,Nuclear migration protein nudC,2490,84,0.95 [0.69-1.30],0.740235646247753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,2059,54,0.76 [0.22-2.61],0.6587255961703136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,2060,56,0.73 [0.39-1.35],0.3103510604071187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT16,U8 snoRNA-decapping enzyme,2121,60,1.14 [0.86-1.52],0.3550831647299142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],2439,83,0.76 [0.52-1.11],0.1556886895662613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUDT5,ADP-sugar pyrophosphatase,2467,84,1.35 [0.91-2.01],0.1325548501361928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUMB,Protein numb homolog,2062,59,0.88 [0.65-1.19],0.407952968943807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NUP50,Nuclear pore complex protein Nup50,2060,56,0.43 [0.14-1.30],0.1334963875544447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPE4,NXPE family member 4,2060,56,0.95 [0.42-2.17],0.905058990122175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH1,Neurexophilin-1,2393,81,2.40 [1.70-3.39],7.476307089819468e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",NXPH3,Neurexophilin-3,2062,59,12.05 [6.12-23.75],6.374512981997027e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OBP2B,Odorant-binding protein 2b,2431,83,1.53 [1.08-2.15],0.0152728346678149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OCLN,Occludin,2118,60,5.58 [3.89-8.00],1.0601885378179312e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ODAM,Odontogenic ameloblast-associated protein,2387,80,1.35 [1.01-1.79],0.0421437476499923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OFD1,Oral-facial-digital syndrome 1 protein,2091,58,0.95 [0.63-1.43],0.8006285021920726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGA,Protein O-GlcNAcase,2124,60,0.93 [0.65-1.34],0.7095107547115976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGFR,Opioid growth factor receptor,2439,83,3.52 [2.12-5.85],1.2035554209188354e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGN,Mimecan,2467,84,6.17 [4.70-8.10],2.6507139948389013e-39
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,2091,58,0.98 [0.65-1.49],0.941181998405596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLFM4,Olfactomedin-4,2005,52,1.16 [0.94-1.44],0.1585289947617133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OLR1,Oxidized low-density lipoprotein receptor 1,2434,82,1.21 [0.91-1.62],0.1915604070514257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMD,Osteomodulin,2472,83,1.07 [0.70-1.62],0.7659285026003539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMG,Oligodendrocyte-myelin glycoprotein,2439,83,0.70 [0.53-0.92],0.011144023846448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OMP,Olfactory marker protein,2061,56,1.14 [0.68-1.92],0.6068773547034529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPHN1,Oligophrenin-1,2116,60,0.94 [0.75-1.18],0.603770698048009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPLAH,5-oxoprolinase,2059,54,1.02 [0.69-1.50],0.9361358837337688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OPTC,Opticin,2439,83,1.73 [1.30-2.30],0.0001633489239279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ORM1,Alpha-1-acid glycoprotein 1,2120,59,5.47 [2.04-14.70],0.000750308341892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSBPL2,Oxysterol-binding protein-related protein 2,2116,60,0.74 [0.34-1.63],0.4600600713097159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSCAR,Osteoclast-associated immunoglobulin-like receptor,2467,83,7.50 [4.55-12.37],2.938942517752655e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSM,Oncostatin-M,2450,84,1.22 [0.94-1.60],0.1394844295733391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSMR,Oncostatin-M-specific receptor subunit beta,2466,83,3.71 [1.59-8.63],0.0023852197774678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OSTN,Osteocrin,2076,58,1.28 [0.77-2.14],0.3403742478953103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTOA,Otoancorin,2061,56,0.79 [0.46-1.37],0.4071525046388752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD6B,Deubiquitinase OTUD6B,2124,60,0.66 [0.42-1.04],0.0734799102653893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OTUD7B,OTU domain-containing protein 7B,2118,60,1.23 [0.82-1.83],0.3167172340321261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",2059,54,0.82 [0.57-1.18],0.2896736027940115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",OXT,Oxytocin-neurophysin 1,2476,84,1.13 [0.99-1.30],0.0771042116757441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",P4HB,Protein disulfide-isomerase,2439,82,2.40 [1.46-3.95],0.0005444390068065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PACS2,Phosphofurin acidic cluster sorting protein 2,2060,56,1.03 [0.67-1.58],0.9090541692146964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI2,Protein-arginine deiminase type-2,2404,82,1.33 [1.06-1.67],0.0148508443803046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PADI4,Protein-arginine deiminase type-4,2387,80,0.91 [0.71-1.18],0.4847132468135494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAEP,Glycodelin,2437,83,1.08 [0.90-1.30],0.399393539743207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,2118,60,1.02 [0.83-1.26],0.8248337721164383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",2091,58,0.66 [0.37-1.16],0.1450140985245147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,2415,83,1.28 [0.92-1.77],0.137646217188447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAGR1,PAXIP1-associated glutamate-rich protein 1,2059,54,0.63 [0.31-1.29],0.2033842598443629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,2041,59,0.98 [0.63-1.53],0.9310249143056812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAK4,Serine/threonine-protein kinase PAK 4,2393,81,0.76 [0.54-1.08],0.1283432171775093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALLD,Palladin,2062,59,1.11 [0.59-2.06],0.7526983005242626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM,Paralemmin-1,2113,59,12.93 [7.79-21.44],3.5906570807040203e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM2,Paralemmin-2,2116,60,6.57 [4.70-9.18],2.607842879476782e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PALM3,Paralemmin-3,2060,56,1.08 [0.78-1.50],0.6371017960541967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAM,Peptidyl-glycine alpha-amidating monooxygenase,2479,84,16.04 [7.92-32.49],1.2797180182560476e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAMR1,Inactive serine protease PAMR1,2467,84,2.02 [1.01-4.05],0.0463825926380683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAPPA,Pappalysin-1,2404,82,0.63 [0.41-0.97],0.0372131348480795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARD3,Partitioning defective 3 homolog,2091,58,0.91 [0.63-1.30],0.6058664829976963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARK7,Parkinson disease protein 7,2467,84,0.71 [0.48-1.07],0.1006415329453248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PARP1,Poly [ADP-ribose] polymerase 1,2461,84,1.05 [0.76-1.45],0.7602766207033697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PAXX,Protein PAXX,2085,56,1.74 [1.06-2.86],0.0282309900668036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBK,Lymphokine-activated killer T-cell-originated protein kinase,2044,59,0.89 [0.40-1.94],0.7617372440242592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBLD,Phenazine biosynthesis-like domain-containing protein,2393,81,0.79 [0.55-1.14],0.2164299196582613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,2124,60,5.62 [3.47-9.08],1.866973580097732e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCARE,Photoreceptor cilium actin regulator,2061,56,0.85 [0.58-1.23],0.3817172279390057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,2080,56,1.02 [0.65-1.58],0.9469526893468448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCBP2,Poly(rC)-binding protein 2,2118,60,0.85 [0.60-1.21],0.3807328358063399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH1,Protocadherin-1,2476,84,5.99 [3.20-11.20],2.152506731131882e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH12,Protocadherin-12,2118,60,1.37 [0.55-3.44],0.4991434888904241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH17,Protocadherin-17,2457,82,2.02 [1.32-3.10],0.0012242279369853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH7,Protocadherin-7,2124,60,3.86 [2.60-5.73],2.0531594544316368e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDH9,Protocadherin-9,2124,60,1.28 [0.64-2.56],0.4906582119987668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCDHB15,Protocadherin beta-15,2117,60,3.44 [2.10-5.64],9.703169708382937e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCNA,Proliferating cell nuclear antigen,2044,59,0.75 [0.46-1.24],0.2617379051351823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK7,Proprotein convertase subtilisin/kexin type 7,2117,60,1.07 [0.67-1.70],0.7872529930742739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCSK9,Proprotein convertase subtilisin/kexin type 9,2490,84,2.34 [1.47-3.74],0.0003655833893775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PCYT2,Ethanolamine-phosphate cytidylyltransferase,2124,60,0.77 [0.54-1.09],0.1429570581982198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDAP1,28 kDa heat- and acid-stable phosphoprotein,2122,60,0.80 [0.61-1.03],0.0863704394645494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1,Programmed cell death protein 1,2472,84,3.15 [2.30-4.32],8.829581993004e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD1LG2,Programmed cell death 1 ligand 2,2439,83,6.03 [4.34-8.37],8.99059433872123e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD5,Programmed cell death protein 5,2476,84,1.04 [0.73-1.47],0.8307529883581448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCD6,Programmed cell death protein 6,2457,82,1.16 [0.85-1.59],0.3487172305812251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDCL2,Phosducin-like protein 2,2044,59,0.90 [0.54-1.50],0.6764532185457401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",2044,59,0.96 [0.57-1.62],0.887765534872597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",2060,56,0.96 [0.60-1.52],0.8603255215154052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",2085,56,0.84 [0.67-1.07],0.1554890517176488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFA,Platelet-derived growth factor subunit A,2490,84,0.88 [0.68-1.14],0.3171310508385722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFB,Platelet-derived growth factor subunit B,2472,83,0.89 [0.72-1.11],0.3095930926897969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFC,Platelet-derived growth factor C,2383,81,1.17 [0.60-2.30],0.6472539444464609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRA,Platelet-derived growth factor receptor alpha,2457,82,5.87 [3.63-9.48],5.277227055433629e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDGFRB,Platelet-derived growth factor receptor beta,2490,84,1.49 [0.85-2.61],0.1653247155419737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA2,Protein disulfide-isomerase A2,2044,59,0.94 [0.50-1.76],0.8376891933835326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA3,Protein disulfide-isomerase A3,2085,56,4.20 [2.10-8.40],5.162587405547917e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA4,Protein disulfide-isomerase A4,2130,58,0.91 [0.60-1.39],0.6627026973965549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDIA5,Protein disulfide-isomerase A5,2044,59,0.93 [0.61-1.42],0.7297757478517071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM5,PDZ and LIM domain protein 5,2118,60,0.92 [0.75-1.13],0.439260791697293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDLIM7,PDZ and LIM domain protein 7,2472,83,1.08 [0.92-1.26],0.3367902332027093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",2383,81,1.20 [0.86-1.65],0.2785305214323245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDRG1,p53 and DNA damage-regulated protein 1,2076,58,0.75 [0.42-1.35],0.3379227647513367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,2044,59,0.91 [0.57-1.46],0.6890183171786484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZD2,PDZ domain-containing protein 2,2060,56,1.11 [0.74-1.66],0.6258424376647436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,2062,59,1.86 [1.27-2.72],0.001530597132076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEAR1,Platelet endothelial aggregation receptor 1,2490,84,6.56 [2.91-14.78],5.757204584317725e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEBP1,Phosphatidylethanolamine-binding protein 1,2467,84,0.90 [0.63-1.28],0.5507846046453149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECAM1,Platelet endothelial cell adhesion molecule,2467,84,1.09 [0.59-2.03],0.7847240513372243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PECR,Peroxisomal trans-2-enoyl-CoA reductase,2059,54,0.31 [0.10-0.93],0.0357254675964233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PENK,Proenkephalin-A,2085,56,7.05 [4.52-11.01],7.783679866394576e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PEPD,Xaa-Pro dipeptidase,2130,61,0.39 [0.18-0.89],0.0241483803521353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PER3,Period circadian protein homolog 3,2062,59,0.88 [0.71-1.09],0.2319399460054896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PF4,Platelet factor 4,2113,59,1.02 [0.79-1.33],0.8728194444899706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN2,Prefoldin subunit 2,2393,81,0.90 [0.61-1.32],0.5843082360307975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN4,Prefoldin subunit 4,2044,59,0.98 [0.60-1.61],0.9341434945819126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFDN6,Prefoldin subunit 6,2076,58,0.52 [0.29-0.96],0.0348760800363221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",2437,83,0.95 [0.74-1.22],0.6944598601754655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGA4,Pepsin A-4,2130,61,1.83 [1.42-2.36],2.606266797404952e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",2122,60,1.05 [0.66-1.66],0.8419085064027305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGF,Placenta growth factor,2490,84,13.14 [8.77-19.70],9.133299147839252e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP1,Peptidoglycan recognition protein 1,2480,84,2.92 [2.15-3.96],5.8255461765882265e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,2100,59,1.10 [0.46-2.62],0.8266576719518987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGLYRP4,Peptidoglycan recognition protein 4,2060,56,0.80 [0.46-1.38],0.418831891809119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGM2,Phosphoglucomutase-2,2076,58,0.73 [0.42-1.28],0.272507757391109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PGR,Progesterone receptor,2062,59,1.02 [0.77-1.33],0.9077012936346917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHACTR2,Phosphatase and actin regulator 2,2118,60,0.90 [0.72-1.12],0.3432210293487778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB1,Pleckstrin homology-like domain family B member 1,2124,60,4.40 [3.10-6.24],1.0407755257877202e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHLDB2,Pleckstrin homology-like domain family B member 2,2044,59,0.92 [0.68-1.24],0.5833327664230138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,2437,83,8.65 [5.31-14.08],4.315286912919467e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,2085,56,1.09 [0.62-1.92],0.7746676823196327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI16,Peptidase inhibitor 16,2130,61,27.69 [10.63-72.10],1.0433400039907942e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PI3,Elafin,2427,83,2.15 [1.79-2.58],5.395604271393408e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",2118,60,0.88 [0.63-1.23],0.463052397782805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIGR,Polymeric immunoglobulin receptor,2433,83,3.34 [2.35-4.75],1.9754696253520143e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,2461,84,0.79 [0.57-1.09],0.1476044193102403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,2467,84,14.55 [10.44-20.27],2.083175504047367e-56
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,2062,59,1.07 [0.67-1.69],0.7820459816569321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRA,Paired immunoglobulin-like type 2 receptor alpha,2467,84,7.49 [4.91-11.43],8.956067711589117e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PILRB,Paired immunoglobulin-like type 2 receptor beta,2457,82,4.58 [3.09-6.80],3.519437737651388e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,2085,56,1.11 [0.76-1.60],0.5888413193281486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PITHD1,PITH domain-containing protein 1,2041,59,1.07 [0.82-1.40],0.6265022893304129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD1,Polycystin-1,2122,60,7.35 [3.28-16.48],1.2600378509917025e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKD2,Polycystin-2,2060,56,1.63 [1.13-2.36],0.0089387902024405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKLR,Pyruvate kinase PKLR,2464,83,0.69 [0.50-0.94],0.0201345941717218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PKN3,Serine/threonine-protein kinase N3,2091,58,0.97 [0.68-1.39],0.8877384427560684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G10,Group 10 secretory phospholipase A2,2437,83,2.06 [1.47-2.88],2.4321019454551952e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G15,Phospholipase A2 group XV,2456,83,2.13 [1.15-3.97],0.0166827046023699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G1B,Phospholipase A2,2488,84,1.72 [1.21-2.44],0.0023442361903551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G2A,"Phospholipase A2, membrane associated",2455,80,1.41 [1.10-1.82],0.0072840168558157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G4A,Cytosolic phospholipase A2,2472,83,0.92 [0.74-1.15],0.4609498211136066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLA2G7,Platelet-activating factor acetylhydrolase,2467,84,0.37 [0.23-0.58],2.3263660115402143e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAT,Tissue-type plasminogen activator,2485,84,0.75 [0.53-1.05],0.0967455361731043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAU,Urokinase-type plasminogen activator,2467,84,1.97 [1.20-3.26],0.0078990948280451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLAUR,Urokinase plasminogen activator surface receptor,2450,83,11.95 [7.76-18.41],1.8824589666519226e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLB1,"Phospholipase B1, membrane-associated",2116,60,1.02 [0.66-1.58],0.9337574778257108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",2062,59,0.55 [0.25-1.20],0.1351231817139316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",2116,60,0.82 [0.63-1.05],0.1163591567444852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLEKHO1,Pleckstrin homology domain-containing family O member 1,2116,60,1.07 [0.75-1.52],0.7016898493943129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLG,Plasminogen,2076,59,0.36 [0.12-1.06],0.0642907020044848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN1,Perilipin-1,2393,81,1.58 [1.03-2.41],0.0345151001785132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLIN3,Perilipin-3,2457,82,2.32 [1.59-3.40],1.530816611099007e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLPBP,Pyridoxal phosphate homeostasis protein,2457,82,0.67 [0.49-0.91],0.0093262575206682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLSCR3,Phospholipid scramblase 3,2111,59,1.58 [1.01-2.48],0.0466976956940881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLTP,Phospholipid transfer protein,2481,84,0.98 [0.61-1.58],0.9375490100320016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC1,Plexin domain-containing protein 1,2383,81,1.91 [1.23-2.95],0.0036732275849774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXDC2,Plexin domain-containing protein 2,2116,60,1.88 [0.90-3.93],0.0947814466609511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNA4,Plexin-A4,2461,84,0.92 [0.72-1.17],0.4857156569458023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB2,Plexin-B2,2482,83,5.96 [3.64-9.75],1.3005119700731386e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PLXNB3,Plexin-B3,2449,82,0.80 [0.52-1.22],0.2994984674065586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,2448,82,1.05 [0.95-1.17],0.3183950578693229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMCH,Pro-MCH,2060,56,0.96 [0.68-1.37],0.8254756394254475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMM2,Phosphomannomutase 2,2060,56,0.81 [0.52-1.28],0.3704761701079038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMS1,PMS1 protein homolog 1,2076,58,1.28 [0.84-1.96],0.258397333485908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PMVK,Phosphomevalonate kinase,2392,81,0.91 [0.77-1.07],0.2515407194226339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIP,Pancreatic triacylglycerol lipase,2130,61,1.25 [0.93-1.69],0.1343491944357426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP1,Inactive pancreatic lipase-related protein 1,2116,60,1.59 [1.24-2.05],0.0002568668378323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNLIPRP2,Pancreatic lipase-related protein 2,2462,83,0.99 [0.93-1.06],0.8082496925548059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA1,Paraneoplastic antigen Ma1,2059,54,0.60 [0.36-1.00],0.0487631643862422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNMA2,Paraneoplastic antigen Ma2,2061,56,1.16 [0.67-2.02],0.5970898925129919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",2404,82,1.04 [0.88-1.23],0.6466788835230217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL,Podocalyxin,2439,83,1.79 [0.52-6.15],0.3556124023876791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PODXL2,Podocalyxin-like protein 2,2456,83,6.68 [3.74-11.92],1.285356035862742e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POF1B,Protein POF1B,2062,59,2.40 [1.69-3.43],1.206496313835234e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2A,DNA-directed RNA polymerase II subunit RPB1,2062,59,0.85 [0.35-2.08],0.7217771787565683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",2439,83,2.22 [1.70-2.90],5.178362986377198e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POMC,Pro-opiomelanocortin,2059,54,1.10 [0.77-1.55],0.6108940702178783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON1,Serum paraoxonase/arylesterase 1,2130,61,0.27 [0.14-0.54],0.0002151396855852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON2,Serum paraoxonase/arylesterase 2,2415,83,0.99 [0.58-1.68],0.9605847790555418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PON3,Serum paraoxonase/lactonase 3,2472,83,0.61 [0.37-1.02],0.0616885266703207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",POSTN,Periostin,2130,58,1.44 [0.76-2.73],0.2630939342666473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPBP,Platelet basic protein,2111,59,1.01 [0.75-1.37],0.9284655033768852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPCDC,Phosphopantothenoylcysteine decarboxylase,2476,84,0.68 [0.45-1.05],0.0794002629722216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIB,Peptidyl-prolyl cis-trans isomerase B,2463,83,0.88 [0.72-1.07],0.2063041541002727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIE,Peptidyl-prolyl cis-trans isomerase E,2091,58,1.12 [0.77-1.64],0.544493470763025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",2130,58,0.66 [0.41-1.06],0.0871153594817909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPL,Periplakin,2062,59,4.50 [2.64-7.67],3.029396692016904e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1A,Protein phosphatase 1A,2383,81,0.64 [0.32-1.29],0.2150337548202417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1B,Protein phosphatase 1B,2062,59,1.01 [0.64-1.60],0.9621165389873269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPM1F,Protein phosphatase 1F,2122,60,0.85 [0.53-1.37],0.50240680922108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPME1,Protein phosphatase methylesterase 1,2439,83,0.70 [0.51-0.97],0.0333674321709362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,2117,60,0.88 [0.64-1.20],0.405012024797944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,2456,83,1.03 [0.85-1.26],0.7446924243249265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,2091,58,0.92 [0.63-1.34],0.6658439325470626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,2118,60,0.91 [0.66-1.27],0.5851029775296086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,2118,60,2.85 [2.10-3.87],1.585701902229824e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R2,Protein phosphatase inhibitor 2,2457,82,0.95 [0.74-1.22],0.6937709051181151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP1R9B,Neurabin-2,2490,84,1.09 [0.89-1.33],0.4111499317972168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,2124,60,0.99 [0.81-1.22],0.9338593714083918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPP3R1,Calcineurin subunit B type 1,2437,83,1.51 [0.96-2.37],0.0713437127178124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPT1,Palmitoyl-protein thioesterase 1,2076,58,0.99 [0.69-1.42],0.9540850184335652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PPY,Pancreatic prohormone,2444,80,1.53 [1.29-1.82],1.0933599733655192e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PQBP1,Polyglutamine-binding protein 1,2383,81,1.23 [0.94-1.60],0.1334130805564506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAME,Melanoma antigen preferentially expressed in tumors,2044,59,1.02 [0.35-2.90],0.9775036077258968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRAP1,Proline-rich acidic protein 1,2130,58,12.73 [6.25-25.92],2.3227199976314697e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRC1,Protein regulator of cytokinesis 1,2117,60,0.85 [0.46-1.57],0.6019778332531762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRCP,Lysosomal Pro-X carboxypeptidase,2476,84,2.71 [1.67-4.40],5.6285354339033525e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX1,Peroxiredoxin-1,2384,82,0.83 [0.66-1.05],0.11375416974292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX2,Peroxiredoxin-2,2099,61,0.48 [0.31-0.74],0.0008431012685795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",2404,82,1.11 [0.85-1.46],0.4240225260087975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX5,"Peroxiredoxin-5, mitochondrial",2490,84,0.84 [0.63-1.12],0.2405084126728454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRDX6,Peroxiredoxin-6,2475,84,0.59 [0.42-0.83],0.0021691002364753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PREB,Prolactin regulatory element-binding protein,2404,82,2.82 [1.97-4.06],1.869756919973659e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRELP,Prolargin,2462,83,8.09 [4.70-13.93],4.8030202296865953e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG2,Bone marrow proteoglycan,2130,58,4.41 [3.00-6.47],3.54604293662462e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRG3,Proteoglycan 3,2130,58,1.99 [1.23-3.22],0.0052402889531845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,2404,82,1.32 [0.96-1.82],0.0926922440218054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,2076,58,1.22 [0.65-2.30],0.5302688492381561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,2457,82,0.90 [0.72-1.14],0.3981760170892868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,2114,60,0.99 [0.71-1.38],0.940508223452868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKCQ,Protein kinase C theta type,2404,82,0.97 [0.60-1.57],0.8996009230009935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKD2,Serine/threonine-protein kinase D2,2060,56,1.20 [0.66-2.18],0.5423677173088628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKG1,cGMP-dependent protein kinase 1,2085,56,0.89 [0.72-1.09],0.2439475421535527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,2383,81,1.04 [0.77-1.39],0.8036319410474669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRL,Prolactin,2476,84,1.23 [0.97-1.56],0.080770536459217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRND,Prion-like protein doppel,2116,60,3.00 [2.06-4.37],9.935998482270348e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROC,Vitamin K-dependent protein C,2464,83,0.51 [0.25-1.06],0.0714931307943158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROCR,Endothelial protein C receptor,2060,56,1.20 [0.56-2.59],0.6336086946886588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROK1,Prokineticin-1,2461,84,1.47 [1.04-2.07],0.0281796135636825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PROS1,Vitamin K-dependent protein S,2126,59,0.38 [0.16-0.91],0.0305756499925523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR4,Proline-rich protein 4,2068,56,1.60 [1.17-2.18],0.0028933697574747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRR5,Proline-rich protein 5,2062,59,0.92 [0.54-1.56],0.7526318505062253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRRT3,Proline-rich transmembrane protein 3,2059,54,5.53 [3.66-8.36],5.1017542553404165e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS2,Trypsin-2,2464,83,1.81 [1.47-2.23],2.7574780077352978e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS22,Brain-specific serine protease 4,2062,59,2.39 [1.68-3.39],1.092598994191678e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS27,Serine protease 27,2452,82,3.45 [2.19-5.42],8.314229464435179e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS53,Serine protease 53,2116,60,1.50 [0.87-2.58],0.1431636688565037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRSS8,Prostasin,2451,83,5.80 [3.84-8.75],5.779233619973621e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,2393,81,0.88 [0.74-1.04],0.1312249867036451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTG,Protogenin,2475,84,4.14 [2.01-8.50],0.0001109624231771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRTN3,Myeloblastin,2400,79,1.57 [1.15-2.14],0.004463439273593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PRUNE2,Protein prune homolog 2,2091,58,1.19 [0.57-2.49],0.652826694078597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAP,Prosaposin,2114,58,15.11 [7.56-30.17],1.4456419296837996e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSAPL1,Proactivator polypeptide-like 1,2124,60,2.82 [2.01-3.97],2.531375918643069e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSCA,Prostate stem cell antigen,2124,60,1.18 [1.06-1.33],0.0039173919409458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSG1,Pregnancy-specific beta-1-glycoprotein 1,2437,83,1.32 [1.09-1.60],0.005378155551746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSIP1,PC4 and SFRS1-interacting protein,2461,84,1.10 [0.84-1.45],0.4852780583450561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMA1,Proteasome subunit alpha type-1,2383,81,0.91 [0.56-1.48],0.7064708951831054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMC3,26S proteasome regulatory subunit 6A,2044,59,0.72 [0.31-1.68],0.4416827596477595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD1,26S proteasome non-ATPase regulatory subunit 1,2118,60,1.13 [0.70-1.82],0.6172337057135527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD5,26S proteasome non-ATPase regulatory subunit 5,2076,58,1.34 [0.96-1.89],0.0887043313029232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMD9,26S proteasome non-ATPase regulatory subunit 9,2439,83,0.57 [0.39-0.84],0.0043968847953533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME1,Proteasome activator complex subunit 1,2435,83,0.73 [0.42-1.26],0.2568559701477588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSME2,Proteasome activator complex subunit 2,2425,81,0.76 [0.43-1.34],0.3457215524233328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG3,Proteasome assembly chaperone 3,2461,84,0.58 [0.39-0.88],0.0094342244360231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSMG4,Proteasome assembly chaperone 4,2062,59,0.77 [0.48-1.22],0.2634720390297979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSPN,Persephin,2461,84,1.23 [0.99-1.52],0.0558503125468781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSRC1,Proline/serine-rich coiled-coil protein 1,2383,81,1.23 [0.92-1.65],0.1542234024275555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,2019,53,0.85 [0.67-1.08],0.1874504701383126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",2393,81,1.01 [0.53-1.93],0.9658793115814944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGDS,Prostaglandin-H2 D-isomerase,2440,83,2.99 [2.04-4.39],2.1876042770027243e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGES2,Prostaglandin E synthase 2,2049,59,1.04 [0.66-1.66],0.8550956876696474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTGR1,Prostaglandin reductase 1,2122,60,1.04 [0.80-1.34],0.7897377022182108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH,Parathyroid hormone,2076,58,1.60 [1.25-2.05],0.0001617751774259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,2461,84,1.88 [1.46-2.41],7.378510711372007e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTK7,Inactive tyrosine-protein kinase 7,2393,81,3.87 [2.63-5.71],8.65874100644167e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTN,Pleiotrophin,2415,83,1.48 [1.07-2.03],0.0168718290084807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTP4A3,Protein tyrosine phosphatase type IVA 3,2062,59,1.67 [1.18-2.37],0.0040333771399601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,2437,83,0.97 [0.75-1.25],0.7968350916280185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,2471,83,0.87 [0.71-1.07],0.1896902566767228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,2059,59,1.38 [0.80-2.38],0.2518509917299709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRB,Receptor-type tyrosine-protein phosphatase beta,2122,60,0.82 [0.37-1.81],0.625508582973274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRC,Receptor-type tyrosine-protein phosphatase C,2130,58,3.85 [1.36-10.86],0.0109605740523288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRF,Receptor-type tyrosine-protein phosphatase F,2490,84,4.39 [2.33-8.24],4.436883320940314e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRH,Receptor-type tyrosine-protein phosphatase H,2124,60,1.73 [1.17-2.56],0.0056853447209016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,2124,60,3.59 [1.62-7.94],0.0016075338366851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRM,Receptor-type tyrosine-protein phosphatase mu,2455,83,1.21 [0.57-2.61],0.6177456293850949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,2429,83,8.71 [5.80-13.10],2.1972186913524177e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRR,Receptor-type tyrosine-protein phosphatase R,2116,60,4.28 [2.81-6.52],1.3825892764101251e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRS,Receptor-type tyrosine-protein phosphatase S,2490,84,7.64 [4.90-11.90],2.6436498837789213e-19
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,2122,60,1.86 [0.88-3.95],0.1036309251888351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,2085,56,0.59 [0.37-0.92],0.0210946597575598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTS,6-pyruvoyl tetrahydrobiopterin synthase,2386,81,0.83 [0.61-1.14],0.250388037323711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTTG1,Securin,2091,58,0.59 [0.29-1.19],0.1375253626028137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PTX3,Pentraxin-related protein PTX3,2461,84,2.12 [1.29-3.47],0.0028763912873766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVALB,Parvalbumin alpha,2465,84,1.12 [0.93-1.34],0.2221948486273941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PVR,Poliovirus receptor,2476,84,2.13 [1.43-3.17],0.00021094810732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXDNL,Peroxidasin-like protein,2117,60,1.10 [0.72-1.69],0.6580385960800252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PXN,Paxillin,2393,81,1.52 [1.12-2.07],0.0069877203884876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYDC1,Pyrin domain-containing protein 1,2059,54,2.07 [1.34-3.20],0.0009764320617719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PYY,Peptide YY,2060,56,1.55 [1.27-1.89],1.976511317851824e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",PZP,Pregnancy zone protein,2126,59,1.15 [0.61-2.19],0.6658934009620783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QDPR,Dihydropteridine reductase,2445,81,0.58 [0.35-0.94],0.0285782422029828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QPCT,Glutaminyl-peptide cyclotransferase,2464,84,22.29 [12.81-38.78],4.500963878202489e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",QSOX1,Sulfhydryl oxidase 1,2079,58,1.81 [1.26-2.60],0.0013292546097836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB10,Ras-related protein Rab-10,2122,60,0.61 [0.37-1.01],0.0528217950334119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB11FIP3,Rab11 family-interacting protein 3,2122,60,0.92 [0.74-1.16],0.4840197784137805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB27B,Ras-related protein Rab-27B,2122,60,0.76 [0.57-1.00],0.0538126148174496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB2B,Ras-related protein Rab-2B,2117,60,0.68 [0.45-1.05],0.0826773163094744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB33A,Ras-related protein Rab-33A,2060,56,0.88 [0.59-1.32],0.5444706543108937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB37,Ras-related protein Rab-37,2404,82,1.05 [0.83-1.33],0.6854253620789057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB39B,Ras-related protein Rab-39B,2060,56,0.88 [0.64-1.23],0.4622882472626463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,2061,56,1.20 [0.82-1.76],0.3440166135083751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB44,Ras-related protein Rab-44,2117,60,1.24 [0.87-1.77],0.2245947032024343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6A,Ras-related protein Rab-6A,2461,84,0.54 [0.37-0.78],0.0009770058820065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAB6B,Ras-related protein Rab-6B,2393,81,1.26 [0.88-1.80],0.2138088786763781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEP1,Rab GTPase-binding effector protein 1,2085,56,0.75 [0.53-1.07],0.1166073585788402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABEPK,Rab9 effector protein with kelch motifs,2383,81,1.10 [0.80-1.51],0.5610304124792225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RABGAP1L,Rab GTPase-activating protein 1-like,2404,82,0.71 [0.50-1.01],0.0540049155425937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAC3,Ras-related C3 botulinum toxin substrate 3,2076,58,0.82 [0.51-1.32],0.4147710858546677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD23B,UV excision repair protein RAD23 homolog B,2383,81,0.98 [0.64-1.51],0.9307335946891748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAD51,DNA repair protein RAD51 homolog 1,2091,58,0.93 [0.53-1.64],0.7938761436396466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALB,Ras-related protein Ral-B,2062,59,1.39 [0.60-3.22],0.4402456662862861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RALY,RNA-binding protein Raly,2117,60,1.56 [1.12-2.18],0.0088728604256775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP1,Ran-specific GTPase-activating protein,2059,54,0.44 [0.26-0.75],0.0021831344062331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANBP2,E3 SUMO-protein ligase RanBP2,2061,56,0.50 [0.21-1.17],0.1111794902034623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RANGAP1,Ran GTPase-activating protein 1,2383,81,1.06 [0.71-1.57],0.7850544549393075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAP1A,Ras-related protein Rap-1A,2062,59,1.06 [0.74-1.52],0.7590209895046143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RAPGEF2,Rap guanine nucleotide exchange factor 2,2091,58,0.76 [0.45-1.28],0.2946784132873298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES1,Retinoic acid receptor responder protein 1,2383,81,3.32 [2.25-4.89],1.357405302235209e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RARRES2,Retinoic acid receptor responder protein 2,2466,83,2.29 [1.77-2.98],3.799548103418652e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASA1,Ras GTPase-activating protein 1,2393,81,1.02 [0.57-1.85],0.9438100223868344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,2044,59,0.76 [0.43-1.36],0.3602324256435193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RASSF2,Ras association domain-containing protein 2,2383,81,1.32 [1.05-1.66],0.0183589605851477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBFOX3,RNA binding protein fox-1 homolog 3,2118,60,7.76 [5.52-10.90],5.021716461161856e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBKS,Ribokinase,2400,82,0.49 [0.34-0.72],0.0002583726741171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM17,Splicing factor 45,2118,60,0.87 [0.62-1.23],0.4389473934990063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM19,Probable RNA-binding protein 19,2060,56,1.46 [0.88-2.41],0.1400952718928671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBM25,RNA-binding protein 25,2044,59,1.46 [0.90-2.38],0.1275135063490791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP1,Retinol-binding protein 1,2076,58,1.34 [1.03-1.74],0.0319938055724024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP2,Retinol-binding protein 2,2439,83,2.05 [1.71-2.45],4.5844501905727806e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP5,Retinol-binding protein 5,2439,83,2.15 [1.63-2.84],5.172615945402629e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBP7,Retinoid-binding protein 7,2124,60,1.50 [1.12-2.01],0.0072751684903017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS,RNA-binding protein with multiple splicing,2062,59,1.07 [0.71-1.59],0.7561378071742026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RBPMS2,RNA-binding protein with multiple splicing 2,2059,54,0.94 [0.72-1.21],0.6124758295231872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCC1,Regulator of chromosome condensation,2117,60,1.46 [1.01-2.11],0.0462847908000182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RCOR1,REST corepressor 1,2415,83,1.00 [0.62-1.59],0.9912711505116945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,2059,54,4.39 [1.46-13.16],0.0082527873890954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REEP4,Receptor expression-enhancing protein 4,2118,60,1.15 [0.79-1.67],0.4720548096596864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1A,Lithostathine-1-alpha,2440,82,4.12 [3.27-5.19],1.6780281437535886e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG1B,Lithostathine-1-beta,2490,84,3.28 [2.66-4.06],3.989720977924666e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3A,Regenerating islet-derived protein 3-alpha,2490,84,2.85 [2.31-3.51],8.957715338664933e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG3G,Regenerating islet-derived protein 3-gamma,2117,60,2.17 [1.28-3.67],0.0040810576366758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REG4,Regenerating islet-derived protein 4,2467,83,3.94 [2.96-5.24],4.2097640328567255e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELB,Transcription factor RelB,2062,59,0.59 [0.30-1.14],0.1133472765677868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RELT,Tumor necrosis factor receptor superfamily member 19L,2467,84,11.27 [7.89-16.09],1.405312115542229e-40
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REN,Renin,2457,82,1.78 [1.51-2.11],1.3280384913930697e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REPS1,RalBP1-associated Eps domain-containing protein 1,2062,59,1.07 [0.54-2.11],0.8454566558665682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REST,RE1-silencing transcription factor,2044,59,0.95 [0.47-1.94],0.890950442655431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,2439,83,1.14 [0.69-1.88],0.6093708008769834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RETN,Resistin,2458,82,3.44 [2.55-4.65],8.830101336253955e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",REXO2,"Oligoribonuclease, mitochondrial",2060,56,0.91 [0.49-1.70],0.7650114016413678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RFC4,Replication factor C subunit 4,2117,60,1.40 [0.51-3.83],0.5072769646782984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGCC,Regulator of cell cycle RGCC,2118,60,0.74 [0.53-1.02],0.0656189674186099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,2091,58,0.83 [0.51-1.33],0.4363087351350001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMA,Repulsive guidance molecule A,2476,84,7.46 [4.36-12.78],2.4684850679829014e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGMB,RGM domain family member B,2476,84,12.76 [8.27-19.68],1.1312874003466e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS10,Regulator of G-protein signaling 10,2118,60,0.79 [0.50-1.22],0.2868257400557084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RGS8,Regulator of G-protein signaling 8,2404,82,1.12 [0.85-1.47],0.4307964917591649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RHOC,Rho-related GTP-binding protein RhoC,2425,82,0.96 [0.81-1.13],0.6163479419641031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RICTOR,Rapamycin-insensitive companion of mTOR,2062,59,0.64 [0.31-1.31],0.2230376152379345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,2085,56,1.89 [1.28-2.80],0.0014869325133536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILP,Rab-interacting lysosomal protein,2470,84,0.72 [0.53-0.99],0.0445509010766141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RILPL2,RILP-like protein 2,2122,60,0.88 [0.68-1.12],0.2975413537301975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,2060,56,1.12 [0.80-1.57],0.5219662851355018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN1,Prorelaxin H1,2118,60,1.66 [1.20-2.30],0.0023934653633845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RLN2,Prorelaxin H2,2080,56,1.64 [1.19-2.25],0.0023984196832145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE1,Ribonuclease pancreatic,2130,61,10.83 [6.50-18.04],5.740964012406064e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE10,Inactive ribonuclease-like protein 10,2059,54,2.30 [1.77-3.01],7.969204711154682e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE3,Eosinophil cationic protein,2448,82,1.17 [1.01-1.36],0.0348280568444352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE4,Ribonuclease 4,2055,58,6.49 [4.14-10.18],3.8704440069493284e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASE6,Ribonuclease K6,2113,60,2.64 [2.06-3.37],1.1689393869274668e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASEH2A,Ribonuclease H2 subunit A,2118,60,0.96 [0.56-1.64],0.868042833336673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNASET2,Ribonuclease T2,2482,84,21.04 [12.70-34.85],2.7260970396720634e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF149,E3 ubiquitin-protein ligase RNF149,2059,54,16.87 [9.62-29.58],5.952725153344583e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF168,E3 ubiquitin-protein ligase RNF168,2062,59,0.99 [0.51-1.91],0.9665142728054597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF31,E3 ubiquitin-protein ligase RNF31,2062,59,1.17 [0.66-2.05],0.5964920934569105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF4,E3 ubiquitin-protein ligase RNF4,2091,58,0.80 [0.50-1.28],0.3601475629847837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF41,E3 ubiquitin-protein ligase NRDP1,2383,81,0.94 [0.70-1.28],0.7069024444451704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF43,E3 ubiquitin-protein ligase RNF43,2091,58,1.40 [1.01-1.94],0.041071284898562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RNF5,E3 ubiquitin-protein ligase RNF5,2059,54,0.79 [0.56-1.13],0.2028362502933867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO1,Roundabout homolog 1,2467,83,2.40 [1.23-4.68],0.0100543499502205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO2,Roundabout homolog 2,2476,84,2.07 [0.99-4.29],0.0520704804258914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROBO4,Roundabout homolog 4,2059,54,7.12 [1.75-28.93],0.0061117733787128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,2457,82,9.80 [6.38-15.05],1.883363732440716e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RP2,Protein XRP2,2439,83,0.96 [0.62-1.46],0.8350233623310049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPA2,Replication protein A 32 kDa subunit,2062,59,0.97 [0.44-2.17],0.9445612233452528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPE,Ribulose-phosphate 3-epimerase,2091,58,0.69 [0.46-1.03],0.0685005589040774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPGR,X-linked retinitis pigmentosa GTPase regulator,2076,58,0.91 [0.48-1.71],0.7662678414679231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPL14,60S ribosomal protein L14,2059,54,1.10 [0.53-2.25],0.8002882389041654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RPS10,40S ribosomal protein S10,2060,56,0.88 [0.43-1.79],0.7261217253987295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRAS,Ras-related protein R-Ras,2076,58,0.96 [0.78-1.17],0.6558286873125021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2,Ribonucleoside-diphosphate reductase subunit M2,2383,81,1.40 [1.07-1.83],0.0147952218077031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,2383,81,1.17 [0.88-1.57],0.2849974275392298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RRP15,RRP15-like protein,2061,56,0.93 [0.69-1.25],0.6161100483650379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO1,R-spondin-1,2437,83,5.08 [2.96-8.72],3.579599630503868e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RSPO3,R-spondin-3,2475,84,8.77 [6.02-12.77],9.958077136004537e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTBDN,Retbindin,2439,83,9.31 [5.43-15.97],5.107305751531247e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTKN2,Rhotekin-2,2060,56,1.05 [0.64-1.74],0.8409836033981073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",2118,60,0.77 [0.59-1.02],0.065737472987944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RTN4R,Reticulon-4 receptor,2475,84,6.17 [4.26-8.94],6.05409610350124e-22
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RUVBL1,RuvB-like 1,2383,81,1.02 [0.84-1.24],0.8434700534368051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RWDD1,RWD domain-containing protein 1,2476,84,0.77 [0.56-1.06],0.104721018294173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",RYR1,Ryanodine receptor 1,2060,56,1.03 [0.52-2.04],0.9390938255308564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A11,Protein S100-A11,2431,81,1.12 [0.78-1.62],0.5416063495511587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A12,Protein S100-A12,2412,83,1.11 [0.85-1.44],0.4385679023763553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A13,Protein S100-A13,2062,59,1.83 [1.10-3.05],0.0201758552894115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A14,Protein S100-A14,2118,60,0.91 [0.56-1.49],0.7150278787024396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A16,Protein S100-A16,2387,80,0.96 [0.69-1.33],0.7952407987426525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A3,Protein S100-A3,2117,60,0.98 [0.59-1.64],0.9523282730935771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100A4,Protein S100-A4,2456,83,0.55 [0.40-0.74],0.0001098718284718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100G,Protein S100-G,2118,60,1.88 [1.28-2.76],0.0013403503558209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",S100P,Protein S100-P,2415,83,1.56 [1.27-1.93],2.691508758794912e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAA4,Serum amyloid A-4 protein,2126,59,0.73 [0.28-1.92],0.5207476983997866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAFB2,Scaffold attachment factor B2,2118,60,1.57 [0.69-3.57],0.2813352492900542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAG,S-arrestin,2061,56,1.04 [0.59-1.81],0.8996511076131208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAMD9L,Sterile alpha motif domain-containing protein 9-like,2461,84,1.07 [0.82-1.41],0.6190615021275794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAP18,Histone deacetylase complex subunit SAP18,2091,58,0.94 [0.66-1.32],0.7102236686508945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SARG,Specifically androgen-regulated gene protein,2116,60,0.92 [0.73-1.14],0.4342720522934855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SART1,U4/U6.U5 tri-snRNP-associated protein 1,2060,56,1.87 [1.29-2.70],0.0008523202246881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT1,Diamine acetyltransferase 1,2060,56,0.96 [0.54-1.72],0.8952096131796856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SAT2,Thialysine N-epsilon-acetyltransferase,2091,58,1.19 [0.88-1.60],0.2560156334634122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SATB1,DNA-binding protein SATB1,2118,60,1.28 [0.56-2.95],0.5594214970411442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SBSN,Suprabasin,2127,58,5.08 [2.92-8.83],8.433368577106898e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCAMP3,Secretory carrier-associated membrane protein 3,2439,83,1.14 [0.90-1.43],0.2763036515094887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARA5,Scavenger receptor class A member 5,2476,84,13.44 [8.92-20.24],1.7010178206348387e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB1,Scavenger receptor class B member 1,2393,81,1.31 [0.98-1.74],0.0678361751340972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARB2,Lysosome membrane protein 2,2389,83,8.39 [6.35-11.08],1.128822391436371e-50
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF1,Scavenger receptor class F member 1,2490,84,2.56 [1.70-3.85],6.358670778663078e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCARF2,Scavenger receptor class F member 2,2476,84,7.74 [5.54-10.82],3.2605429376762024e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG2,Secretogranin-2,2466,84,15.88 [10.24-24.62],4.4733653708957855e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCG3,Secretogranin-3,2467,83,4.76 [2.76-8.19],1.8203931793664568e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB1A1,Uteroglobin,2462,83,4.69 [3.25-6.76],1.183286544628607e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB2A2,Mammaglobin-A,2060,56,0.85 [0.32-2.31],0.7571091159708964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A1,Secretoglobin family 3A member 1,2085,56,2.27 [0.88-5.82],0.0885261784353272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGB3A2,Secretoglobin family 3A member 2,2471,83,1.35 [1.15-1.58],0.0001776248038194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCGN,Secretagogin,2404,82,2.97 [2.16-4.08],1.852644096200396e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCIN,Adseverin,2061,56,1.10 [0.79-1.53],0.5724000088200962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCLY,Selenocysteine lyase,2470,84,1.04 [0.72-1.50],0.8318724551239689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2A,Sodium channel protein type 2 subunit alpha,2061,56,0.70 [0.37-1.32],0.2741093870633264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN2B,Sodium channel subunit beta-2,2076,58,1.19 [0.48-2.94],0.7019590524693627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3A,Sodium channel protein type 3 subunit alpha,2076,58,0.56 [0.24-1.30],0.1777086929332436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN3B,Sodium channel subunit beta-3,2061,56,0.77 [0.40-1.50],0.4457974044527569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCN4B,Sodium channel subunit beta-4,2059,54,3.98 [2.76-5.73],1.4097533278912377e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCP2,Non-specific lipid-transfer protein,2383,81,1.17 [0.92-1.48],0.2039557738053761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCPEP1,Retinoid-inducible serine carboxypeptidase,2054,54,0.73 [0.42-1.27],0.2663224323579761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRG1,Scrapie-responsive protein 1,2122,60,7.82 [4.32-14.16],1.0943901450135514e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRIB,Protein scribble homolog,2059,54,1.06 [0.80-1.41],0.689519215826268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCRN1,Secernin-1,2461,84,1.09 [0.76-1.56],0.6391024966435364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SCT,Secretin,2076,58,1.79 [1.15-2.78],0.010438368092038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC1,Syndecan-1,2457,82,3.54 [2.57-4.87],7.451335565935517e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDC4,Syndecan-4,2457,82,0.48 [0.33-0.69],8.42211922273207e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDCCAG8,Serologically defined colon cancer antigen 8,2117,60,1.00 [0.80-1.24],0.9829302720072404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDHB,Succinate dehydrogenase,2124,60,1.08 [0.71-1.63],0.7205024885921636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SDK2,Protein sidekick-2,2085,56,1.85 [1.21-2.85],0.0049241548351112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEC31A,Protein transport protein Sec31A,2059,54,0.73 [0.53-1.02],0.0678409859712522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEL1L,Protein sel-1 homolog 1,2059,54,0.97 [0.20-4.62],0.9698651552123004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELE,E-selectin,2490,84,1.59 [1.13-2.24],0.0075082515208971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELENOP,Selenoprotein P,2126,59,0.44 [0.15-1.26],0.1264123365036185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELL,L-selectin,2126,59,1.36 [0.45-4.10],0.5906426180779147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELP,P-selectin,2464,83,0.99 [0.70-1.40],0.9552162575288804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SELPLG,P-selectin glycoprotein ligand 1,2461,84,0.84 [0.46-1.55],0.5809266770959047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3F,Semaphorin-3F,2457,82,11.29 [6.19-20.60],2.7669661907062884e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA3G,Semaphorin-3G,2085,56,1.73 [1.11-2.71],0.0155697879022719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4C,Semaphorin-4C,2439,83,1.67 [1.25-2.22],0.0004308263675668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA4D,Semaphorin-4D,2476,84,0.96 [0.50-1.83],0.8987501405995104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA6C,Semaphorin-6C,2062,59,2.27 [1.31-3.94],0.0035369005150683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEMA7A,Semaphorin-7A,2485,84,3.10 [1.89-5.10],8.367336125234921e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN3,Neuronal-specific septin-3,2118,60,1.07 [0.80-1.43],0.6514741086471832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN7,Septin-7,2091,58,1.28 [0.95-1.72],0.1115187365491868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN8,Septin-8,2109,60,5.65 [3.63-8.79],1.5949597154346418e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEPTIN9,Septin-9,2439,83,1.65 [1.02-2.69],0.0429144242359833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA1,Alpha-1-antitrypsin,2090,59,13.19 [0.58-298.47],0.1050484680666612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA11,Serpin A11,2490,84,1.22 [0.77-1.92],0.4002367590820311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA12,Serpin A12,2399,78,0.93 [0.78-1.12],0.4447744314655275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA3,Alpha-1-antichymotrypsin,2118,59,5.98 [1.31-27.42],0.0212494285968117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA4,Kallistatin,2083,59,0.42 [0.16-1.13],0.0845265594493994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA5,Plasma serine protease inhibitor,2091,59,1.60 [0.72-3.53],0.2496950789946206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA6,Corticosteroid-binding globulin,2126,59,1.06 [0.23-4.94],0.9435307275922208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA7,Thyroxine-binding globulin,2126,59,0.33 [0.10-1.06],0.0625623612694191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINA9,Serpin A9,2432,83,1.15 [0.89-1.49],0.283697183641509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB1,Leukocyte elastase inhibitor,2460,84,0.96 [0.77-1.19],0.6996728804395262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB5,Serpin B5,2415,83,1.56 [1.03-2.38],0.0375473315625803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB6,Serpin B6,2468,84,1.35 [0.97-1.88],0.0739888733095904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB8,Serpin B8,2490,84,1.58 [1.31-1.90],1.412066108032321e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINB9,Serpin B9,2437,83,0.86 [0.47-1.56],0.6137871176548995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINC1,Antithrombin-III,2121,59,0.93 [0.18-4.73],0.9280665958197094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPIND1,Heparin cofactor 2,2121,59,0.77 [0.34-1.77],0.5373320376143331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE1,Plasminogen activator inhibitor 1,2490,84,0.89 [0.67-1.18],0.4157563549301302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINE2,Glia-derived nexin,2122,60,0.77 [0.52-1.14],0.1868403200260647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF1,Pigment epithelium-derived factor,2095,59,17.00 [7.22-39.98],8.535542403380438e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINF2,Alpha-2-antiplasmin,2081,59,0.31 [0.05-1.93],0.2077889419406754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPING1,Plasma protease C1 inhibitor,2121,59,1.18 [0.33-4.31],0.7986740149597821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINH1,Serpin H1,2091,58,1.02 [0.84-1.24],0.8149905495276352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI1,Neuroserpin,2084,55,1.63 [0.70-3.80],0.2562751215235498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SERPINI2,Serpin I2,2124,60,1.14 [0.77-1.69],0.52222469971637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,2393,81,1.01 [0.74-1.38],0.9411252708185373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SETMAR,Histone-lysine N-methyltransferase SETMAR,2430,83,0.73 [0.38-1.42],0.3580788970857296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6,Seizure protein 6 homolog,2076,58,2.47 [1.40-4.37],0.0018921159401437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L,Seizure 6-like protein,2456,83,7.90 [4.95-12.61],4.4764307243355016e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SEZ6L2,Seizure 6-like protein 2,2439,83,2.98 [1.78-4.98],3.339120147674432e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SF3B4,Splicing factor 3B subunit 4,2439,83,0.86 [0.65-1.14],0.2976348698222203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP1,Secreted frizzled-related protein 1,2429,83,2.55 [1.99-3.25],6.143036438363426e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFRP4,Secreted frizzled-related protein 4,2085,56,3.47 [1.89-6.38],6.377160647369788e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA1,Pulmonary surfactant-associated protein A1,2383,81,1.47 [1.12-1.93],0.0051144054679148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPA2,Pulmonary surfactant-associated protein A2,2383,81,1.31 [0.92-1.86],0.132827875422546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SFTPD,Pulmonary surfactant-associated protein D,2457,82,1.01 [0.76-1.34],0.949325458980214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SGSH,N-sulphoglucosamine sulphohydrolase,2092,60,1.38 [0.91-2.09],0.1291827539031894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2B3,SH2B adapter protein 3,2383,81,0.92 [0.75-1.12],0.3992800328567755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH2D1A,SH2 domain-containing protein 1A,2461,84,1.27 [0.95-1.69],0.108847103628133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,2061,56,1.20 [0.85-1.70],0.3086705826944007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3BP1,SH3 domain-binding protein 1,2124,60,0.93 [0.57-1.51],0.7662292662200514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GL3,Endophilin-A3,2080,58,1.13 [0.84-1.53],0.4234590434613718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SH3GLB2,Endophilin-B2,2116,60,0.89 [0.61-1.29],0.528422728877326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHBG,Sex hormone-binding globulin,2130,61,1.16 [0.72-1.87],0.5394853758950413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHC1,SHC-transforming protein 1,2044,59,1.07 [0.85-1.34],0.5758286802214011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHD,SH2 domain-containing adapter protein D,2054,56,1.10 [0.85-1.42],0.4518051511624312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHH,Sonic hedgehog protein,2062,59,0.94 [0.52-1.69],0.8247426764989698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHISA5,Protein shisa-5,2130,58,0.44 [0.11-1.66],0.2225998796760289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHMT1,"Serine hydroxymethyltransferase, cytosolic",2471,83,1.02 [0.81-1.29],0.8788604660331872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SHPK,Sedoheptulokinase,2091,58,1.11 [0.62-1.97],0.7323256222699843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIAE,Sialate O-acetylesterase,2453,83,1.68 [1.12-2.51],0.0120812839904751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC1,Sialoadhesin,2472,83,5.19 [3.58-7.51],3.009357411963925e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC10,Sialic acid-binding Ig-like lectin 10,2461,84,4.23 [3.14-5.69],1.7447784172408855e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC15,Sialic acid-binding Ig-like lectin 15,2393,81,1.19 [0.97-1.46],0.1028085716209473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC5,Sialic acid-binding Ig-like lectin 5,2467,84,1.75 [1.39-2.21],2.0207319541201093e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC6,Sialic acid-binding Ig-like lectin 6,2475,84,7.93 [5.00-12.55],1.083131337363086e-18
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC7,Sialic acid-binding Ig-like lectin 7,2457,82,3.90 [2.12-7.17],1.2471801454690131e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC8,Sialic acid-binding Ig-like lectin 8,2059,54,1.98 [1.22-3.21],0.0058484327112389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIGLEC9,Sialic acid-binding Ig-like lectin 9,2473,84,1.79 [0.96-3.37],0.0690678958825537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIL1,Nucleotide exchange factor SIL1,2059,54,1.36 [0.72-2.56],0.3387748243608919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,2466,83,2.87 [1.85-4.47],2.864374206027347e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRPB1,Signal-regulatory protein beta-1,2455,83,6.20 [4.47-8.59],6.2786286722399e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT1,NAD-dependent protein deacetylase sirtuin-1,2062,59,1.14 [0.86-1.50],0.3618752104691132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT2,NAD-dependent protein deacetylase sirtuin-2,2439,83,0.84 [0.66-1.05],0.1272540551277113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",2393,81,0.92 [0.62-1.36],0.6656628702785785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SIT1,Signaling threshold-regulating transmembrane adapter 1,2404,82,1.15 [0.81-1.63],0.4292157019105372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP1,Src kinase-associated phosphoprotein 1,2433,83,0.84 [0.64-1.11],0.2290393814236047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKAP2,Src kinase-associated phosphoprotein 2,2472,83,0.96 [0.79-1.16],0.6630646143150527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SKIV2L,Helicase SKI2W,2060,56,0.97 [0.48-1.96],0.92721924414517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLA2,Src-like-adapter 2,2118,60,0.83 [0.66-1.05],0.1261292836222049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF1,Signaling lymphocytic activation molecule,2404,82,2.63 [1.94-3.57],4.820902963950126e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF6,SLAM family member 6,2383,81,2.06 [1.38-3.05],0.0003646851175418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF7,SLAM family member 7,2461,84,1.99 [1.48-2.69],6.696433240808402e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLAMF8,SLAM family member 8,2383,81,2.19 [1.56-3.07],5.654554040660229e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC12A2,Solute carrier family 12 member 2,2060,56,1.13 [0.39-3.34],0.8186138252347296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC13A1,Solute carrier family 13 member 1,2117,60,0.97 [0.63-1.50],0.888701429754811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC16A1,Monocarboxylate transporter 1,2393,81,1.18 [0.83-1.68],0.3505096878517882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC1A4,Neutral amino acid transporter A,2076,58,1.27 [0.77-2.08],0.3516979878192073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC27A4,Long-chain fatty acid transport protein 4,2393,81,1.07 [0.79-1.44],0.6574357030567224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC28A1,Sodium/nucleoside cotransporter 1,2044,59,1.35 [0.97-1.89],0.0772618337092983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC34A3,Sodium-dependent phosphate transport protein 2C,2044,59,1.01 [0.56-1.81],0.9754423984092008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A14,Zinc transporter ZIP14,2393,81,2.37 [1.81-3.12],5.110908839889522e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC39A5,Zinc transporter ZIP5,2461,84,1.81 [1.52-2.15],1.6446836212416228e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC44A4,Choline transporter-like protein 4,2076,58,1.12 [0.79-1.61],0.5187395091961655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC4A1,Band 3 anion transport protein,2130,58,0.44 [0.24-0.80],0.0069460509729981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC51B,Organic solute transporter subunit beta,2060,56,1.19 [0.89-1.60],0.2371222326050412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,2085,56,0.90 [0.66-1.22],0.4968315135739201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,2124,60,1.34 [0.94-1.92],0.1081114530636184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",2044,59,1.40 [0.98-1.98],0.0616018440795623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLIT2,Slit homolog 2 protein,2393,81,1.25 [0.90-1.75],0.1830049922955429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK1,SLIT and NTRK-like protein 1,2062,59,3.17 [1.69-5.95],0.0003324213284888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK2,SLIT and NTRK-like protein 2,2475,84,3.55 [2.27-5.55],2.8560621840441253e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLITRK6,SLIT and NTRK-like protein 6,2415,83,4.76 [3.26-6.95],6.152056455032622e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLK,STE20-like serine/threonine-protein kinase,2091,58,1.07 [0.78-1.48],0.6775488045662308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLMAP,Sarcolemmal membrane-associated protein,2124,60,1.44 [1.09-1.90],0.0098829530266539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SLURP1,Secreted Ly-6/uPAR-related protein 1,2116,58,6.75 [4.27-10.69],3.4987008932297313e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD1,Mothers against decapentaplegic homolog 1,2383,81,0.97 [0.76-1.23],0.7882322042907332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD2,Mothers against decapentaplegic homolog 2,2117,60,0.84 [0.58-1.21],0.337059876415875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD3,Mothers against decapentaplegic homolog 3,2117,60,0.84 [0.52-1.37],0.4915868104957067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMAD5,Mothers against decapentaplegic homolog 5,2439,83,1.15 [0.43-3.08],0.7857240031907589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMARCA2,Probable global transcription activator SNF2L2,2393,81,1.13 [0.86-1.49],0.3776336784461152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMC3,Structural maintenance of chromosomes protein 3,2044,59,0.84 [0.49-1.46],0.540144766631111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMNDC1,Survival of motor neuron-related-splicing factor 30,2124,60,1.18 [0.85-1.62],0.3224597852058596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC1,SPARC-related modular calcium-binding protein 1,2475,84,4.65 [3.11-6.97],8.588768729070397e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMOC2,SPARC-related modular calcium-binding protein 2,2472,83,7.15 [5.14-9.94],1.4919855118812716e-31
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD1,Sphingomyelin phosphodiesterase,2468,84,1.46 [1.03-2.07],0.0331607888611236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPD3,Sphingomyelin phosphodiesterase 3,2062,59,1.38 [0.98-1.95],0.0687658655416769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,2465,83,1.01 [0.75-1.35],0.9644534397407138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,2117,60,0.88 [0.61-1.27],0.4915479196627819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMS,Spermine synthase,2061,56,1.04 [0.71-1.52],0.8490714810106565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SMTN,Smoothelin,2112,60,1.44 [1.14-1.81],0.0024986179178935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP23,Synaptosomal-associated protein 23,2457,82,0.87 [0.71-1.08],0.2206702503767023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP25,Synaptosomal-associated protein 25,2061,56,0.81 [0.48-1.38],0.4414398900524984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAP29,Synaptosomal-associated protein 29,2456,83,0.99 [0.80-1.22],0.8963181666307546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNAPIN,SNARE-associated protein Snapin,2118,60,0.67 [0.44-1.04],0.0734117547864758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCA,Alpha-synuclein,2085,56,0.79 [0.63-0.98],0.0352736128561588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNCG,Gamma-synuclein,2437,83,4.02 [3.07-5.26],3.4907043252556514e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",2059,54,1.50 [0.68-3.29],0.3151383892147473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNRPB2,U2 small nuclear ribonucleoprotein B'',2116,60,1.56 [1.20-2.03],0.0008058960735386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNU13,NHP2-like protein 1,2060,56,0.91 [0.56-1.47],0.6899476285803248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX15,Sorting nexin-15,2085,56,0.75 [0.47-1.21],0.2402041427929834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX18,Sorting nexin-18,2124,60,1.46 [0.89-2.39],0.1291747643294573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX2,Sorting nexin-2,2117,60,1.06 [0.81-1.38],0.6695892022494385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX5,Sorting nexin-5,2059,54,0.41 [0.15-1.14],0.0882368171648831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SNX9,Sorting nexin-9,2457,82,1.06 [0.80-1.42],0.6828071096966482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD1,Superoxide dismutase [Cu-Zn],2408,80,0.58 [0.38-0.90],0.0149546225107361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD2,"Superoxide dismutase [Mn], mitochondrial",2467,84,1.22 [0.83-1.81],0.3120692039491186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOD3,Extracellular superoxide dismutase,2130,61,1.13 [0.84-1.51],0.4125149587275791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORBS1,Sorbin and SH3 domain-containing protein 1,2118,60,1.84 [1.37-2.46],4.238834304619728e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORCS2,VPS10 domain-containing receptor SorCS2,2383,81,6.88 [4.85-9.75],2.7299706132979407e-27
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORD,Sorbitol dehydrogenase,2464,83,0.65 [0.51-0.82],0.0003536844411372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SORT1,Sortilin,2457,82,1.11 [0.68-1.82],0.6718046830575435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOST,Sclerostin,2457,82,2.49 [1.56-3.95],0.0001144915479948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,2076,58,0.93 [0.55-1.57],0.7977906094993581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX2,Transcription factor SOX-2,2114,59,0.33 [0.11-1.04],0.0574904293277729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SOX9,Transcription factor SOX-9,2076,58,6.27 [2.46-16.02],0.0001235604984959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,2118,60,2.81 [1.79-4.40],6.625977880321806e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPAG1,Sperm-associated antigen 1,2118,60,1.01 [0.64-1.60],0.9690677025806202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARC,SPARC,2456,83,1.03 [0.79-1.36],0.8126668780740589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPARCL1,SPARC-like protein 1,2451,82,5.41 [3.01-9.73],1.7327954988591522e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPART,Spartin,2085,56,0.92 [0.65-1.30],0.6542693200977869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPESP1,Sperm equatorial segment protein 1,2122,60,2.42 [1.32-4.43],0.0042604149462855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK1,Serine protease inhibitor Kazal-type 1,2467,84,5.77 [4.37-7.60],1.9159870558030149e-35
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK2,Serine protease inhibitor Kazal-type 2,2085,56,5.04 [3.04-8.36],3.58413127423365e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK4,Serine protease inhibitor Kazal-type 4,2461,84,2.98 [2.42-3.66],4.769541232817102e-25
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK5,Serine protease inhibitor Kazal-type 5,2467,84,6.89 [4.39-10.83],5.524896485527616e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK6,Serine protease inhibitor Kazal-type 6,2475,84,3.08 [2.12-4.48],4.085832800766963e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINK8,Serine protease inhibitor Kazal-type 8,2060,56,0.70 [0.29-1.67],0.4198327373260588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT1,Kunitz-type protease inhibitor 1,2460,84,3.98 [2.38-6.65],1.449167203291319e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT2,Kunitz-type protease inhibitor 2,2472,83,4.11 [2.87-5.89],1.2365968604385691e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPINT3,Kunitz-type protease inhibitor 3,2124,60,1.06 [0.90-1.24],0.4984011120566037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPOCK1,Testican-1,2437,83,0.32 [0.18-0.58],0.0002018965132544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON1,Spondin-1,2467,83,5.90 [4.14-8.41],9.250129958064252e-23
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPON2,Spondin-2,2448,82,16.24 [10.41-25.35],1.2803213195630767e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPP1,Osteopontin,2485,84,4.14 [3.06-5.61],5.2299178050638605e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",2062,59,1.04 [0.56-1.93],0.8908992037597653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRING1,SREBP regulating gene protein,2044,59,1.49 [1.12-1.98],0.0057198158130007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR1B,Cornifin-B,2091,58,1.09 [0.84-1.42],0.5069848506115572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRR3,Small proline-rich protein 3,2116,60,2.05 [1.60-2.64],1.9150316120698444e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPRY2,Protein sprouty homolog 2,2404,82,0.88 [0.70-1.09],0.2339886456194578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",2061,56,0.59 [0.24-1.48],0.2636378225072365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SPTLC1,Serine palmitoyltransferase 1,2116,60,1.67 [1.13-2.47],0.0101245898890695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRC,Proto-oncogene tyrosine-protein kinase Src,2452,83,0.94 [0.80-1.10],0.4221187719498837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRP14,Signal recognition particle 14 kDa protein,2439,83,1.02 [0.73-1.42],0.9149271393814424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPK2,SRSF protein kinase 2,2461,84,1.02 [0.82-1.29],0.8330804145704492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SRPX,Sushi repeat-containing protein SRPX,2122,60,1.69 [0.90-3.20],0.1045773613204246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSB,Lupus La protein,2393,81,1.01 [0.73-1.39],0.9583511881007408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",2062,59,1.17 [0.64-2.14],0.6193802623772012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,2457,82,0.81 [0.70-0.93],0.0037513041412863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,2464,83,1.11 [0.71-1.74],0.6359199165768092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSH3,Protein phosphatase Slingshot homolog 3,2044,59,0.82 [0.32-2.09],0.6812155999334126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SSNA1,Sjoegren syndrome nuclear autoantigen 1,2124,60,0.96 [0.59-1.58],0.8866018999281546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST13,Hsc70-interacting protein,2085,56,0.56 [0.35-0.88],0.0121020877962398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",2439,83,1.88 [1.44-2.45],3.5254876093887168e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",2490,84,4.11 [2.32-7.26],1.2006457592043597e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",2062,59,1.00 [0.60-1.67],0.9962774018458738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAB2,Stabilin-2,2130,58,2.84 [1.13-7.11],0.0260465589357399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAM,Signal transducing adapter molecule 1,2117,60,1.78 [1.03-3.08],0.0401024449239673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAMBP,STAM-binding protein,2433,83,0.79 [0.57-1.10],0.1622822094416941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT2,Signal transducer and activator of transcription 2,2062,59,1.12 [0.81-1.54],0.4833119179304659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAT5B,Signal transducer and activator of transcription 5B,2439,83,0.91 [0.79-1.05],0.1801916168758437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,2044,59,1.07 [0.75-1.53],0.7043885392170193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC1,Stanniocalcin-1,2476,84,2.57 [1.85-3.57],1.8341044433359562e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STC2,Stanniocalcin-2,2462,83,9.39 [4.31-20.44],1.6677086619844125e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STEAP4,Metalloreductase STEAP4,2061,56,1.21 [0.89-1.65],0.2315643319890723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STIP1,Stress-induced-phosphoprotein 1,2463,84,0.71 [0.51-0.97],0.0335833038547246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK11,Serine/threonine-protein kinase STK11,2415,83,0.85 [0.64-1.12],0.2536715182381897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK24,Serine/threonine-protein kinase 24,2393,81,0.82 [0.59-1.14],0.2352504183455288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STK4,Serine/threonine-protein kinase 4,2457,82,0.81 [0.64-1.02],0.0673171249226883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STOML2,"Stomatin-like protein 2, mitochondrial",2044,59,0.96 [0.73-1.26],0.7718060775452709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX16,Syntaxin-16,2383,81,1.21 [0.85-1.72],0.2824160370791229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX1B,Syntaxin-1B,2076,58,1.67 [1.09-2.55],0.0190807568274798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX3,Syntaxin-3,2116,60,0.78 [0.36-1.66],0.5124467059559144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX4,Syntaxin-4,2439,83,1.44 [1.13-1.85],0.0036780087058702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX5,Syntaxin-5,2062,59,0.78 [0.39-1.59],0.5005056614274642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX6,Syntaxin-6,2383,81,1.03 [0.75-1.41],0.8717737499086023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX7,Syntaxin-7,2062,59,1.56 [0.92-2.63],0.0954332757535976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STX8,Syntaxin-8,2461,84,1.46 [1.00-2.13],0.0504240943388361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP1,Syntaxin-binding protein 1,2118,60,0.87 [0.63-1.19],0.3814026693192008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",STXBP3,Syntaxin-binding protein 3,2383,81,0.96 [0.60-1.55],0.8815280923991196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGP1,SURP and G-patch domain-containing protein 1,2124,60,1.10 [0.61-2.00],0.7427564833921183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUGT1,Protein SGT1 homolog,2383,81,0.83 [0.65-1.07],0.1528300512497991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT1A1,Sulfotransferase 1A1,2476,84,0.93 [0.80-1.08],0.3312630220399759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SULT2A1,Bile salt sulfotransferase,2461,84,1.29 [1.02-1.64],0.0323290408345668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF1,Formylglycine-generating enzyme,2062,59,0.90 [0.58-1.39],0.6334500425009624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,2476,84,1.17 [0.79-1.74],0.4219355800838933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUOX,"Sulfite oxidase, mitochondrial",2118,60,1.32 [0.95-1.83],0.0948824254272989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD1,Sushi domain-containing protein 1,2415,83,0.78 [0.53-1.16],0.2206962203516169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD2,Sushi domain-containing protein 2,2467,84,1.92 [1.01-3.62],0.0449688034384765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD4,Sushi domain-containing protein 4,2117,60,1.90 [1.46-2.47],1.904209260329075e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SUSD5,Sushi domain-containing protein 5,2077,55,10.93 [5.76-20.76],2.7197517696526977e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SV2A,Synaptic vesicle glycoprotein 2A,2076,58,1.14 [0.78-1.67],0.4978942066333786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SWAP70,Switch-associated protein 70,2124,60,1.96 [1.21-3.17],0.0061751203468618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYAP1,Synapse-associated protein 1,2085,56,0.70 [0.44-1.14],0.1527330077216875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,2061,56,0.74 [0.43-1.26],0.2640356567081347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYT1,Synaptotagmin-1,2116,60,2.42 [1.78-3.29],1.796729005701614e-08
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",SYTL4,Synaptotagmin-like protein 4,2122,60,0.79 [0.55-1.14],0.212455850760005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,2091,58,0.96 [0.75-1.22],0.7233787517531309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACC3,Transforming acidic coiled-coil-containing protein 3,2439,83,0.99 [0.83-1.16],0.8621740729913867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TACSTD2,Tumor-associated calcium signal transducer 2,2165,77,5.79 [3.37-9.92],1.7421501295527404e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TADA3,Transcriptional adapter 3,2117,60,0.91 [0.49-1.72],0.7822560460885726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAFA5,Chemokine-like protein TAFA-5,2439,83,6.86 [5.04-9.34],1.5839501287314535e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAGLN3,Transgelin-3,2044,59,1.47 [1.02-2.10],0.038284173977601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TALDO1,Transaldolase,2125,58,1.02 [0.57-1.83],0.9481830301261136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TANK,TRAF family member-associated NF-kappa-B activator,2404,82,0.84 [0.62-1.12],0.2336416826894791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAP1,Antigen peptide transporter 1,2091,58,1.31 [1.03-1.68],0.0297198967867923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARBP2,RISC-loading complex subunit TARBP2,2393,81,1.02 [0.79-1.32],0.8906705727893782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",2076,58,1.13 [0.81-1.58],0.4573559633005609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",2117,60,0.68 [0.33-1.38],0.2804855553351694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TAX1BP1,Tax1-binding protein 1,2116,60,1.45 [1.01-2.10],0.045595775364928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D17,TBC1 domain family member 17,2393,81,0.60 [0.36-0.98],0.0419614920477529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D23,TBC1 domain family member 23,2439,83,0.99 [0.80-1.24],0.9548854069597066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBC1D5,TBC1 domain family member 5,2461,84,1.08 [0.85-1.37],0.505306322241608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCA,Tubulin-specific chaperone A,2085,56,0.82 [0.60-1.14],0.2422260123353585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCB,Tubulin-folding cofactor B,2437,83,0.89 [0.73-1.08],0.2329406170751088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBCC,Tubulin-specific chaperone C,2437,83,0.86 [0.67-1.10],0.2405066969441921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBL1X,F-box-like/WD repeat-containing protein TBL1X,2383,81,0.95 [0.75-1.21],0.686933140658549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TBR1,T-box brain protein 1,2076,58,0.70 [0.37-1.33],0.2757689050693728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1A,T-cell leukemia/lymphoma protein 1A,2437,83,0.73 [0.61-0.88],0.0007924471366436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCL1B,T-cell leukemia/lymphoma protein 1B,2415,83,0.90 [0.68-1.19],0.4744809766653091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN1,Transcobalamin-1,2077,59,0.83 [0.41-1.69],0.6086166301034763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCN2,Transcobalamin-2,2485,84,5.95 [4.10-8.64],6.613634010556575e-21
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCOF1,Treacle protein,2122,60,2.20 [1.32-3.69],0.0026902584230383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCP11,T-complex protein 11 homolog,2091,58,0.80 [0.46-1.38],0.4228113201929735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TCTN3,Tectonic-3,2122,60,1.01 [0.47-2.20],0.9751414825224972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDGF1,Teratocarcinoma-derived growth factor 1,2393,81,1.12 [0.99-1.27],0.0710072911112597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDO2,"Tryptophan 2,3-dioxygenase",2076,58,0.97 [0.51-1.83],0.922186044020877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDP1,Tyrosyl-DNA phosphodiesterase 1,2117,60,1.12 [0.83-1.51],0.4520219861745281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TDRKH,Tudor and KH domain-containing protein,2393,81,1.01 [0.80-1.29],0.9137770707725696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEF,Thyrotroph embryonic factor,2060,56,1.17 [0.70-1.95],0.5460240554580578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEK,Angiopoietin-1 receptor,2456,83,1.87 [0.83-4.17],0.1289619016312362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TERF1,Telomeric repeat-binding factor 1,2062,59,1.42 [0.63-3.16],0.3951420161684638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TET2,Methylcytosine dioxygenase TET2,2086,58,0.87 [0.64-1.18],0.3765557787775512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX101,Testis-expressed protein 101,2076,58,1.93 [1.33-2.79],0.0004870914358993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TEX33,Testis-expressed protein 33,2091,58,0.87 [0.43-1.78],0.7045178147612503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TF,Serotransferrin,2126,59,0.35 [0.13-0.93],0.0349868330459135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFAP2A,Transcription factor AP-2-alpha,2061,56,0.70 [0.42-1.17],0.1718514305690276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF1,Trefoil factor 1,2455,84,2.27 [1.96-2.62],1.5498030127922452e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF2,Trefoil factor 2,2471,83,2.96 [2.43-3.61],1.0998399213562195e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFF3,Trefoil factor 3,2444,82,2.83 [2.36-3.39],2.623616761256594e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI,Tissue factor pathway inhibitor,2455,83,1.26 [0.80-1.99],0.3192557529799813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFPI2,Tissue factor pathway inhibitor 2,2453,83,1.89 [1.47-2.42],5.516685811590333e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TFRC,Transferrin receptor protein 1,2463,83,1.86 [1.19-2.92],0.0065553803042119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TG,Thyroglobulin,2117,60,1.38 [1.14-1.68],0.0009651058154114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFA,Protransforming growth factor alpha,2461,84,2.68 [1.97-3.64],2.935145179129651e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB1,Transforming growth factor beta-1 proprotein,2484,84,2.14 [1.49-3.07],4.206274400160279e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFB2,Transforming growth factor beta-2 proprotein,2117,60,1.38 [0.87-2.21],0.173385170594308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBI,Transforming growth factor-beta-induced protein ig-h3,2445,83,0.80 [0.41-1.57],0.5122138358853343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR1,TGF-beta receptor type-1,2062,59,4.86 [2.48-9.52],4.191330745911187e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR2,TGF-beta receptor type-2,2456,83,6.34 [4.93-8.16],6.843493852897152e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGFBR3,Transforming growth factor beta receptor type 3,2490,84,7.86 [5.28-11.68],2.2938149006571112e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGM2,Protein-glutamine gamma-glutamyltransferase 2,2451,82,0.79 [0.61-1.01],0.062591568651446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TGOLN2,Trans-Golgi network integral membrane protein 2,2130,61,20.35 [11.34-36.50],5.2645920549028984e-24
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THAP12,52 kDa repressor of the inhibitor of the protein kinase,2041,59,0.74 [0.51-1.07],0.1125220548326826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBD,Thrombomodulin,2457,82,7.39 [5.23-10.46],1.263761714022112e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS2,Thrombospondin-2,2467,84,1.95 [1.39-2.74],0.0001021769360811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THBS4,Thrombospondin-4,2460,83,1.68 [1.14-2.48],0.0082885488468706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THOP1,Thimet oligopeptidase,2449,81,0.42 [0.25-0.70],0.0008210025690603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THPO,Thrombopoietin,2415,83,1.29 [0.81-2.06],0.2797210706219232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THRAP3,Thyroid hormone receptor-associated protein 3,2060,56,1.07 [0.85-1.34],0.5874551615786812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THSD1,Thrombospondin type-1 domain-containing protein 1,2049,58,0.96 [0.46-2.02],0.9243602843730526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THTPA,Thiamine-triphosphatase,2113,60,0.90 [0.67-1.20],0.4654571193682559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",THY1,Thy-1 membrane glycoprotein,2476,84,11.25 [7.40-17.10],9.299639203353069e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIA1,Nucleolysin TIA-1 isoform p40,2389,81,0.90 [0.76-1.06],0.1977371939835469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIE1,Tyrosine-protein kinase receptor Tie-1,2490,84,1.47 [0.86-2.51],0.1601621356647404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",2389,81,1.28 [0.85-1.93],0.2279230041364164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,2091,58,1.53 [1.22-1.91],0.0001911475204738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,2464,83,1.65 [1.09-2.50],0.0178492034886125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,2122,60,0.96 [0.51-1.81],0.8964528330229111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,2116,60,0.76 [0.56-1.02],0.0711134435047611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP1,Metalloproteinase inhibitor 1,2425,82,6.88 [4.87-9.73],7.522644091638608e-28
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP2,Metalloproteinase inhibitor 2,2122,60,2.19 [1.57-3.06],4.1941310399491214e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP3,Metalloproteinase inhibitor 3,2472,83,1.02 [0.88-1.18],0.8244527881361314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TIMP4,Metalloproteinase inhibitor 4,2467,84,2.80 [1.85-4.24],1.241943957723283e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TINAGL1,Tubulointerstitial nephritis antigen-like,2453,82,18.27 [8.69-38.43],1.853827288516108e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJAP1,Tight junction-associated protein 1,2456,83,0.94 [0.75-1.19],0.6261465362808208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TJP3,Tight junction protein ZO-3,2061,56,1.22 [0.73-2.04],0.4395701955803911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TK1,"Thymidine kinase, cytosolic",2091,58,1.30 [0.82-2.05],0.2585305570340114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR1,Toll-like receptor 1,2062,59,2.62 [1.16-5.89],0.0202883054026503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR2,Toll-like receptor 2,2091,58,2.55 [0.85-7.66],0.0949440310376363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR3,Toll-like receptor 3,2490,84,1.38 [1.00-1.91],0.0471214975768483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TLR4,Toll-like receptor 4,2062,59,1.04 [0.43-2.52],0.9246685703308752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,2076,58,0.93 [0.57-1.50],0.7536392725269955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED1,Transmembrane emp24 domain-containing protein 1,2091,58,1.24 [0.80-1.91],0.3431250415623604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED10,Transmembrane emp24 domain-containing protein 10,2060,56,0.65 [0.27-1.55],0.3279309797440133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED4,Transmembrane emp24 domain-containing protein 4,2060,56,0.91 [0.55-1.52],0.7207119170150422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMED8,Protein TMED8,2124,60,0.88 [0.69-1.11],0.2843733678525439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM106A,Transmembrane protein 106A,2117,60,0.84 [0.58-1.21],0.3392655213135599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM132A,Transmembrane protein 132A,2059,54,0.89 [0.59-1.35],0.5792335046150934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMEM25,Transmembrane protein 25,2118,60,1.33 [0.80-2.24],0.2752737413205828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMOD4,Tropomodulin-4,2044,59,2.57 [1.47-4.47],0.0008754048689913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11B,Transmembrane protease serine 11B,2061,56,1.16 [0.85-1.59],0.3444955642780375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS11D,Transmembrane protease serine 11D,2109,60,3.53 [2.51-4.97],3.6803902417119073e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS15,Enteropeptidase,2439,83,1.38 [1.12-1.71],0.0030217011114796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMPRSS5,Transmembrane protease serine 5,2428,83,1.41 [0.85-2.35],0.1877427211799245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TMSB10,Thymosin beta-10,2467,84,1.57 [1.22-2.02],0.0004785349206506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNC,Tenascin,2464,83,1.83 [1.26-2.66],0.0014584064972642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNF,Tumor necrosis factor,2413,83,4.46 [0.00-4377084209291.47],0.9154220417348464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,2124,60,1.33 [0.92-1.94],0.1308889652576144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,2404,82,0.87 [0.51-1.49],0.6132655613714574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,2085,56,0.67 [0.43-1.05],0.0813686523886792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,2437,83,3.68 [2.93-4.61],1.3904470087163924e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,2437,83,1.79 [1.58-2.02],2.5395971824173783e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,2470,84,1.92 [1.28-2.89],0.0016787719516727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,2490,84,6.63 [5.06-8.68],9.632248761550733e-43
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,2462,83,5.58 [3.27-9.51],2.5971745570839985e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,2456,83,8.96 [6.28-12.80],1.56417948332819e-33
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,2467,83,3.67 [2.89-4.66],1.8157537295417478e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,2404,82,2.68 [1.94-3.70],1.9850949980623064e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,2467,83,8.53 [6.16-11.81],3.433170722727125e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,2085,56,5.34 [3.05-9.36],4.8731730335230765e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,2475,84,5.73 [4.40-7.46],1.8647368952131154e-38
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,2467,84,16.10 [11.30-22.93],2.2579525804134916e-53
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,2467,84,2.21 [1.91-2.56],4.079866338504097e-26
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,2476,84,16.43 [10.49-25.74],2.5317637591141607e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,2484,84,7.13 [5.24-9.71],7.972267872555446e-36
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,2437,83,2.35 [1.89-2.92],1.6091542247359663e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,2476,84,3.07 [2.28-4.14],1.452637553382957e-13
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,2437,83,3.37 [2.77-4.10],8.69965477380266e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF10,Tumor necrosis factor ligand superfamily member 10,2490,84,1.41 [0.68-2.92],0.3598665542076075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF11,Tumor necrosis factor ligand superfamily member 11,2461,84,0.95 [0.69-1.31],0.7642067279702159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF12,Tumor necrosis factor ligand superfamily member 12,2490,84,0.54 [0.27-1.08],0.0824847592112306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13,Tumor necrosis factor ligand superfamily member 13,2472,83,10.39 [5.99-18.03],8.853481303286954e-17
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,2489,84,2.78 [1.64-4.73],0.0001516421082672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF14,Tumor necrosis factor ligand superfamily member 14,2437,83,1.06 [0.75-1.50],0.7314334791845544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNFSF8,Tumor necrosis factor ligand superfamily member 8,2130,58,1.85 [1.01-3.38],0.0463621844199436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNIP1,TNFAIP3-interacting protein 1,2116,60,0.91 [0.68-1.22],0.5363589612818882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNN,Tenascin-N,2130,58,2.04 [1.15-3.61],0.0143520807681197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNNI3,"Troponin I, cardiac muscle",2415,83,1.32 [1.05-1.66],0.0177877411775952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNPO1,Transportin-1,2091,58,1.32 [0.66-2.67],0.4361277385381534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNR,Tenascin-R,2437,83,2.07 [1.33-3.21],0.0012257547333149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TNXB,Tenascin-X,2467,84,0.73 [0.36-1.47],0.3826168935284924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,2122,60,0.96 [0.69-1.34],0.8096960199151013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1,DNA topoisomerase 1,2124,60,1.26 [1.03-1.55],0.0247706527111167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP1MT,"DNA topoisomerase I, mitochondrial",2044,59,0.67 [0.36-1.24],0.1996976686898609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOP2B,DNA topoisomerase 2-beta,2062,59,1.06 [0.78-1.44],0.7165226785841226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TOR1AIP1,Torsin-1A-interacting protein 1,2059,54,0.98 [0.60-1.61],0.938505359611866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53,Cellular tumor antigen p53,2383,81,1.02 [0.65-1.58],0.9411446100762207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53BP1,TP53-binding protein 1,2062,59,1.27 [0.96-1.69],0.0928005129612677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53I3,Quinone oxidoreductase PIG3,2035,53,0.63 [0.37-1.06],0.0836168022758656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP53INP1,Tumor protein p53-inducible nuclear protein 1,2415,83,1.13 [0.62-2.04],0.6878935545639095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TP73,Tumor protein p73,2076,58,1.04 [0.48-2.27],0.9126616994098598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPBGL,Trophoblast glycoprotein-like,2076,58,0.88 [0.45-1.74],0.7120047431489431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPD52L2,Tumor protein D54,2085,56,0.86 [0.68-1.09],0.2245896550048833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPK1,Thiamin pyrophosphokinase 1,2122,60,2.70 [1.17-6.23],0.0203062852175712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPM3,Tropomyosin alpha-3 chain,2060,56,1.37 [0.81-2.30],0.2423502903077025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPMT,Thiopurine S-methyltransferase,2383,81,0.53 [0.40-0.70],1.1223540766445565e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPP1,Tripeptidyl-peptidase 1,2444,83,1.76 [1.26-2.47],0.0009290300629392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP2,Tubulin polymerization-promoting protein family member 2,2091,58,1.31 [0.98-1.75],0.0731823414634244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPPP3,Tubulin polymerization-promoting protein family member 3,2393,81,1.33 [0.78-2.27],0.290013228347859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPR,Nucleoprotein TPR,2060,56,1.29 [0.90-1.86],0.1706162560102872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPRKB,EKC/KEOPS complex subunit TPRKB,2044,59,1.21 [0.89-1.66],0.2285276543068924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSAB1,Tryptase alpha/beta-1,2486,84,2.06 [1.38-3.07],0.0003858432514455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSD1,Tryptase delta,2118,60,2.84 [1.90-4.25],3.300491576748921e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPSG1,Tryptase gamma,2062,59,0.96 [0.37-2.45],0.9248149260942318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TPT1,Translationally-controlled tumor protein,2404,82,1.12 [0.85-1.47],0.4217727519238619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF2,TNF receptor-associated factor 2,2461,84,1.05 [0.79-1.39],0.7257917489708592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3,"TNF receptor-associated factor 3, Isoform 2",2062,59,0.89 [0.45-1.73],0.7209403781456067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,2060,56,0.84 [0.47-1.49],0.5440847906368647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,2091,58,0.80 [0.58-1.11],0.187681502862607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREH,Trehalase,2130,58,0.90 [0.65-1.25],0.541031096566997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREM2,Triggering receptor expressed on myeloid cells 2,2462,83,1.97 [1.45-2.67],1.4178833147995317e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML1,Trem-like transcript 1 protein,2130,61,0.92 [0.57-1.49],0.7467566840608951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TREML2,Trem-like transcript 2 protein,2467,84,4.06 [2.67-6.16],4.5761008234499615e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIAP1,TP53-regulated inhibitor of apoptosis 1,2475,84,1.66 [1.22-2.26],0.0011699759200103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM21,E3 ubiquitin-protein ligase TRIM21,2461,84,0.83 [0.63-1.09],0.1773339842397068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM24,Transcription intermediary factor 1-alpha,2088,58,1.08 [0.74-1.58],0.6899620584618839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,2124,60,1.00 [0.79-1.26],0.9822350865983598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM26,Tripartite motif-containing protein 26,2044,59,1.02 [0.67-1.56],0.931993936974318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM40,E3 ubiquitin ligase TRIM40,2076,58,0.96 [0.69-1.34],0.8251484790986923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM5,Tripartite motif-containing protein 5,2461,84,0.91 [0.73-1.14],0.4100110018204516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRIM58,E3 ubiquitin-protein ligase TRIM58,2117,60,0.89 [0.67-1.17],0.3988568720406006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TRPV3,Transient receptor potential cation channel subfamily V member 3,2060,56,1.17 [0.76-1.81],0.4768082286322475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC1,Hamartin,2062,59,1.10 [0.80-1.53],0.5541701736146485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSC22D1,TSC22 domain family protein 1,2118,60,0.84 [0.56-1.25],0.3831438316078988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSHB,Thyrotropin subunit beta,2457,82,0.73 [0.56-0.97],0.0282219163214152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSLP,Thymic stromal lymphopoietin,2415,83,0.95 [0.67-1.34],0.7693282220238417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSNAX,Translin-associated protein X,2060,56,0.46 [0.22-0.95],0.0349134512991693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN1,Tetraspanin-1,2415,83,0.86 [0.67-1.11],0.2594653154741523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN15,Tetraspanin-15,2060,56,1.29 [0.86-1.92],0.2142486930151479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN7,Tetraspanin-7,2061,56,0.80 [0.56-1.13],0.1958959398759573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPAN8,Tetraspanin-8,2124,60,1.11 [0.87-1.42],0.400662291341312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TSPYL1,Testis-specific Y-encoded-like protein 1,2062,59,1.08 [0.58-2.02],0.8169611048823743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TST,Thiosulfate sulfurtransferase,2391,81,1.04 [0.79-1.36],0.7941085406294816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTF2,Transcription termination factor 2,2076,58,0.84 [0.49-1.43],0.5225232488985925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTN,Titin,2060,56,1.29 [0.93-1.78],0.127140512974174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TTR,Transthyretin,2103,59,0.44 [0.18-1.11],0.0833513579537629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TUBB3,Tubulin beta-3 chain,2061,56,0.89 [0.33-2.38],0.8190799864730667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TWF2,Twinfilin-2,2130,58,0.87 [0.64-1.18],0.3594881234011334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXK,Tyrosine-protein kinase TXK,2091,58,1.01 [0.73-1.39],0.9718220703847866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXLNA,Alpha-taxilin,2437,83,0.95 [0.75-1.19],0.6333117616399278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXN,Thioredoxin,2093,59,0.73 [0.38-1.40],0.3426960457424933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC15,Thioredoxin domain-containing protein 15,2456,83,1.16 [0.58-2.31],0.6716488176327202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC5,Thioredoxin domain-containing protein 5,2476,84,1.73 [1.32-2.28],7.79834240964172e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNDC9,Thioredoxin domain-containing protein 9,2116,60,0.84 [0.51-1.38],0.4978464645278297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNL1,Thioredoxin-like protein 1,2059,56,0.96 [0.73-1.26],0.7661869051623542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",2467,84,0.83 [0.54-1.26],0.3788117632921827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYMP,Thymidine phosphorylase,2441,81,1.07 [0.78-1.45],0.6793122482114986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRO3,Tyrosine-protein kinase receptor TYRO3,2457,82,2.24 [1.14-4.40],0.0196927746971259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",2062,59,2.22 [1.47-3.36],0.0001591262161905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBAC1,Ubiquitin-associated domain-containing protein 1,2439,83,0.48 [0.27-0.85],0.0116272814903935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2B,Ubiquitin-conjugating enzyme E2 B,2117,60,0.95 [0.38-2.37],0.9107148917096488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,2122,60,1.32 [0.87-2.00],0.1871884826929988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,2062,59,1.14 [0.74-1.78],0.5493414020060498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBQLN3,Ubiquilin-3,2060,56,1.53 [1.21-1.93],0.0003017450169985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UBXN1,UBX domain-containing protein 1,2085,56,0.88 [0.59-1.29],0.503533938132591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,2124,60,0.90 [0.75-1.08],0.2600431084451288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UGDH,UDP-glucose 6-dehydrogenase,2060,56,0.98 [0.74-1.29],0.8682577229827869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UHRF2,E3 ubiquitin-protein ligase UHRF2,2060,56,0.55 [0.21-1.46],0.233895300713213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ULBP2,UL16-binding protein 2,2437,83,9.91 [6.85-14.35],5.225770370891139e-34
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UMOD,Uromodulin,2484,84,0.32 [0.25-0.42],3.3470793994893373e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC5D,Netrin receptor UNC5D,2062,59,3.10 [1.81-5.29],3.59759970487283e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNC79,Protein unc-79 homolog,2044,59,0.97 [0.62-1.54],0.9114125353272508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UNG,Uracil-DNA glycosylase,2117,60,1.11 [0.52-2.35],0.7860035629465374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPB1,Beta-ureidopropionase,2122,60,0.97 [0.76-1.24],0.8230524552894048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3A,Uroplakin-3a,2061,56,0.93 [0.55-1.57],0.7905471855861099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UPK3BL1,Uroplakin-3b-like protein 1,2087,57,1.23 [0.89-1.71],0.2083434474262252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROD,Uroporphyrinogen decarboxylase,2085,56,0.53 [0.35-0.79],0.0019946306574795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UROS,Uroporphyrinogen-III synthase,2076,58,0.62 [0.39-0.96],0.0338781669269566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USO1,General vesicular transport factor p115,2439,83,0.92 [0.74-1.15],0.4671566377033238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP25,Ubiquitin carboxyl-terminal hydrolase 25,2117,60,1.00 [0.70-1.42],0.978377032774852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP28,Ubiquitin carboxyl-terminal hydrolase 28,2116,60,2.80 [1.99-3.93],3.156496337380921e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP47,Ubiquitin carboxyl-terminal hydrolase 47,2060,56,1.00 [0.75-1.35],0.9734583705032188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",USP8,Ubiquitin carboxyl-terminal hydrolase 8,2415,83,0.87 [0.70-1.09],0.219013954289681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",UXS1,UDP-glucuronic acid decarboxylase 1,2383,81,0.92 [0.62-1.37],0.6918986672490814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP5,Vesicle-associated membrane protein 5,2415,83,1.28 [0.95-1.72],0.0986470701086597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAMP8,Vesicle-associated membrane protein 8,2062,59,0.93 [0.69-1.25],0.6319319825110747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASH1,Tubulinyl-Tyr carboxypeptidase 1,2461,84,0.86 [0.68-1.10],0.2332579878972066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASN,Vasorin,2420,81,7.84 [4.61-13.32],2.7825029144465958e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VASP,Vasodilator-stimulated phosphoprotein,2130,61,0.85 [0.60-1.19],0.3417987148835195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,2439,83,2.66 [1.10-6.45],0.0303409647695792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VAV3,Guanine nucleotide exchange factor VAV3,2061,56,0.98 [0.75-1.27],0.864758178599944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAM1,Vascular cell adhesion protein 1,2464,83,6.50 [3.86-10.94],1.928893290351568e-12
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCAN,Versican core protein,2476,84,3.35 [1.80-6.24],0.0001413085601804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VCPKMT,Protein-lysine methyltransferase METTL21D,2044,59,1.17 [0.91-1.50],0.2279048165805015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFA,Vascular endothelial growth factor A,2481,84,2.23 [1.66-2.99],1.174996950553538e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFB,Vascular endothelial growth factor B,2062,59,4.93 [2.34-10.39],2.6390367956629555e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFC,Vascular endothelial growth factor C,2456,83,1.02 [0.73-1.43],0.8921031025114987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VEGFD,Vascular endothelial growth factor D,2485,84,4.51 [3.05-6.66],4.33485661719928e-14
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VGF,Neurosecretory protein VGF,2118,60,6.54 [3.61-11.86],5.856891411626383e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIM,Vimentin,2415,83,0.93 [0.79-1.10],0.4133412239203393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIPR1,Vasoactive intestinal polypeptide receptor 1,2059,54,0.33 [0.09-1.22],0.0973647691042403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VIT,Vitrin,2122,60,3.87 [2.10-7.13],1.3926648320482925e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VMO1,Vitelline membrane outer layer protein 1 homolog,2439,83,3.54 [2.60-4.81],7.300075564069277e-16
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN1,Pantetheinase,2130,61,0.77 [0.57-1.04],0.0895036834759774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VNN2,Vascular non-inflammatory molecule 2,2439,83,1.57 [1.02-2.42],0.0400756531899112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS28,Vacuolar protein sorting-associated protein 28 homolog,2091,58,0.68 [0.45-1.04],0.0734390059083198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS37A,Vacuolar protein sorting-associated protein 37A,2439,83,0.98 [0.77-1.26],0.8947980661906842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS4B,Vacuolar protein sorting-associated protein 4B,2117,60,0.89 [0.68-1.16],0.3872105703246322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VPS53,Vacuolar protein sorting-associated protein 53 homolog,2439,83,0.98 [0.76-1.25],0.8637715791094873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10,V-set and immunoglobulin domain-containing protein 10,2117,60,1.09 [0.56-2.15],0.7951817023768815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,2060,56,2.20 [1.22-3.98],0.008609655373015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG2,V-set and immunoglobulin domain-containing protein 2,2117,60,2.72 [2.12-3.47],1.5871472173530873e-15
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIG4,V-set and immunoglobulin domain-containing protein 4,2462,83,9.25 [6.79-12.62],5.64712142661946e-45
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,2453,82,1.14 [0.84-1.54],0.3885899247941953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSNL1,Visinin-like protein 1,2116,60,1.82 [1.08-3.06],0.0246345693610681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM1,V-set and transmembrane domain-containing protein 1,2393,81,1.91 [1.34-2.72],0.0003371684045045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2B,V-set and transmembrane domain-containing protein 2B,2091,58,0.89 [0.45-1.76],0.7454657540353429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,2415,83,1.37 [1.03-1.83],0.03313786830803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,2476,84,0.82 [0.61-1.09],0.1660351171554923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTCN1,V-set domain-containing T-cell activation inhibitor 1,2383,81,1.78 [1.08-2.93],0.0227704097274217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,2085,56,1.04 [0.67-1.62],0.8572473578422939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA1,von Willebrand factor A domain-containing protein 1,2472,84,1.25 [0.79-2.00],0.3421677638716616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWA5A,von Willebrand factor A domain-containing protein 5A,2044,59,0.86 [0.59-1.25],0.4236095316288756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2,Brorin,2429,83,8.43 [5.91-12.02],4.716864720479245e-32
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWC2L,von Willebrand factor C domain-containing protein 2-like,2118,60,1.79 [1.27-2.54],0.0009158181457589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",VWF,von Willebrand factor,2490,84,1.34 [1.04-1.73],0.0257960465924865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WARS,"Tryptophan--tRNA ligase, cytoplasmic",2467,84,1.88 [1.15-3.07],0.0114227351665833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WAS,Wiskott-Aldrich syndrome protein,2404,82,1.00 [0.74-1.35],0.9929458838820092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF1,Wiskott-Aldrich syndrome protein family member 1,2415,83,0.92 [0.74-1.14],0.4471362685912786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASF3,Wiskott-Aldrich syndrome protein family member 3,2393,81,1.09 [0.86-1.38],0.4677337729375456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASHC3,WASH complex subunit 3,2116,60,1.22 [0.89-1.67],0.208924290631725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WASL,Neural Wiskott-Aldrich syndrome protein,2062,59,0.96 [0.61-1.50],0.8439896185308511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WDR46,WD repeat-containing protein 46,2117,60,1.04 [0.52-2.09],0.9022669171360852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC1,WAP four-disulfide core domain protein 1,2080,59,1.57 [1.19-2.09],0.0016621875203357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC12,WAP four-disulfide core domain protein 12,2471,84,2.02 [1.56-2.63],1.08878174756508e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFDC2,WAP four-disulfide core domain protein 2,2335,77,6.19 [4.83-7.93],2.740263447515464e-47
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",2430,83,0.90 [0.57-1.40],0.62579894054607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",2467,83,5.00 [2.89-8.63],7.827940015704321e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WIF1,Wnt inhibitory factor 1,2475,84,1.30 [0.75-2.26],0.3472972687193426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WNT9A,Protein Wnt-9a,2404,82,5.08 [3.61-7.16],1.406195498872774e-20
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,2437,83,0.89 [0.61-1.30],0.5443775500061798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XCL1,Lymphotactin,2475,84,1.63 [1.27-2.08],9.227806680391814e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XG,Glycoprotein Xg,2476,84,6.80 [4.87-9.51],3.010972819596839e-29
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XIAP,E3 ubiquitin-protein ligase XIAP,2062,59,1.37 [0.91-2.07],0.1296694315968857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XPNPEP2,Xaa-Pro aminopeptidase 2,2456,83,0.78 [0.66-0.91],0.0021849490312311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",XRCC4,DNA repair protein XRCC4,2393,81,0.84 [0.48-1.47],0.5465202629449589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YAP1,Transcriptional coactivator YAP1,2116,60,18.00 [10.92-29.65],7.814726830417563e-30
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",2124,60,0.92 [0.77-1.09],0.3134227394902035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YES1,Tyrosine-protein kinase Yes,2439,83,1.07 [0.90-1.26],0.4482684627164311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YJU2,Splicing factor YJU2,2117,60,0.82 [0.36-1.84],0.6268067167114127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YOD1,Ubiquitin thioesterase OTU1,2060,56,0.62 [0.42-0.94],0.023007556646327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YTHDF3,YTH domain-containing family protein 3,2404,82,0.86 [0.68-1.08],0.1995982297716419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YWHAQ,14-3-3 protein theta,2085,56,0.84 [0.59-1.21],0.3508068221768012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",YY1,Transcriptional repressor protein YY1,2062,59,0.92 [0.37-2.31],0.864636547329862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBP1,Z-DNA-binding protein 1,2062,59,1.52 [0.93-2.49],0.0932547589318461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB16,Zinc finger and BTB domain-containing protein 16,2383,81,0.95 [0.72-1.26],0.742163492983535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZBTB17,Zinc finger and BTB domain-containing protein 17,2415,83,1.88 [1.42-2.49],1.0416125030924008e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZCCHC8,Zinc finger CCHC domain-containing protein 8,2060,56,1.05 [0.71-1.55],0.8202800647781858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZFYVE19,Abscission/NoCut checkpoint regulator,2124,60,0.89 [0.67-1.18],0.414914629209952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZHX2,Zinc fingers and homeoboxes protein 2,2116,60,1.64 [1.06-2.54],0.0257463862863522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF174,Zinc finger protein 174,2062,59,1.20 [0.65-2.23],0.5645381516033077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF75D,Zinc finger protein 75D,2091,58,1.09 [0.73-1.61],0.6787620679629236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNF830,Zinc finger protein 830,2117,60,1.19 [0.88-1.61],0.2584846288751961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRD2,Protein ZNRD2,2124,60,1.16 [0.83-1.62],0.3754544988391597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,2117,60,1.02 [0.64-1.63],0.9333274111621488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP3,Zona pellucida sperm-binding protein 3,2059,54,0.97 [0.88-1.07],0.525834984588819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZP4,Zona pellucida sperm-binding protein 4,2044,59,0.73 [0.29-1.84],0.4985595500343577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",ZPR1,Zinc finger protein ZPR1,2061,56,0.58 [0.37-0.89],0.0140703009857964
